EWMA2022 Programme

THE JOINT EWMA
& JOURNÉES
CICATRISATIONS
CONFERENCE
2022
23 - 25 MAY
PARIS
PALAIS DES CONGRÈS
ORGANISATION OF CARE, PATHWAYS

AND COORDINATION AROUND
COMPLEX WOUND HEALING
ENGLISH
PROGRAMME
EWMA-CICA2022.ORG
EWMA-CICA 2022 web-app kindly sponsored by
VIEW THE CONFERENCE WEB-APP

ABSTRACTS
NS
PR
LA
OG
FLOOR P
RAMME
N
EA
SP
I
O
KE I T
RS HI B
EX
GO DIRECTLY TO THE WEB-APP

BY SCANNING THE QR CODE:
EWMA-CICA 2022 web-app kindly sponsored by

INDEX
Welcome
Organisation 5
About EWMA 7
DEAR PARTICIPANT, About SFFPC 7
General information 8
On behalf of the EWMA and the SFFPC, it is our great
pleasure to welcome you to Paris for the joint EWMA & Venue map 11
Journées Cicatrisations Conference, EWMA-CICA 2022. We Programme overview 14
are delighted that we are able to meet in person in Paris.
Detailed programme
During three exciting conference days, you will experience Monday 23rd May 23
a diverse bilingual programme that includes keynote Tuesday 24th May 28
sessions, free paper sessions, workshops, full-day Wednesday 25th May 35
streams, guest sessions and sponsored satellite symposia.
EWMA education activities 42
Theme of the EWMA-CICA 2022 Conference is: E-poster sessions and

Organisation of care, pathways and coordination paper poster walks 43
around complex wound healing E-posters and paper posters
by category 44
All health care systems need to handle a great number of
EWMA Cooperating
complex wounds, including the primary types of non-
Organisations 58
healing ulcers as well as the rarer types.
Industry sponsored
As we are still struggling to establish clear pathways for satellite symposia 64
the primary types of ulcers in many countries around the
world, some wounds also require special attention to Sponsor and exhibitor list 78
ensure that patients get access to the specialist evaluation Exhibition floor plan 90
they require. Given the variations in health care structures
and engagement of health care professionals in different
countries, this is a complex task which is central to the
provision of high-quality care for our patients.
During these three conference days, we will dedicate a

special focus to the questions and solutions related to
pathways, organisation, and coordination supporting the
healing of complex wounds.
We wish all conference participants a very pleasant and

interesting time in Paris.
Sebastian Probst, Luc Téot,

EWMA President SFFPC President &
EWMA Scientific Recorder
3
Management
EWMA
of the Diabetic Foot
Pisa International Diabetic Foot Course
SOCIAL
13th Course · 5-8 October 2022 · Pisa · Italy
MEDIA
5-8
October
Get the latest updates about
the #EWMA-CICA 2022 Conference
and keep updated on what’s happening
2022 at EWMA:
Join @ewmawound
Save the date for the Pisa International
Diabetic Foot Course 2022
Share your experiences and thoughts

with other attendees and your network by
Theory & Practice Programme includes using the conference hashtag
4-day theoretical · Neuropathy
course and practical · Charcot #EWMA-CICA 2022
training · Infection
· Ischaemia
Date & Place · Surgery
5-8 October 2022 Including a live transmis-
Hotel San Ranieri sion from the operating
room of the Diabetic Foot
& Pisa University Clinic
Hospital · Hands-on workshops
Pisa · Italy
Members of EWMA receive a 10 % discount for the course.
www.diabeticfootcourses.org
The course is endorsed by EWMA

INFORMATION
EUROPEAN WOUND MANAGEMENT ASSOCIATION LA SOCIÉTÉ FRANÇAISE ET FRANCOPHONE DE PLAIES
ET CICATRISATION (SFFPC)
EWMA EXECUTIVE COMMITTEE
Sebastian Probst, President EXECUTIVE COMMITTEE
PROGRAMME
Alberto Piaggesi, Immediate Past President Dr Luc Téot, President
OVERVIEW
Alexandra Marques, Honorary Secretary Dr Sylvie Meaume, Vice-President
Kirsi Isoherranen, Treasurer Mme Anne Philippe, Vice-President
Luc Téot, Scientific Recorder Pr Franck Duteille, Secretary
Mr Pascal Vasseur, Treasurer
COUNCIL MEMBERS
Dimitri Beeckman COUNCIL MEMBERS
Mark Collier Dr René Dondelinger, Gériatre – Luxembourg
Magdalena Annersten Gershater Pr Franck Duteille, Centre des Brûlés – Nantes
Beata Gress Halasz Dr Nathalie Faucher, Hôpital Bichat, APHP - Paris
Pedro Luis Pancorbo Hidalgo Mme Isabelle Fromantin, IDE PhD, - Institut Curie Paris
Samantha Holloway Dr Marguerite Masanovic, Médecine Physique - Réadaptation - La Reunion
PROGRAMME
Elena Conde Montero Dr Sylvie Meaume, Gériatre - Dermatologue - Hôpital Rotschild AP-HP
DETAILED
Andrea Pokorna Mme Françoise Mekki, Cadre Infirmier, Ploemeur
Kerstin Protz Dr Sonia Gaucher, Chirurgien plasticien - Hôpital Cochin AP-HP
Paulo Ramos Dr Luc Téot, Chirurgien, Unité Plaies et Cicatrisation - CHU Montpellier
Tanja Planinsek Rucigaj Mr Pascal Vasseur, IDE libéral - Marseille
José Verdu Soriano Dr Hubert Vuagnat, Gériatrie - Hôpitaux Universitaires - Geneve
Evelien Touriany Dr Emmanuelle Candas, Gériatrie - Hôpital Sainte Perrine AP-HP
Hubert Vuagnat Mme Anne Philippe, Infirmière consultante, Hôpital Saint Antoine AP-HP
Ruth Bryant
Hayley Ryan ORGANISING COMMITTEE OF THE JOURNÉES CICATRISATIONS
Dr Luc Téot, Chirurgien, Montpellier, SFFPC President
SCIENTIFIC COMMITTEE Dr Sylvie Meaume, Gériatre, dermatologue, Paris, Vice-president of SFFPC
Luc Téot, EWMA, Scientific Recorder Mme. Anne Philippe, IDE, Paris, Vice-president of SFFPC
SESSIONS
Rossi Alessandra, AISLeC Dr Nathalie Faucher, Gériatre, Paris
Paggi Battistino, AISLeC Dr Emmanuelle Candas, Gériatre, Paris
Dimitri Beeckman, EWMA Dr Margot Masanovic, MRP, Montpellier
Valentina Dini, AIUC M. Pascal Vasseur, IDE, Marseille
Chiara Goretti, AISLeC Mme. Marisa Villebrun, Juriste, Montpellier
Kirsi Isoherranen, EWMA
Alexandra Marques, EWMA SCIENTIFIC COMMITTEE OF THE JOURNÉES CICATRISATIONS
Sylvie Meaume, SFFPC Marjorie Landes, IDE, Montpellier
Alberto Piaggesi, EWMA Emmanuelle Candas, Gériatre, Paris
Sebastian Probst, EWMA Olivier Chapuis, Chirurgien, Paris
Elia Ricci, AIUC Alexis Desmoulière, Professeur de physiologie, Limoges
Anne Dompmartin, Dermatologue, Caen
POSTERS
Franck Duteille, Chirurgien, Nantes
Nathalie Faucher, Gériatre, Paris
Christine Faure, Pharmacienne, Montpellier
Nicolas Frasson, MPR, St Clément de Rivière
Isabelle Fromantin, IDE, Paris
Sonia Gaucher, Chirurgien, Paris
Chloé Géri, Médecin, Montpellier
Georges Ha Van, Podologue, Paris
Christine Jurus, Médecin vasculaire, Lyon
Véronique Labbe Gentils, Pédicure podologue, Paris
Anne Le Touze, Chirurgien, Tours
Hugues Lefort, Médecin urgentiste, Metz
SATELLITE
SYMPOSIA
Philippe Léger, Médecin vasculaire, Toulouse

Hervé Maillard, Dermatologue, Le Mans
Marguerite Masanovic, MPR, Montpellier
Sylvie Meaume, Gériatre, dermatologue, Paris
Cécile Moisan, Chirurgien, Saint-Brieuc
EWMA Secretariat Sylvie Palmier, IDE, Montpellier
Nordre Fasanvej 113 Francis Pesteil, Chirurgien, Limoges
2000 Frederiksberg Anne Philippe, IDE, Paris
Ariane Sultan, Diabétologue, Montpellier
Denmark Luc Téot, Chirurgien, Montpellier
+45 7020 0305 Maud Vanderbrugghe, Cadre IDE, Paris
ewma@ewma.org Pascal Vasseur, IDE, Marseille
SPONSORS &
EXHIBITORS
ewma.org
5
WOUND COURSES
ENDORSED BY EWMA
Institutions and companies with courses, online education and seminars endorsed by EWMA
As part of EWMA’s aim to identify high standard education programmes for healthcare professionals,
we offer the possibility to have courses and seminars reviewed and endorsed by EWMA.
For more information, go to www.ewma.org or contact the EWMA Secretariat (ewma@ewma.org).
6
About EWMA About SFFPC
The European Wound Management Association The French and Francophone Society of Wounds and
(EWMA) was founded in 1991. The association Wound Healing (Société Française et Francophone
works to promote the advancement of education de Plaies et Cicatrisation (SFFPC)) was founded in
and research into native epidemiology, pathology, 1996. Since its creation, the multidisciplinary spirit
diagnosis, prevention and management of wounds of has not been lost; on the contrary, it has evolved in a
all aetiologies. constant respect for the partnership that is essential
in the management of wounds. Wounds are a daily
EWMA is an umbrella organisation linking wound occurrence, and everyone has their own habits
management associations across Europe and a (sometimes secret), their own recipes, their own
multidisciplinary group bringing together individuals certainties. It is often difficult to change mentalities
and organisations interested in wound management. on the subject or to make people understand the
principles of healing.
EWMA works to reach its objectives by being an
educational resource, holding conferences, supporting/ The only certainty is the needs. 2.5 million wounds
carrying out international projects related to wound in France, 65% of which will heal if we can propose
management, actively supporting the implementation solutions validated by the HAS. 35% are complex,
of existing knowledge within wound management, requiring knowledge and talent, complementarities
providing information and publications on all aspects between the vascular surgeon, the plastic surgeon, the
of wound management. rehabilitator, the doctors, the nurses, and the nurses
again. The SFFPC is the nerve center of this mix, the
meeting place where the specialties work together to
EWMA Secretariat shape the work and get the stagnant bud to leave,
Nordre Fasanvej 113, 2. help the keratinocyte to move forward, fight against
DK-2000 Frederiksberg pain, and close the wound.
Denmark
Training courses are developed throughout France and
+45 7020 0305 the DU are the key to professional certification for both
nurses and doctors. Article 51 is a solution to increase
ewma@ewma.org expertise, while waiting for advanced practices which
will be available soon.
www.ewma.org
Learn more on
www.sffpc.org
7
GENERAL INFORMATION
CONFERENCE VENUE
Palais des Congrès de Paris
2 Place de la Porte Maillot
75017 Paris
France
palaisdescongresdeparis.com
EWMA SECRETARIAT CONFERENCE HOURS

Nordre Fasanvej 113 Monday, 23 May
2000 Frederiksberg, 08:00-18:00 Registration
Denmark 11:00-17:15 Commercial Exhibition
ewma@ewma.org 09:30-10:00 Opening Ceremony
+45 3842 9542 10:00-18:00 Plenary & Scientific Sessions
Tuesday, 24 May
CONFERENCE SECRETARIAT
07:30-18:30 Registration
The EWMA Conference Secretariat is located on level 3.
08:30-18:30 Scientific Sessions
Please see overview map for exact location. The
09:00-17:45 Commercial Exhibition
telephone and e-mail will be answered from 08:00-
20:00 every day during the conference. Wednesday, 25 May
ewma@ewma.org 08:00-15:30 Registration
+45 3842 9542 08:30-16:30 Scientific Sessions
09:15-16:15 Commercial Exhibition
CONFERENCE WEB APP 16:00-16:30 Closing Ceremony
The EWMA 2022 web app gives you instant access to all
conference details. You can easily browse the entire MOBILE PHONES
programme, search the full exhibitor list and navigate All mobile phones must be on silent mode during the
the venue through an interactive map. sessions.
The web app is kindly sponsored by URGO. BADGES

All participants should wear their name badge in the
View the web app here: conference area at all times. The badge must be
visible.
DISABLED ACCESS
The venue is accessible for people using a wheelchair.
All session rooms and exhibition areas are located at
level 2 and level 3 and are accessible via lifts.
WIFI PARKING
Free WiFi is available at the venue. Under the Convention Center, you will find the car park
Free WiFi is kindly sponsored by Mölnlycke. ‘Indigo Porte Maillot’.
WiFi name: EWMA-CICA freeWIFI_by Molnlycke CURRENCY

Password: Patients EURO
8
INFORMATION
ATM LOST AND FOUND
There is an ATM at the conference venue located on Found items should be turned in at the registration.
level 0 by the main entrance. If you lose something, please report to the registration
desk.
ACCOMMODATION
MCI has been appointed as the official hotel accommo- POSTERS
dation agent for the EWMA-CICA 2022 in Paris and will ELECTRONIC POSTERS (E-POSTERS)
handle all related arrangements. E-Posters are on display on touch screens situated in
Please contact MCI directly: the Poster area. E-Posters should be uploaded online
PROGRAMME
OVERVIEW
inscriptions@cicatrisations2022.org before the conference. E-Poster sessions are held at
the screens placed in the Poster Area. Each e-Poster
CME CREDITS will be displayed for 3 minutes guided by a chair.
The conference is accredited by the European Accredi- Authors are kindly asked to be present and discuss
tation Council for Continuing Medical Education their e-Poster with other participants. Please check
(EACCME). For further information, please visit uems. the programme for specific time and place.
net
PAPER POSTERS
EWMA-CICA 2022 is designated for a maximum of 14 Paper posters are on display on level 3. Two paper
PROGRAMME
CME credits. In order to obtain the credits please log poster walks on 23rd and 24th May will give partici-
DETAILED
your attendance each day before 14.00h by scanning pants the opportunity to meet the authors of the
your badge at the logging stations in the registration posters. See the times for the poster walks in the
area. programme.
PRINT YOUR CERTIFICATES PRESENTER AWARDS

You can print your CME certificate and certificate of EWMA First Time International Presenter
attendance after 14.00h on your last day of attendance. Prize: This award is designed to encourage people who
have not previously presented their work at an interna-
ENTITLEMENTS tional conference. To be eligible for this prize you must
SESSIONS
The registration fee includes final programme book, have submitted your abstract to EWMA and be a novice
abstracts (available in the web app), admission to the presenter. The value of the prize is 450 EURO.
full conference programme including all special
sessions. E-POSTER PRIZES
The e-Poster Prizes are designed to reward the
SPEAKERS PREVIEW ROOM considerable work that goes into preparing an e-Poster
(ORAL PRESENTATIONS) for presentation. To be eligible for consideration you
Please bring your presentation on a memory stick to must have a paper accepted for e-Poster presentation
the Speakers Preview Room at least 2 hours before at the EWMA-CICA 2022 Conference.
POSTERS
your presentation.
A panel of judges will attend the e-Poster sessions,
Opening hours: and authors are strongly encouraged to be present at
Monday 23 May 08:00-17:30 these sessions in order to answer questions concern-
Tuesday 24 May 07:30-18:00 ing their work. The panel will award three e-Poster
Wednesday 25 May 07:30-15:00 prizes. The value of each e-Poster prize is 200 EURO.
A technician will assist you in transferring the presen Your accepted e-Poster will automatically be consid-
tation to a central conference server. ered for this award, provided that it has not previously
been submitted elsewhere (all categories except Case
SATELLITE
SYMPOSIA
We do not allow the use of personal laptops for Studies and Professional Communication).
presentations. Unless otherwise agreed, all presenta-
tions will be deleted to secure that no copyright issues
will arise at the end of the conference.
SPONSORS &
EXHIBITORS
9
EWMA
2023
ABSTRACT SUBMISSION DEADLINE:
1 DECEMBER 2022
THE 33RD CONFERENCE

OF THE EUROPEAN
WOUND MANAGEMENT
ASSOCIATION
WOUND CARE – FROM ART TO SCIENCE

DALL’ARTE ALLA SCIENZA: L’EVOLUZIONE DELLA CURA DELLE FERITE
MILAN, ITALY
3 – 5 MAY 2023
OTHER COLLABORATORS
EWM A 2023.ORG
VENUE MAP
Level 0
LEVEL 0
le
Access to cash
Hyatt Hotel
Accès à
l'hôtel Hyatt
res
to
porte Neuilly 3 foyer lobby porte Paris 1

Neuilly 1 entrance Paris 1 entrance
Accueil du congrès
Registration
CME
log
&
print
Cloakroom
Vestiaire b
porte Maillot 3 porte Maillot 2 porte Maillot 1

Maillot 3 entrance Maillot 2 entrance Maillot 1 entrance
Escalator Lift Toilets Pharmacy Cash point
11
e-poster Passy
Invited area EWMA
lounge office
VENUE MAP
LEVEL 2
Level 2
273M 263M
272M 262M
261M
level
271M
toilettes
Amphithéâtre toilets
Bleu
253 escalator
243 escalator
242
252 B
AB
242 ascenseu
A lift
237M 227M
236M 251 241 226M

235M
224M-225M
234M
Hall Maillot 204

Exhibition level 2 CICA Organisers
Exposition au Niveau 2 Office
Bureau des
233M 231M-232M organisateurs CICA
Room Maillot
Salle Maillot
211 201 1M 22M 23M
202-203 22 2 2
Escalator Lift Toilets Recharge mobile
For exhibtion floor plan see page 92.

For list of exhibitors see page 78.
12
LEVEL 3
Level 3
4
36 3
36 2 nive
36
361 leve
353
343
toile
toi
352
Fresnter papier
342
er angosters
Po
B
lais
ch pa français
p
352 342
er
per poste
English pap
A A
Poster papi
asce
339M 329M li
351 rs
341
338M 328M
337M 327M
336M 326M recharge
mobile r
335M 325M
Amphi- Invited speakers lounge 305
théâtre Lounge dédié aux
304
invités/orateurs
Havane EWMA Organisers
330M Office 320M
334M Hall Havane Hall Bordeaux Bureau des 324M
331M organisateurs321M
Exhibition Exhibition cloisons
333M 332M EWMA 322M 323M
Exposition Amphithéâtre Exposition movable
Speakers prep room

311 Salle Bordeaux
de pré-projection
312
Escalator Lift Toilets Recharge mobile
For exhibtion floor plan see page 92.

For list of exhibitors see page 78. Hô
RE
13
niveau/level 4 PA
niveau/level 3
PROGRAMME OVERVIEW MONDAY
AMPHITHEATRE
TIME MAILLOT HAVANE 351 352A 252B 252A
BLEU
MONDAY 23 MAY
08:30- 08:30-12:30
09:30 Veterinary
Wound Healing
Association
Conference
(VWHA)
Session 1:
09:30- EWMA-CICA 2022
Surgical Site
10:00 Opening Ceremony
Infections (SSI)
Cérémonie
d'ouverture de
EWMA-CICA 2022
( )
10:00- Opening key
11:30 session: EWMA
past, present, and
future activities
Session d'ouverture
: Activités passées,
présentes et futures
MONDAY 23 MAY · Registration 08:00-18:00 · Sessions 9:30-18:00 · Exhibition 11:00-17:15
de EWMA
( )
11:30-
12:30
11:45-13:00: e-Poster sessions: Antimicrobials and infection (screen 1), Dressings (screen 2)
12:30- Industry Sponsored Industry Sponsored Industry Sponsored

13:30 Satellite Symposium Satellite Symposium Satellite Symposium
Symposium satellite Symposium satellite Symposium satellite
sponsorisé par sponsorisé par sponsorisé par
l’industrie l’industrie l’industrie
( ) ( ) ( )
13:30-
13:45
13:45- Key session: Key session: The European Tissue Free paper session: Workshop: Workshop:
15:00 Surgical tissue- Impact of Lifestyle Repair Society Negative Pressure 3 biggest mistakes Offloading in the
sparing procedures Factors on Wound (ETRS) guest Wound Therapy of my career 1: Diabetic Foot 14:00-16:00
Session principale: Management session Inflammatory Veterinary
Procédures Session principale: ulceration Wound Healing
chirurgicales de Impact sur la Association
préservation des gestion des plaies Conference
tissus des facteurs relatifs (VWHA)
au mode de vie
Session 2:
( ) ( ) Open Wounds
15:00- 15:00-15:30: Paper poster walk: all categories (Level 3)
15:30
15:30-16:30: e-Poster sessions: Acute Wounds (screen 1), Diabetic Foot (screen 2)
Symposium satellite
sponsorisé par
l’industrie
( ) 16:15-18:00
Veterinary
16:30- Wound Healing
16:45 Association
16:45- Key session: Key session: Free paper session: Free paper session: Focus session: Free paper session: Conference
18:00 Artificial intelligence Paediatric Wounds Basic Science Infection and Deep vein Leg Ulcers (VWHA)
Session principale: Session principale: antimicrobials thrombosis (DVT) Session 3:
Intelligence Plaies en pédiatrie and post-thrombotic Celebration of
artificielle syndrome the 25th
Anniversary of
the VWHA
( ) ( )
Opening/Closing Ceremony W
orkshops, Education Session G
uest Session / VWHA Conference
Break Industry Sponsored Satellite Symposium Journées Cicatrisations
Key
session Free Paper Session
F
ocus Session e
-Poster session / Paper Poster Walk
14
( ) Spoken language: English. Simultaneous translation: French
( ) Spoken language: French. Simultaneous translation: English
INFORMATION
Spoken language: English. No simultaneous translation
Spoken language: French. No simultaneous translation
BORDEAUX 342AB 241 251 243 343 212-213
PROGRAMME
OVERVIEW
PROGRAMME
DETAILED
SESSIONS
Module 1 : Module 2 : Module 3 : Module 4 : Module 5 : Module 6 : Communications
Plaies et ostéites Qu’est-ce qu’un Plaies et démence : Les ulcères de Sémiologie & Plaies domestiques orales Session 1 :
Wounds and osteitis pansement lourd et faire face à une causes rares vus prévention des de l'enfant Escarres 1
complexe au regard prise en charge plus par le dermatologue plaies du pied
de la NGAP? complexe diabétique
( )
POSTERS
Industry Sponsored Industry Sponsored
Satellite Symposium Satellite Symposium
Symposium satellite
sponsorisé par
l’industrie
( )
SATELLITE
SYMPOSIA
Module 7 : Module 8 : Module 9 : Module 10 : Module 11 : Communications Communications

Les Brûlures : Classification et Evaluation Méthodes de Soins de plaies orales Session 2 : orales Session 3 :
Arbre décisionnel utilisation des vasculaire au lit du prévention de la dans les pays Recherche / Plaies du pied
pour une prise en pansements malade : IPS, récidive des plaies tropicaux et Plaies aigües diabétique /
charge à domicile pression d’orteil, du pied diabétique équatoriaux Ulcères de jambe
Burns: Decision tree oxymétrie cutanée
for home care
( )
SPONSORS &
EXHIBITORS
Due to CME regulations no industry names or logos are allowed in the overview programme.
Detailed programme of industry sessions is available on pages 64-75.
15
PROGRAMME OVERVIEW TUESDAY
AMPHITHEATRE
BLEU
TUESDAY 24 MAY
08:30- Free paper session: Focus session: Free paper session: Focus session: Free paper session: Workshop: 8:30-10:00
09:45 Health Economics Wounds in geriatric, Diabetic Foot 1 Skin Tears Pressure Ulcers Debridement Veterinary
& Outcome and disabled and frail Wound Healing
Acute Wounds patients Association
Communications Conference
Orales Session: (VWHA)
Économie de la Session 4:
santé et résultats, Short
plaies aiguës Communications
( )
09:45- 9:45-11:00: e
-Poster sessions: Education, e-Health, Nutrition and Health Economics & Outcome (screen 1),
10:00 Devices & Intervention (screen 2)
10:00- Industry Sponsored Industry Sponsored Industry Sponsored EWMA International 10:00-10:30
11:00 Satellite Symposium Satellite Symposium Satellite Symposium partner session: Veterinary
Symposium satellite Symposium satellite Symposium satellite Wound Wound Healing
TUESDAY 24 MAY · Registration 08:00-18:00 · Sessions 8:30-18:30 · Exhibition 9:15-18:00
sponsorisé par sponsorisé par sponsorisé par management in Association

l’industrie l’industrie l’industrie resource-limited Conference
settings or in health (VWHA): AGM
systems disrupted
by war (Ukraine)
( ) ( ) ( )
11:00- 11:00-13:15
11:15 Veterinary
Wound Healing
11:15- Key session: Key session: EWMA Education 11:15-12:45 Free paper session: Workshop: Association
12:15 Delivering & Oxygenotherapy: session: Equality G-Scars guest Nutrition, pain, After debridement Conference
Measuring hyperbaric or local? and inclusivity of session Quality of Life and (VWHA)
Outcomes in Session principale: different skin tones pressure ulcers Session 5:
Chronic Wounds: Oxygénothérapie : in wound care Wound Centre
From Wound hyperbare ou teaching practices: Meeting
Management to locale ? Sharing Good
Wound Closure Practice
Session principale:
Obtenir et mesurer
des résultats dans
le traitement des
plaies chroniques :
de la gestion à la
fermeture des
plaies ( ) ( )
12:15-
13:30
12:30-13:30: e-Poster sessions: Negative Pressure Wound

Therapy (screen 1), Leg Ulcers (screen 2)
13:45-14:15: e-Poster sessions: Wound Assessment (screen 1), 13:15-14:30

Burns (screen 2) G-Scars guest
session
( ) ( ) ( )
14:30-
14:45
Key
F
ocus Session e
16
INFORMATION
BORDEAUX 342AB 241 251 243 343 212-213
Module 12 : Module 13: Module 14 : Module 15 : SPE01 : Communications Module 16 :

Classification et Hypnose et plaies Diagnostic et prise Expertise Prévention des orales Session 4 : Pansement et
indications des en charge des médico-légale de la escarres en période Innovations Décharge : quelle
pansements lymphoedèmes pratique infirmière COVID : des cohabitation ?
Bandage classifica- en soins des plaies recommandations à
PROGRAMME
OVERVIEW
tion and application la pratique pour
s'organiser à
domicile, en EHPAD,
à l'hôpital ou en
réanimation
( )
PROGRAMME
DETAILED
Module 17: Module 18 : Module 19 : Module 20 : SPE02 : Communications Module 21 :
Plaies malodorantes Les greffes TPN de localisation Toxicités cutanées Le stade 0 de orales Session 5 : Plaies et fixateurs
SESSIONS
Malodorous wounds cutanées en secteur difficile des traitements l’escarre est-il Éducation / externes
dermatologique anti-cancéreux détectable ? Politique de santé
systémiques
( )
POSTERS
12:25-13:25 12:25-13:25 12:25-13:25
Industry Sponsored Symposium satellite Symposium satellite
Satellite Symposium sponsorisé par sponsorisé par
l’industrie l’industrie SATELLITE
SYMPOSIA
SPONSORS &
EXHIBITORS
17
PROGRAMME OVERVIEW TUESDAY
AMPHITHEATRE
BLEU
TUESDAY 24 MAY
14:30-
14:45
14:45- Key session: If Key session: Free paper session: Focus session: Focus session: Atelier : Accelerated
15:45 diabetic foot is like Communication in Education and Atypical Wounds Negative Pressure Après le Technology
TUESDAY 24 MAY · Registration 08:00-18:00 · Sessions 8:30-18:30 · Exhibition 9:15-18:00
cancer should we… the wound manage- e-Health Induced iatro Wound Therapy débridement Adoption in the
Session principale: ment context genically or by U.S. The
Si le pied Session principale: addiction EXCITE
diabétique est La communication International
comme un cancer, dans le contexte de Approach
devons-nous… la gestion des
plaies
( )
15:45-
16:15 ( )
15:45-16:15: Paper poster walk: all categories (Level 3)
16:15- e-Poster sessions: Industry Sponsored Industry Sponsored Dystrophic Industry Sponsored Industry Sponsored
17:15 Atypical Wounds Satellite Symposium Satellite Symposium Epidermolysis Satellite Symposium Satellite Symposium
(screen 1), Symposium satellite Symposium satellite Bullosa Research
Pressure Ulcers sponsorisé par sponsorisé par Association
(screen 2) l’industrie l’industrie (DEBRA) guest
session
( ) ( )
17:15-
17:30
17:30- CICA Plénière 1 : Key session: Focus session: Workshop: Workshop: Workshop: EXCITE
18:30 Quoi de neuf ? Emotionality and Will new materials Storytelling in Is this wound Choosing a meet-the-experts
Plenary session chronic wound change wound wound infected or not? dressing session
No. 1: What's new? Session principale: management in the management Real cases
Émotivité et plaies near future? A duel discussion
chroniques
( ) ( )
Key
F
ocus Session e
18
INFORMATION
BORDEAUX 342AB 241 251 243 343 212-213
Module 22 : Module 23 : Module 24 : Module 25: SPE03 : Module 26 :

Comprendre la prise Plaies liées aux Ulcères de jambes : Déchirure cutanée : Table-ronde Peau périlésionnelle
PROGRAMME
en charge des dispositifs médicaux complications diagnostics et prise Patients à risque
OVERVIEW
plaies vasculaires infectieuses en charge d’escarre et éduca-
Understanding care tion thérapeutique :
of vascular ulcers du présentiel au
numérique,
nouvelles approches
organisationnelles
( )
PROGRAMME
Industry Sponsored Industry Sponsored Industry Sponsored Industry Sponsored
DETAILED
Satellite Symposium Satellite Symposium Satellite Symposium Satellite Symposium
Symposium satellite
sponsorisé par
l’industrie
( )
SPE04 : Module 28 : Module 29 : Module 30 : Communications Module 31 : Communications

Escarres complexes Douleur et plaies: Plaies, réanimation L’évaluation orales Session 6 : Brûlures orales Session 7 :
SESSIONS
à domicile ou en différentes et COVID vasculaire des Innovations / domestiques Soins
établissement : approches possibles pieds, un défi E-santé chez l'enfant
Y a t-il un parcours d’interprétation
de soins idéal ?
Complex pressure
ulcers at home or in
hospital: Is there an
ideal care pathway?
( )
POSTERS
SATELLITE
SYMPOSIA
SPONSORS &
EXHIBITORS
19
PROGRAMME OVERVIEW WEDNESDAY
TIME AMPHITHEATRE BLEU MAILLOT HAVANE 351 352A 252B
WEDNESDAY 25 MAY
08:30- CICA Plénière 2 : Free paper session: Workshop: Undergraduate nurses' Free paper session: Cooperating
09:30 Plaies persistantes Diabetic Foot 2 3 biggest mistakes of session Wound Assessment Organisations
Plenary session No. 2: Communications my career 2: Session: The role of
Persistent wounds Orales Session: Pied PU and VLU compression therapy
diabétique 2 in the management
of leg ulcers
( )
09:30-
09:45 ( )
09:45- Industry Sponsored Industry Sponsored
10:45 Satellite Symposium Satellite Symposium
10:00-10:45: e-Poster sessions: Basic and translational Science (screen 1), Symposium satellite
Prevention, Home Care, Covid-19 and Quality of Life (screen 2) sponsorisé par
l’industrie
WEDNESDAY 25 MAY · Registration 08:00-15:30 · Sessions 8:30-16:30 · Exhibition 9:15-16:15
( )
10:45-
11:00
11:00- CICA Plénière 3 : Key session: Focus session: Free paper session: Focus session: Workshop:
12:00 Actualités dans la Palliative Wound Care The surgical Burns and dressings The “Living With Getting the
prévention des plaies Session principale: management of Chronic Wounds” complexity of the
chroniques? Plenary Soins palliatifs des pressure ulcers project alive Diabetic Foot
session No. 3: News in plaies Syndrome or how
the prevention of not to loose the
chronic wounds patient for saving
the limb
( ) ( )
12:00-
12:15
13:15-
13:30
13:30- Key session: Focus session: Free paper session: European Council of
14:30 New technologies in Scar prevention and Diabetic Foot 3 Enterostomal
Tissue Replacement treatment modalities Therapy (ECET)
Session principale: Guest Session:
Nouvelles technologies Peristomal skin
de remplacement des complications
tissus
( )
14:30-
14:45
14:45- Key session: Diabetic Key session: Pressure Free paper session: Free paper session:
15:45 foot - ulcer prevention Devices & Intervention Basic and
New insights in Session principale: translational science
pathogenesis Diagnostic différentiel
Session principale: de l'escarre?
Pied diabétique – De
nouvelles données sur
la pathogenèse
15:45-
16:00 ( ) ( )
16:00- Closing Ceremony
16:30 and Prizes
Cérémonie de clôture
et remise des prix
( )
Key
F
ocus Session e
20
INFORMATION
BORDEAUX 342AB 241 251 243 343 212-213
Module 32 : Module 33 : Module 34 : Module 35 : SPE05 : Communications

Les complications Soutien au parcours Dermite associée à Traitement de Médecine de orales Session 8 :
cutanées patient dans les l'incontinence (DAI) l'escarre du sujet catastrophe Thérapeutique /
péristomiales pays émergents âgé Brûlures
Peristomal skin
PROGRAMME
OVERVIEW
complications
( )
PROGRAMME
DETAILED
Module 36 : Module 37 : Module 38: Module 39 : Communications Module 40 : Session spéciale
Plaies du sujet âgé : Traitement Organisation de la Nutrition et plaies orales Session 9 : Le b.a.-ba de la CATEL : Recos de
les connaître et les endovasculaire dans prise en charge des chroniques Escarres 2 plaie aigue, mise en bonnes pratiques
prendre en charge la prise en charge plaies pendant la situation HAS
Introduction to des plaies : période COVID
wounds in elderly la vraie vie
patients
( )
Symposium satellite Symposium satellite Symposium satellite Industry Sponsored
SESSIONS
sponsorisé par sponsorisé par sponsorisé par Satellite Symposium
Module 41 : Module 42 : Module 43 : Module 44 : Communications Module 46 :

Quand s'inquiéter L’entretien clinique Prise en charge Substituts orales Session 10 : DU Plaie / Protocole
devant un ulcère de du patient porteur initiale d'un trauma dermiques dans la Cicatrisation / de coopération / IPA
jambe ? d’ulcères de jambe sévère de membres prise en charge des Cicatrices : y voir plus clair
When should you plaies de tous types
POSTERS
worry about a leg
ulcer?
( )
Module 47 : Module 48 : Module 49 : Module 50 : Communications Module 51 : Communications

Education Plaie et précarité Détersion : une Le b.a.-ba de la orales Session 11 : Plaies, psychologie orales Session 12 :
thérapeutique chez affaire d’équipe en cicatrisation Pansement et et psycho- Éducation /politique
le diabétique : ville et en hôpital médicaments pathologie : de santé / Soins
qui fait quoi? quelles
Therapeutic interactions ?
education of diabetic
patients: who does
SATELLITE
SYMPOSIA
what?
( )
SPONSORS &
EXHIBITORS
21
International Lymphoedema Framework
Who we are: We currently work on:
• A UK-based charity founded in 2009 with 15 national • Genital oedema – to understand the educational
frameworks across the world. needs of both patients and professionals.
• Board of Directors with 10 international members. • Children with lymphoedema – to develop a “Quality
• Extensive activities such as conferences, of Life” tool for children and young people.
international research and data collection, active • Chronic oedema outcomes – to develop global
communication and community-building through chronic oedema outcome measures for the
our website, social media, webinars, and regular treatment of lymphoedema.
newsletters. • LIMPRINT & Child LIMPRINT studies – to capture
the scale and impact of chronic oedema.
What we believe: • Increased awareness about lymphoedema in
• Patients should always be at the heart of all projects. resource-limited countries/settings.
• Only a collaborative and multidisciplinary partners
hip between all stakeholders can lead to an Follow us on social media:
improvement in the management of lymphoedema.
• Improving the management of lymphoedema is a Free online resources, publications, films, webinars
dynamic process that requires ongoing research on-demand and much more available at:
and implementation into practice.
• International collaboration is essential. www.lympho.org
INFORMATION
DETAILED PROGRAMME
MONDAY 23 MAY 2022
09:30-10:00 EWMA-CICA 2022 Opening Ceremony ( ) Amphitheatre

Bleu
Welcome address by the EWMA President
Sebastian Probst, Switzerland
Welcome address by SFFPC President & EWMA Scientific Recorder
PROGRAMME
OVERVIEW
Luc Téot, France
10:00-11:30 Opening Key session: EWMA past, present, and future activities ( ) Amphitheatre
Chairs: Sebastian Probst, Luc Téot Bleu
Crossing the red sea of the Covid-19 pandemic

Sylvie Meaume, France
EWMA achievements and projects in the near future
Highlights in the French programme
Luc Téot, France
Economy, where are we now?
PROGRAMME
Julian Guest, United Kingdom
DETAILED
08:30-12:30 VWHA Session 1: Surgical Site Infections (SSI) Room 252A
Opening through the VWHA President

Jacintha Wilmink, Netherlands
Definition and Causes of SSI
Denis Verwilghen, Australia
The surgical safety checklist – evolution and outcomes
Bryden Stanley, United States
Use of Chlorhexidine for surgical preparation in a veterinary perspective
Georgina Hollis, United Kingdom
Evidence based surgical site preparation anno 2022
SESSIONS
Denis Verwilghen, Australia
Antiseptics in veterinary medicine – What is the evidence
Georgina Hollis, United Kingdom
Coffee break
Dealing with wound dehiscence
Multimodal approach to prevent SSI – what’s the role of the “antibiotic umbrella”?
Mirja Nolff, Switzerland
Treatment of SSI using NPWT – how to manage multi drug resistant infections
POSTERS
The effect of NPWT on incisions under tension
Panel discussion
All speakers
11:45-13:00 e-Poster Session and display: Antimicrobials and infection e-Poster
Chair: Joan-Enric Torra Bou Screen 1
11:45-13:00 e-Poster Session and display: Dressings e-Poster

Chair: Tânia Santos Screen 2
12:30-13:30 Industry Sponsored Satellite Symposium ( ) Amphitheatre

Information available on page 65 Bleu
SATELLITE
SYMPOSIA
12:30-13:30 Industry Sponsored Satellite Symposium ( ) Room Maillot

Information available on page 65
12:30-13:30 Industry Sponsored Satellite Symposium ( ) Room Havane
13:45-15:00 Key session: Surgical tissue-sparing procedures ( ) Amphitheatre
Chairs: Luc Téot, Christian Willy Bleu
Saving tissue in complex wounds using complementary techniques

Ibby Younis, United Kingdom
Interdisciplinary surgical approaches in complex wounds with free flaps in vascularly
compromised patients
SPONSORS &
EXHIBITORS
Raymund E. Horch, Germany

New revascularisation techniques
Hage Rami, France
23
MONDAY 23 MAY (continued)
Strategies in war tissue salvage

Christian Willy, Germany
13:45-15:00 Key session: The Impact of Lifestyle Factors on Wound Management ( ) Room Maillot
The session is based on the ongoing EWMA project on The Impact of patient’s health
and lifestyle factors on wound healing.
Read more on: https://ewma.org/what-we-do/projects/lifestyle-factors
Chair: Georgina Gethin
The Impact of Lifestyle Factors on Wound Healing document:
Introduction & Focus on stress and nutrition
Georgina Gethin, Ireland
Focus on sleep and alcohol
Focus on smoking and illicit drugs
Evelien Touriany, Belgium
Focus on physical activity
Jaap van Netten, Netherlands
13:45-15:00 European Tissue Repair Society (ETRS) Guest Session Room Havane
Chair: Ulrich auf dem Keller
The dermo-epidermal dialogue during wound healing:
participation of the epidermal basement membrane in dermal repair
Patricia Rousselle, France
Combining cellular and ECM perspectives in tissue repair
Yuval Rinkevich, Germany
Cold atmospheric plasma for wound healing
Bouke Boekema, Netherlands
Macrophage acute contact induces fibroblast intracellular stress in a calcium-
and gap-junction-dependent process
Maya Ezzo, Canada
13:45-15:00 Free Paper Session: Negative Pressure Wound Therapy Room 351
Chair: Jan Stryja
006 Closed incision negative pressure wound therapy reduces surgical site infection following
emergency laparotomy
Jordan Ng, United Kingdom
007 Resource use for negative pressure wound therapy compared to conventional wound
treatment: Results of the multicenter sawhi randomized controlled trial
Doerthe Seidel, Germany
009 Effect of high negative pressure wound therapy on healing in diabetic foot ulcers
Laila Al Sabbagh, Egypt
011 Negative pressure wound therapy for post-sternotomy mediastinitis reduces mortality rate
and sternal re-infection rate compared to conventional treatment
Sardor Rakhmonov, Russian Federation
012 Clinical experience with the use of negative pressure wound therapy combined with
manuka honey viscose dressing in mixed wounds: A retrospective study of 60 cases
Nihal Khatib, Israel
13:45-15:00 Workshop: 3 Biggest Mistakes of My Career 1: Inflammatory Ulceration Room 352A
The workshop will be repeated three times, each session with a different KOL on different chronic wound model;
the KOL will describe professional failure/mistakes/cases gone bad of his/her practice and will be open to discuss
and interact with the audience and to address any query or comment. In this session: Inflammatory Ulceration
3 biggest mistakes of my career 1: Inflammatory ulceration

Kirsi Isoherranen, Finland
13:45-15:00 Workshop: Offloading in the Diabetic Foot Room 252B
This workshop aims to define and describe a systematic clinical approach to the D.F. patient in an outpatient
setting, giving both the why’s and the how’s of the clinical evaluation and of the offloading in the acute and
post-acute phase, displaying most of the techniques live.
Offloading in the Diabetic Foot

Alberto Piaggesi, Italy
14:00-16:00 VWHA Session 2: Open Wounds Room 252A
How to recognize infection in open wounds – equine and small animal patients
Systemic antibiotics: do they reach the granulating wound?
Manfred Kietzmann, Germany
What is the effect of topical honey during open wound therapy in small animals?
The influence of pH on wound healing and bacterial growth
Elin Jørgensen, Denmark
24
INFORMATION
Laser treatment of open wounds: what does it add?

Panel discussion
All speakers, Denmark
14:00-15:00 Journees CICA Session: Module 1: Wounds and osteitis ( ) Room
Bordeaux
Wounds and osteitis
Eric Senneville, France
Wounds and osteitis
PROGRAMME
OVERVIEW
Jean-Baptiste Bonnet, France
15:00-15:30 Paper Poster Walk: All categories Paper poster
area, level 3
15:30-16:30 e-Poster Session and display: Acute Wounds e-Poster
Chair: Elia Ricci Screen 1
15:30-16:30 e-Poster Session and display: Diabetic Foot e-Poster

Chair: Klaus Kirketerp-Møller Screen 2
15:30-16:30 Industry Sponsored Satellite Symposium Room Maillot

15:30-16:30 Industry Sponsored Satellite Symposium 352A
PROGRAMME
DETAILED
15:30-16:30 Industry Sponsored Satellite Symposium ( ) 252B
15:30-16:30 Industry Sponsored Satellite Symposium ( ) Room 243
15:30-16:30 Industry Sponsored Satellite Symposium Room
Information available on page 67 212+213
16:15-18:15 VWHA Session 3: Celebration of 25th Anniversary of the VWHA Room 252A
Welcome to the 25th anniversary of the VWHA

Founding of the VWHA: why and where did we start in 1996
SESSIONS
Derek Knottenbelt, United Kingdom
The evolution of wound management products over 25 years
Sarah Cockbill, United Kingdom
Cutaneous wounds and veterinary dermatology: challenges and developments
over 25 years
David Lloyd, United Kingdom
The role of pharmacology, toxicology and pharmacy during the treatment of wounds
over the past 25 years
Manfred Kietzmann, Germany
VWHA 25th anniversary: where are we now and which challenges do we face?
POSTERS
Announcement of honorary members
16:45-18:00 Key Session: Artificial Intelligence ( ) Amphitheatre
Chairs: Luc Téot, Dimitri Beeckman Bleu
AI for a better diagnosis of chronic wounds

Jacopo Secco, Italy
Modelling Wound Healing and Tumour growth
María José Gómez-Benito, Spain
16:45-18:00 Key Session: Paediatric Wounds ( ) Room Maillot
The spectrum of “Paediatric’ includes the neonate through to the teenager with considerable variation
SATELLITE
SYMPOSIA
in the development of the skin and ability to cope with wounds. This session aims to highlight the need
for different approaches to paediatric versus adult wound care management
Chairs: Paulo Ramos, Evelien Touriany
Negative Pressure Wound Therapy in paediatric wound care:
state of the evidence base and recommendations for practice
Guido Ciprandi, Italy
Pain management and psychological care
Anna-Barbara Schlüer, Switzerland
Antimicrobials in paediatric care
Speaker to be announced
SPONSORS &
EXHIBITORS
25
16:45-18:00 Free Paper Session: Basic Science Room Havane

Chair: Ulrich auf dem Keller
013 Does the immunosuppressive treatment reduce the healing potential of stem cells
separated from bone marrow of diabetic patients?
Jitka Husakova, Czech Republic
014 Myoglobin creates a hostile wound microenvironment

Lisa Tucker-Kellogg, United States
015 Steps towards bioprinting a personalized skin model

Lucília da Silva, Portugal
016 Breakdown, identification and observation of the micro-environment in acute and chronic
wounds (wound-biome project) – proteomic patterns and signature
Julian-Dario Rembe, Germany
017 Biomolecular profiles and biomarkers of the micro-environment in acute and chronic
wounds - a systematic scoping review with qualitative and quantitative evaluation
Julian-Dario Rembe, Germany
16:45-18:00 Free Paper Session: Infection and antimicrobials Room 351
Chair: Christian Willy
018 Immunohistochemical evaluation of the expression of mmp9, mmp2 and timp2 in venous
leg ulcers before and after biomodulation with fluorescent light energy
Agata Janowska, Italy
019 Validation of the TILI (Terapeutic Index for Local Infections) score for the diagnosis of
local wound infections: Results of a retrospective european analysis
Joachim Dissemond, Germany
020 Investigation of bacterial colonisation of wound dressings and efficacy of mechanical

debridement: Results of a prospective study with 151 patients using fluorescence imaging
Maurice Moelleken, Germany
021 Impact of probiotics on pathogen survival in an innovative human plasma biofilm model
(hpbiom)
Ewa Klara Stürmer, Germany
022 Clinical evaluation of a poly-absorbent silver dressing on wounds at risk or with clinical
signs of local infection: Results of an observational, prospective, multicentre study in
paediatrics patients
023 Real world data on microbial situation of chronic wounds - results from 277 clinical
findings
Thomas Eberlein, Germany
024 Hyperbaric oxygen therapy in surgical site complications

Eylem Koca, Turkey
025 A comparative study of the microenvironment and transcriptome of an in vitro chronic

wound model and an ex vivo porcine model - an evaluation employing human chronic
wound data
Jan Lorenzen, Denmark
16:45-18:00 Focus Session: Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome Room 352A
After this session participants will be able to:
- Identify causes of DVT
- Describe the management of DVT
- Identify the treatment options of a post-thrombotic syndrome
- Describe the noninvasive therapeutic options (compression, medications, and lifestyle changes)
for treatment and prevention of post-thrombotic syndrome.
Chair: Sebastian Probst
Prevention and treatment of the post thrombotic syndrome
Damien Pastor, Switzerland
The care aspect of DVT
Christine Moffatt, United Kingdom
16:45-18:00 Free Paper Session: Leg Ulcers Room 252B
Chairs: José Verdú Soriano, Pedro Pancorbo-Hidalgo
040 Covid impact on leg ulcer management

Marco Romanelli, Italy
041 Static stiffness index of new bandage compression system:

Results of a randomized controlled trial on healthy volunteers
Jean Patrick Benigni, France
044 Sucrose octasulfate dressing and two-layer compression system in the local management
of venous ulcers treated by punch grafting: Results of a spanish clinical trial
Elena Conde Montero, Spain
045 Treating venous leg ulcers with sucrose octasulfate lipidocolloid dressing:
clinical outcomes from two randomized clinical trials
26
INFORMATION
046 Why venous leg ulcer patients self-treat their ulcers?

Mirna Žulec, Croatia
047 The role of medical chestnut honey for infection, inflamation, granulation and
epithelisation phases
Tanja Planinšek Ručigaj, Slovenia
048 Diagnosis of martorell hypertensive ischemic ulcers (hytilu):

A retrospective observationaldescriptive study
María Isabel Pastor Orduña, Spain
PROGRAMME
049 Photodynamic plasmatherapy of wounds
OVERVIEW
Georg Daeschlein, Germany
16:45-17:45 Journees CICA Session: Module 7: Burns: Decision tree for home care ( ) Room
Bordeaux
Burns: Decision tree for home care
Franck Duteille, France
Burns: Decision tree for home care
Aurélie Geoffroy, France
PROGRAMME
DETAILED
SESSIONS
POSTERS
SATELLITE
SYMPOSIA
SPONSORS &
EXHIBITORS
27
TUESDAY 24 MAY 2022
08:30-09:45 Free Paper Session: Health Economics & Outcome and Acute Wounds ( ) Amphitheatre
Chairs: Tânia Santos, Corrado Durante Bleu
026 Community-based woundcare in the Netherlands:

Implementing a regionalnetwork for wound care
Annemiek Stienstra, Netherlands
027 Observed impact of skin substitutes in lower extremity diabetic ulcers:

A retrospective analysis of a medicare limited database (2015–2018)
William Tettelbach, United States
028 Secondary data analysis of statutory health insurance data to determine the prevalence of
chronic wounds
Leah Dörr, Germany
072 Hypochlorous acid in acetic acid increases early reepthelialzation of superficial acute
wounds – a randomized controlled trial
Ewa Anna Burian, Denmark
074 Split skin grafts as a work horse for surgeons in low resources settings
Aman Arora, India
077 Results of a multicentre, prospective, observational study on the performances of

tlc-nosf polyabsorbent dressings* on chronic wounds
Matthias Augustin, Germany
08:30-09:45 Focus Session: Wounds and dementia, how to deal with complex management? ( ) Room Maillot
With age, the risk of acute or chronic wounds increases considerably.
Moreover, age is the primary risk factor for the development of dementia.
The demented patient has an increased risk of developing a wound, whether it is specific to the situation as an elderly
person, or whether it is specifically related to the dementia.
How to deal with these complex situations ?
This session offers strategies to understand, support and assist caregivers in the always complex management of
wounds in the elderly patient with dementia.
Chair: Emma Candas
What are dementia-related behavioral disorders?
Nathalie Salles, France
Wounds and dementia in daily practice
Valerie Hanssens, Belgium
Wounds and dementia, how to deal with complex management?
Emma Candas, France
08:30-09:45 Free Paper Session: Diabetic Foot 1 Room Havane
Chair: Klaus Kirketerp-Møller
001 A topical natural formulation* efficiently promoted healing in diabetic foot ulcer
Pouya Salahi, Iran
002 Effect of tlc-nosf dressings in neuro-ischaemic DFUs considering their level of

ischaemia: Post-hoc analysis of the explorer rct
José Luis Lázaro Martínez, Spain
003 Rapid improvement of wound healing and health-related quality of life in patients with
DFUs treated with tlc-nosf polyabsorbent dressings - results from a prospective,
multicentre real-life study
Claas Lüdemann, Germany
004 Impact of autologous cell therapy on wound healing in diabetic patients with chronic
limb-threatening ischemia. a randomized controlled trial
Michal Dubsky, Czech Republic
005 A pilot study - healing of diabetic foot ulcers, microcirculation status and their possible
correlate with small artery disease
Radka Jarosikova, Czech Republic
095 Cold plasma – a valuable treatment option in hard-to-heal wounds?

Martin Berli, Switzerland
08:30-09:45 Focus session: Skin Tears Room 351
Although commonly associated with the older adult population, skin tears can also occur in the critically ill,
paediatric, and premature neonatal populations. A comprehensive risk assessment should include assessment
of the individual’s general health (chronic/critical disease, polypharmacy, and cognitive, sensory, visual, auditory,
and nutritional status), mobility (history of falls, impaired mobility, dependent activities, mechanical trauma), and skin
(extremes of age, fragile skin, previous skin tears). This focus session will cover the fundamentals of skin tear
prevention and treatment, including skin tear classification, dressing selection, skin tear treatment and methods for
wound edge re-approximation.
Learning objectives:
- Appreciate the epidemiology, classification, aetiology, prevention and treatment
- Understanding the principles of skin tears in acute care settings
- Understanding the methods for wound edge re-approximation
Chair: Samantha Holloway
Skin Tears Year 2022: An update on definition, epidemiology, classification, etiology,
prevention and treatment
Dimitri Beeckman, Belgium
28
INFORMATION
TUESDAY 24 MAY (continued)
Skin tears in acute care settings, the hidden wound

Julia Bresnai-Harris, United Kingdom
Primary closure of skin tears: a different perspective
Dave Baer, Switzerland
08:30-09:45 Free Paper Session: Pressure Ulcers Room 352A
Chairs: Elia Ricci, Beáta Grešš Halász
030 Prevention of pressure injuries resulting from surgical positioning: Heels Operating Room
Pressure Injury Trial (HORPIT)
PROGRAMME
Thaís Eberhardt, Brazil
OVERVIEW
031 Failed phagocytosis during the impaired healing of pressure ulcers
Lisa Tucker-Kellogg, United States
032 Pressure ulcers prolong the hospital stay – do we have evidence in data?
Andrea Pokorna, Czech Republic
033 Prevention of pressure injuries resulting from surgical positioning: Heels operating room
pressure injury trial (horpit)
Thaís Eberhardt, Brazil
035 Do we still need to assess nurses’ attitudes towards pressure ulcers prevention?
A systematic review
Pinar Avsar, Ireland
PROGRAMME
DETAILED
037 Repositioning for preventing pressure ulcers: A systematic review and meta-analysis
Pinar Avsar, Ireland
039 Natural history of pressure injury among ethnically, racially diverse nursing home
residents
Barbara Bates-Jensen, United States
08:30-09:45 Workshop: Debridement Room 252B
Debridement is known and described by many wound care experts as an essential process of wound bed
preparation that promotes wound healing. This workshop helps participants become familiar with surgical/sharp
debridement and its different techniques (biosurgical and mechanical). Participants will gain knowledge about wound
evaluation, the goals of debridement (when and why), tricks and traps. Attendees will be able to practice sharp
debridement during the workshop and learn some helpful practical skills to further more integrate this essential
practice in their wound care management.
SESSIONS
Debridement
Jürg Traber, Switzerland
Debridement
Brigitte Megert, Switzerland
08:30-10:00 VWHA Session 4: Short Communications Room 252A
Use of a knotless absorbable barbed suture combined with a topical adhesive skin
closure system in horses following ventral midline celiotomy: a comparative clinical study
Olivier Lepage, France
Antimicrobial peptide hydrogels for wound care
Rojan Modaresi
The antimicrobial potential of medium chain monoglycerides in wound healing
POSTERS
Henk van Faassen
Use of a silicone skin extension medical device for equine wound management
Olivier Lepage, France
08:30-09:30 Journees CICA Session: Module 12: Bandage classification and application ( ) Room
Bordeaux
Bandage classification and application
Christine Faure, France
Bandage classification and application
09:45-11:00 e-Poster Session and display: Education, e-Health, Nutrition and e-Poster
Health Economics & Outcome Screen 1
SATELLITE
SYMPOSIA
Chair: Elisabeth Lindahl

09:45-11:00 e-Poster Session and display: Devices & Intervention e-Poster
Chair: Lenka Veverková Screen 2


SPONSORS &
EXHIBITORS
29
10:00-11:00 EWMA International partner session: Wound management in resource-limited settings Room 352A
or in health systems disrupted by war (Ukraine)
Chair: David Keast
Live-launch and presentation of the book: Wound and Lymphoedema Management,
2nd edition: Focus on Resource-Limited settings
David Keast, Canada
EWMA Ukraine War Wounds Initiative: Wound-healing recommendations for resource
limited settings
Hubert Vuagnat, Switzerland, and Evelien Touriany, Belgium
Impacts of war on wound care: Experiences from Ukraine
Ukrainian speaker, Ukraine
Wounds, plants, and traditional healers in the Akonolinga region, Cameroun
Marie Therese Ngo Nsoga, Switzerland
11:00-13:15 VWHA Session 5: Wound Centre Meeting Room 252A
Welcome
Why do we need a wound centre structure
Skin grafting versus reconstructions: what to choose
Dylan Gorvy, Sweden
Program to develop into a recognized wound centre
Cases and trouble shooting
Questions and discussion with participants
All speakers, Denmark
11:15-12:15 Key Session: Delivering & Measuring Outcomes in Chronic Wounds: ( ) Amphitheatre
From Wound Management to Wound Closure Bleu
A core outcome set (COS) is a minimum set of outcomes that should be measured and reported in all clinical trials for
a specific clinical area as agreed on by stakeholders in that field. An outcome is any identifiable consequence of the
exposure to a health care intervention, such as a drug or a dressing. An outcome must be appropriate, measurable,
and meaningful to stakeholders. COS are gaining recognition as a means of improving the potential for meta- analysis
within systematic reviews and ultimately synthesising results of trials that include outcomes of importance to patients
and key stakeholders. A COS also reduces the risk of outcome-reporting bias. This key session will cover the latest
trends in core outcome set development in the woundcare field, including COS for pressure ulcers, incontinence-
associated dermatitis, venous leg ulcers and burns.
Learning objectives:
- Understanding the objectives and needs for core outcome sets in woundcare
- Understanding the methods to develop core outcome sets
- Understanding the COS for pressure ulcers, incontinence- associated dermatitis, venous leg ulcers and burns.
Chairs: Dimitri Beeckman, Georgina Gethin
Core Outcome Sets in skin and wound care: what is it and why do we need it?
Jan Kottner, Germany
Core outcome sets in venous leg ulcers
CONSIDER: The development of a CORE outcome set for incontinence- associated
dermatitis (IAD)
11:15-12:15 Key Session: Oxygenotherapy: Hyperbaric or Local? ( ) Room Maillot
Chair: Andrew J. M. Boulton
Topical Oxygen Therapy- Is There Supporting Evidence?
Robert Frykberg, United States
Hyperbaric Oxygenotherapy
Magnus Löndahl, Sweden
11:15-12:15 EWMA Education session: Equality and inclusivity of different skin tones in Room Havane
wound care teaching for healthcare students: Sharing Good Practice
Objectives of the session:
• To raise awareness of the need for more equality and inclusivity of different skin tones in teaching for all healthcare
students
• To discuss existing disparities for patients with pressure injuries and dark skin tones
• To examine teaching practice for nursing students in relation to pressure injuries and skin tone diversity
• To identify strategies for teaching medical students about differentiating skin diseases in individuals with dark skin
Chair: Samantha Holloway
Pressure Injuries - Disparity for Patients with Dark Skin Tones
Barbara Bates-Jensen, United States
Pressure injuries and skin tone diversity in undergraduate nurse education
Neesha Oozageer Gunowa, United Kingdom
30
INFORMATION
Differentiating skin diseases in dark skin: embedding clinical skills in medical student
teaching
11:15-12:45 G-ScarS Guest Session Room 351
Chair: Luc Téot
Introduction
Luc Téot, France
The myofibroblast anniversary
PROGRAMME
Alexis Desmoulière, France
OVERVIEW
The myofibroblast anniversary
Giulio Gabbiani, Switzerland
Recent advances in skin substitutes
Esther Middlekoop, Netherlands
Mechanomodulation: The clinical answer to mechanobiology in scarring
Peter Moortgat, Belgium
Lasers and injectables
Ioannis Goutos, United Kingdom
Fractional lasers for scar remodeling
PROGRAMME
Matteo Tretti Clementoni, Italy
DETAILED
11:15-12:15 Free Paper Session: Nutrition, pain, quality of life and pressure ulcers Room 352A
Chairs: Andrea Pokorna, Paulo Ramos
034 Pressure ulcer management in France: An understanding study

061 Zinc derivatives inhibit bacterial growth and promote wound healing in a simulated chronic
wound environment in vitro
062 A randomized, double-blind, placebo-controlled study to determine the analgesic efficacy,

safety and tolerability of vpx638 administered topically on a single study occasion, to
patients with painful wounds
Sergio Parra, United States
SESSIONS
063 Significant improvement of health-related quality of life in patients with chronic wounds
treated with tlc-nosf dressings in real life settings
Matthias Augustin, Germany
064 Standardized local management of malignant fungating wounds: The pebo approach
Giulia Davini, Italy
065 Methodologies used for assessing health-related quality of life in patients with
lymphedema of the lower limb: A systematic review
Comfort Chima, Ireland
11:15-12:30 Workshop: After Debridement Room 252B
The aims of the workshop will be to:
- Evaluate shortly different debridement methods and their effectiveness, including practical examples
POSTERS
- Perform an expedient aftercare following an debridement procedure
- Work appropriately with special antimicrobial wound therapeutics (present antimicrobial wound dressings)
- Explain the criteria for the ideal use of wound care products and categorise these into different groups of products;
(dressings, solutions etc.), including their indications, contraindications, and application, and apply the products
correctly in an appropriate situation
- Discuss the potential and limitations of new alternative treatments for wound management (NWPT; use of an
advanced therapy bi-layered living cellular construct “skin equivalent”; laser therapy)
After debridement
Chantal Rosset, Lucie Charbonneau, Paul Bobink, Switzerland
11:15-12:15 Journees CICA Session: Module 17: Malodorous wounds ( ) Room
Bordeaux
Aetiology and impact of an odour
Isabelle Fromantin, France
SATELLITE
SYMPOSIA
Local anti-odour solutions

Elodie Labedade, France
12:25-13:25 Industry Sponsored Satellite Symposium Room 241
12:30-13:30 e-Poster Session and display: Negative Pressure Wound Therapy e-Poster
Chair: David Pérez Barreno Screen 1
12:30-13:30 e-Poster Session and display: Leg Ulcers e-Poster

Chair: Jasmina Begic Screen 2
13:15-14:30 G-ScarS Guest Session Room 351
How to limit surgical scars?

SPONSORS &
EXHIBITORS
Ibby Younis, United Kingdom

The future of scar management
Geoffrey C. Gurtner, United States
31
Flaps or dermal subsitutes in skin reconstruction?

Franco Bassetto, Italy

13:45-14:15 e-Poster Session and display: Wound Assessment e-Poster
Chair: Elisabeth Lindahl Screen 1
13:45-14:15 e-Poster Session and display: Burns e-Poster

Chair: Sasa Milicevic Screen 2
14:45-16:00 Key Session: If Diabetic Foot Is Like Cancer Should We… ( ) Amphitheatre
Chair: Andrew J. M. Boulton Bleu
Prevent it more aggressively?

Treat it differently?
David G. Armstrong, United States
Communicate Foot Ulcer Risk Differently?
Loretta Vileikyte, United Kingdom
14:45-15:45 Key Session: Communication in the Wound Management Context ( ) Room Maillot
The session will focus on the importance of communication in the wound care clinical setting and to
suggest possible strategies to improve its quality within wound management environment
The communication in the wound management process
Aurora Piaggesi, Italy
Narrative medicine as a resource for wound healers
Nellie Hermann, United States
The gaps to fill for improving the quality of communication in wound management and the
role of EWMA
14:45-15:45 Free Paper Session: Education and e-Health Room Havane
Chair: Andrea Pokorna
050 Learning goals and content for wound care education in finnish nursing education
Emilia Kielo-Viljamaa, Finland
051 Gamification in wound care education

Nele Callaerts, Belgium
053 User experience of a mHealth application for foot care in patients with diabetes mellitus
Helena Maria Silveira Fraga Maia, Brazil
054 The wound App (SårApp) – a citizen tool

Trine Rolighed Thomsen, Denmark
14:45-15:45 Focus Session: Atypical Wounds Induced Iatrogenically or by Addiction Room 351
Atypical wounds can be caused by many different reasons, and medication and drugs are one cause.
In the clinics, the amount of these patients is clearly increasing and the diagnosis and treatment of these wounds
is challenging. This session provides an overview of different types of atypical wounds caused iatrogenically or
by addiction and tries to give clinical hints to the audience. In addition, some clinical cases are presented and the
theory will be reflected in these cases.
Chair: Elia Ricci
Atypical Wounds Induced iatrogenically
Atypical wounds caused by medication or by surgery
Anne Dompmartin, France
14:45-15:45 Focus session: NPWT: Focus perspectives of EWMA guidance document under Room 352A
preparation
NPWT with instillation
Luc Téot, France
NPWT with closed-incision
Christian Willy, Germany
Use of NPWT in primary care and patient perspectives
Ann-Mari Fagerdahl, Sweden
32
INFORMATION
14:45-15:45 Workshop: After Debridement Room 252B

The aims of the workshop will be to:
- Evaluate shortly different debridement methods and their effectiveness, including practical examples
- Perform an expedient aftercare following an debridement procedure
- Work appropriately with special antimicrobial wound therapeutics (present antimicrobial wound dressings)
- Explain the criteria for the ideal use of wound care products and categorise these into different groups of products;
(dressings, solutions etc.), including their indications, contraindications, and application, and apply the products
correctly in an appropriate situation
- Discuss the potential and limitations of new alternative treatments for wound management (NWPT; use of an
advanced therapy bi-layered living cellular construct “skin equivalent”; laser therapy)
PROGRAMME
After debridement
OVERVIEW
Chantal Rosset, Lucie Charbonneau, Paul Bobbink, Switzerland
14:45-16:15 Accelerated Technology Adoption in the U.S. The EXCITE International Approach Room 252A
Introduction: Background to Disjointed pathway from innovation to adoption

Leslie Levin, C. Michael Gibson
Introduction: Regulatory expectations and processes
C. Michael Gibson
Introduction: Payer processes
Leslie Levin
CMS Transitional Coverage for Emerging Technologies (TCET):
PROGRAMME
Leslie Levin
DETAILED
What’s Important to Payers and Expert End Users: including review of PAC Domains
Leslie Levin
Evidence development and meeting payer and expert end-user expectations through
early direct engagement. The ETR approach with examples
Leslie Levin
Using the ETR to develop clinical trials that represent the interests of the Company,
expert end-users and payers
C. Michael Gibson
Is the EXCITE approach a value-add to industry?
Geir Almaas, Norway
14:45-15:45 Journees CICA Session: Module 22: Understanding care of vascular ulcers ( ) Room
SESSIONS
Bordeaux
Understanding care of vascular ulcers
Francis Pesteil, France
Understanding care of vascular ulcers
Philippe Léger, France
15:45-16:15 Paper Poster Walk: All categories Paper poster
area, level 3
16:15-17:15 e-Poster Session and display: Atypical Wounds e-Poster
Chair: Sasa Milicevic Screen 1
16:15-17:15 e-Poster Session and display: Pressure Ulcers e-Poster

Chair: Márcia Santos Screen 2
POSTERS
16:15-17:15 Industry Sponsored Satellite Symposium Room 352A
16:15-17:15 Industry Sponsored Satellite Symposium Room 252B
SATELLITE
SYMPOSIA
16:15-17:15 Industry Sponsored Satellite Symposium ( ) Room 343

16:15-17:15 Dystrophic Epidermolysis Bullosa Research Association (DEBRA) guest session Room 351
Novel therapies for wound healing in EB

Alain Hovnanian, France
Burden of caregivers and out-of-pocket expenditures related to epidermolysis bullosa
in France
Younès Telali, France
SPONSORS &
EXHIBITORS
17:30-18:30 Journees CICA Session: Plenary session No. 1: What's new? ( ) Amphitheatre
Bleu
What's new in dressings and local wound treatment?
Christine Faure, France
33
What's new in technology?

What's new in telemedicine?
Anne Dompmartin, France
What's new in skin substitutes?
Luc Téot, France
17:30-18:30 Key Session: Emotionality and Chronic Wounds ( ) Room Maillot
Chairs: Loretta Vileikyte, Kirsi Isoherranen
The feelings of a wounded person: the experience of the Living with Chronic Wound
Project
Generalized versus Specific Emotional Distress and the Diabetic Foot
Loretta Vileikyte, United Kingdom
The psychosomatic wound
17:30-18:30 Focus session: Room Havane
Will New Materials Change Wound Management in the Near Future?
To debate the pros and cons of the insertion of new materials with advanced technological concepts
in the management of chronic wounds and explore their cost/effectiveness and safety profiles
Chair: Klaus Kirketerp-Møller
Will New Materials Change Wound Management in the Near Future? A Duel
Alexandra Marques, Portugal
Will New Materials Change Wound Management in the Near Future? A Duel
Edwin den Braber, Germany
17:30-18:30 Workshop: Storytelling in Wound Management Room 351
A professional Storyteller will introduce the technique and the art of storytelling and will elaborate
the possibilities of adopting it as a tool in wound management
The Art of Storytelling: a powerful tool for wound healers

17:30-18:30 Workshop: Is This Wound Infected or Not? Real Cases Discussion Room 352A
In chronic wounds, one of the most important factors leading to delayed healing is wound infection. However,
it is not always straightforward to determine whether infection is present in a non-healing wound. There are various
clinical signs that have to be observed and they can be combined to different scores. In this workshop, the different
clinical aspects and signs to diagnose wound infection will be discussed and the assessment of wound infection will
be practiced in several case studies.
Is this wound infected or not? Real cases discussion

Is this wound infected or not? Real cases discussion
José Verdú Soriano, Spain
17:30-18:30 Workshop: Choosing a Dressing Room 252B
Choosing the ideal dressing for a patients wound is an important step to promote wound healing, however it can
also be challenging for the Clinician involved. Clinician choice should correspond to the main assessed needs of
the wound, which can change during the healing process. This workshop will assist participants to focus on rapid
identification of the main factors likely to affect healing - within the wound margins, on the wound bed and on the
surrounding skin - and promote the choice of the most suitable generic interactive dressing and help participants
plan the date of the next 'anticipated' dressing change. The facilitators will also highlight other factors that have been
shown to influence dressing choice, such as the cost-effectiveness and efficacy of a dressing (and when combined
with compression therapy, offloading etc.).
Choosing a dressing
Jan Stryja, Czech Republic
Choosing a dressing
Mark Collier, United Kingdom
17:30-18:30 EXCITE International: Meet-the-experts Room 252A
Geir Almaas, Leslie Levin,C. Michael Gibson

17:30-18:30 Journees CICA Session: Complex pressure ulcers at home or in hospital: ( ) Room
Is there an ideal care pathway? Bordeaux
Chair: Nicolas Benoît
Feedback: In Brittany
Aurélie Duruflé, France
Feedback: In Occitania
Chloé Géri, France
Feedback: In the Paris region
Nathalie Faucher, France
Summary and prospects
Nicolas Benoît, France
34
INFORMATION
WEDNESDAY 25 MAY 2022
08:30-09:30 Journees CICA Session: Plenary session No. 2: Persistent wounds ( ) Amphitheatre

Chairs: Isabelle Fromantin, Sylvie Meaume Bleu
Assessment shortcomings
Julie Malloizel, France
Assessing comorbidities
The role of local infection
Eric Senneville, France
PROGRAMME
OVERVIEW
Non-healing wounds
08:30-09:45 Free Paper Session: Diabetic Foot 2 ( ) Room Maillot
Chair: Andrew Boulton
066 Hyperspectral imaging in the healing prognosis of patients with diabetic foot ulcers:
A comparison with routine vascular non-invasive techniques
067 Evolution of the TCPO2 values following hyperoxygenated fatty acids emulsion

application in patients with diabetic foot disease: Results of a clinical trial
PROGRAMME
068 A multi-center, blinded, randomized controlled clinical trial evaluating the effect of fish skin
DETAILED
graft in the treatment of chronic, non-responsive diabetic foot ulcers
John Lantis, United States
069 Risk factors for major amputation for midfoot ulcers in hospitalized diabetic patients
Kyung-Chul Moon, Rep. of South Korea
070 Maggot therapy for wound care: A retrospective cohort and meta-analysis
Chumpon Wilasrusmee, Thailand
071 Hidden dangers revealed by misdiagnosed peripheral neuropathy – a comparison of

clinical tests for detection
Cynthia Formosa, Malta
08:30-09:30 Workshop: 3 Biggest Mistakes of My Career 2: PU and VLU Room Havane
SESSIONS
and interact with the audience and to address any query or comment. In this session: PU and VLU
3 biggest mistakes of my career 2: PU and VLU

Luc Téot, France
08:30-09:30 Free Paper Session: Wound Assessment Room 352A
Chairs: Magdalena Annersten Gershater, Georgina Gethin
055 The assessment of chronic wounds : A review of psychometric properties of instruments

and a study of the cognitive process of decision making
056 Comparison of the detection of seven common wound pathogens from a range of wounds
and from the contralateral limb
POSTERS
Samantha Westgate, United Kingdom
057 The effect of inflammation management on ph, temperature and bacterial burden
Rosemarie Derwin, Ireland
058 A reliability study of four validated diabetic foot ulcer classification systems
Cynthia Formosa, Malta
059 Effectiveness of fast-track pathway for diabetic foot ulcerations:

Preliminary data from Italy
Marco Meloni, Italy
060 Hyperspectral Imaging (HsI) delineates maggot efficacy supporting wound healing by
enhanced hemodynamics
Georg Daeschlein, Germany
SATELLITE
SYMPOSIA
08:30-09:30 Cooperating Organisations Session: Room 352A

The role of compression therapy in the management of leg ulcers
3-4 speakers from EWMA's Cooperating Organisations will present their experiences with compression therapy
in the management of leg ulcers.
08:30-09:30 Journees CICA Session: Module 32: Peristomal skin complications ( ) Room

Bordeaux
Peristomal skin complications
Danièle Chaumier, France
Peristomal skin complications
Martine Pages, France
SPONSORS &
EXHIBITORS

09:45-10:45 Industry Sponsored Satellite Symposium ( ) Room 252B
35
WEDNESDAY 25 MAY (continued)
10:00-10:45 e-Poster Session and display: Basic and translational Science e-Poster
Chair: Joan-Enric Torra Bou Screen 1
10:00-10:45 e-Poster session and display: Prevention, Home Care, Covid-19 and Quality of Life e-Poster
Chair: Márcia Santos Screen 2
11:00-12:00 Journees CICA Session: Plenary session No. 3: News in the prevention of ( ) Amphitheatre
chronic wounds Bleu
Chairs: Nathalie Faucher, Christine Jurus
News in pressure ulcer prevention in 2021
Anthony Gélis, France
News in the prevention of leg ulcers
Monira Nou, France
News in the prevention in the Diabetic Foot
Georges Ha Van, France
News in the role of nursing in prevention
Pascal Vasseur, France
11:00-12:00 Key Session: Palliative Wound Care ( ) Room Maillot
Chairs: Georgina Gethin, Dimitri Beeckman
To define the scope of palliative wound care and to introduce the European Task Force on
Palliative wound care/Core outcome sets in palliative wound care
To present current research on interventions to manage wound symptoms including odour
and pain
To review the evidence on current practice for the management of the peri-wound area
To present current research on the use of electrochemotherapy and drug therapies in
palliative wound care
Joy Odili, United Kingdom
11:00-12:00 Focus Session: The Surgical Management of Pressure Ulcers Room Havane
Chairs: Franco Bassetto, Franck Duteille
The debridement of PU: new tricks from a fox
Franck Duteille, France
The reconstruction of PU: doing more with less
11:00-12:00 Free Paper Session: Burns and dressings Room 351
Chairs: Jürg Traber, Chantal Rosset
076 Persistent systemic inflammation in patients with severe burn injury is accompanied by
influx of immature neutrophils and shifts in t cell subsets and cytokine profiles
Patrick Mulder, Netherlands
078 Clinical safety and effectiveness of a novel wound dressing derived from eggshell
membrane in treatment of venous leg ulcers
Kevin Mercer, United Kingdom
079 Efficacy of a new antioxidant amorphous hydrogel containing an extract of olea europaea
leaves versus a standard hydrogel in wound healing. A randomised controlled trial
José Verdú Soriano, Spain
11:00-12:00 Focus Session: The “Living With Chronic Wounds” Project Alive Room 352A
The session will focus on the LWCW project, and introduce the development that starting from these experience
EWMA is going to promote, to integrate the patients', caregivers' and institutions' point of views into the debate on
wound management
The birth of the idea and the making of the project
The second life of LWCW: online and beyond
Samantha Holloway, United Kingdom
11:00-12:00 Workshop: Getting the complexity of the Diabetic Foot Syndrome Room 252B
or how not to loose the patient for saving the limb
and interact with the audience and to address any query or comment. In this session: Diabetic foot
Getting the complexity of the Diabetic Foot Syndrome or how not to loose the patient for
saving the limb
11:00-12:00 Journees CICA Session: Module 36: Introduction to wounds in elderly patients ( ) Room
Bordeaux
Introduction to wounds in elderly patients
Anne Philippe, France
36
INFORMATION
Introduction to wounds in elderly patients

Emma Candas, France
12:15-13:15 Industry Sponsored Satellite Symposium Room 252B
PROGRAMME
OVERVIEW
13:30-14:30 Key Session: New technologies in Tissue Replacement ( ) Amphitheatre

The aim of the session is to introduce the new document on new technology on tissue replacement Bleu
to be published by EWMA in 2022; to explore the most important aspect of the document and display
some preliminary contents on the main topics covered by the document
Chair: Alberto Piaggesi
The idea behind the document and its structure
The new materials for tissue replacement, what it's in the pipeline?
PROGRAMME
New surgical options for tissue replacement
DETAILED
Will the new MDR revolutionise new tissue replacement strategies?
Edwin den Braber, Germany
13:30-14:30 Focus Session: Scar prevention and treatment modalities Room Havane
Chair: Luc Téot
Introduction / The burden of scars
Hubert Vuagnat, Switzerland
Scars, prevention and treatment
Luc Téot, France
Scars, lightwaves modalities for treatment
SESSIONS
Hans-Joachim Laubach, Switzerland
13:30-14:30 Free Paper Session: Diabetic Foot 3 Room 351
Chair: José Luis Lazaro Martinez
091 Metabolic surgery as the possibility to reverse foot purulent-necrotic lesion in type ii
diabetes patient
Podpryatov Sergiy, Ukraine
092 Medical thermography has the potential to detect diabetic foot disease
Alfred Gatt, Malta
093 Calf muscle electrostimulation effects vascular perfusion and claudication distance in
patients with peripheral arterial disease in diabetes mellitus
Alfred Gatt, Malta
POSTERS
096 Clinical efficacy and cost effectiveness of ceramic dressings over saline gauze dressings
among diabetic foot ulcers
Rajesh Kesavan, India
13:30-14:30 ECET Guest Session: Peristomal skin complications Room 252B
Chairs: Renata Batas, Gabriele Kroboth
Peristomal skin irritations - The challenges of treatment in homecare
Renata Batas, Slovenia
Score systems and peristomal skin injuries
Gabriele Kroboth, Austria
Peristomal wounds – how to manage different cases
SATELLITE
SYMPOSIA
Gabriele Kroboth and Renata Batas, Austria and Slovenia

13:30-14:30 Journees CICA Session: Module 41: When should you worry about a leg ulcer? ( ) Room
Bordeaux
When should you worry about a leg ulcer? - Why is a leg ulcer not healing?
Tiffany Klejtman, France
When should you worry about a leg ulcer? - The factors affecting healing you should
know and be able to recognise during care
Sara De Sousa, France
14:45-16:00 Key Session: Diabetic Foot - New Insights in Pathogenesis ( ) Amphitheatre
To give and updated overview of the themes at the center of the scientific debate in an extremely Bleu
challenging and complex model of chronic wound affecting more than one million persons in Europe.
SPONSORS &
EXHIBITORS
The chronic neuropathic oedema and its neglected role in the pathogenesis and
development of DFU
37
The role of arterial and arteriolar calcification in the clinical manifestation and evolution of
arteriopathy in the DF patients
Roberto Ferraresi, Italy
14:45-16:00 Key Session: Pressure Ulcer Prevention ( ) Room Maillot
Chair: José Verdú Soriano
Artificial intelligence, Data science, Ethics : toward zero avoidable PU?
Sandrine Robineau, France
Microenvironment monitoring in order to prevent PU
Valentina Dini, Italy
14:45-16:00 Free Paper Session: Devices & Intervention Room 351
Chairs: Mark Collier, Evelien Touriany
081 Clinical analysis of communicating artery between the dorsal and plantar foot
Hwanjun Choi, Korea, Rep. of South
082 Faster than projected healing in chronic venous and diabetic foot ulcers when treated
with intact fish skin grafts compared to expected healing times for standard of care:
An outcome-based model from a regional* hospital
Hilmar Kjartansson, Iceland
083 Efficacy of platelet rich plasma(prp) as a treatment modality for wound healing
Anna Jose, India
084 Case series evaluating thigh administered intermittent pneumatic compression (ipc) as an
adjunct therapy for patients with hard to heal mixed/venous leg ulcers
Nicola Ivins, United Kingdom
14:45-15:45 Free Paper Session: Basic and translational science Room 252B
Chairs: Joachim Dissemond, Alexandra Marques
086 Micropatterning of a cultured skin substitute with folliculoid appendages

087 Impact of the chronic wound microenvironment and the effect of marine omega-3 fatty
acids on in vitro wound healing
088 Side effects of frequently used antihypertensive drugs and antidiabetics at wound healing
in-vitro
043 Clinical evaluation of a multicomponent compression system:

Results of a prospective, observational, multicentre study on 702 patients
14:45-15:45 Journees CICA Session: Module 47: Therapeutic education of diabetic patients: ( ) Room
who does what? Bordeaux
Therapeutic education of diabetic patients: who does what?

Catherine Boegner, France
Therapeutic education of diabetic patients: who does what?
Aude Djongang Bourgery, France
16:00-16:30 Closing Ceremony and Prizes ( ) Room Maillot
Closing words and awards by SFFPC President and EWMA Scientific Recorder
Luc Téot, France
EWMA 2023 in Milan, Italy by AISLeC President
Laura Stefanon, Italy
38
1818 Scientific
th th
Scientific
Meeting
Meeting
ofof
thethe
Diabetic
DiabeticFoot
FootStudy
StudyGroup
Group
TheThe
Original
Original
Scientific
Scientific
Diabetic
Diabetic
Foot
Foot
Meeting
Meeting
Save
Savethe
thedate
date
16 16
- 18
- 18
September
September 2022
2022
Bratislava
Bratislava
· Slovakia
· Slovakia
Advancement
Advancement
of knowledge
of knowledge
on all
onaspects
all aspects
of diabetic
of diabetic
footfoot
carecare www.dfsg.org
www.dfsg.org
8TH ANNUAL CONFERENCE OF THE

International Association of
Diabetic Foot Surgeons (IADFS)
14 - 16 September 2022
Bratislava · Slovakia
Abstract submission deadline: 23 June 2022
International
Association
of Diabetic
Read more on www.iadfs.org Foot Surgeons
EWMA Publications
New and coming soon: Publications in 2021-2022
WOUND EWMA Curriculum:

CURRICULUM FOR
STUDENT NURSES WOUND CURRICULUM FOR STUDENT NURSES - EUROPEAN QUALIFICATION
EUROPEAN FRAMEWORK LEVEL 4
QUALIFICATION
FRAMEWORK
LEVEL 4
This curriculum presents a framework and key content on skin integrity and wound care which is
recommended for inclusion in student nurse curricula (general nurse education). In most countries in
Europe, this curriculum corresponds with the European Qualification Framework (EQF) level 4.
Published: December 2021
THE IMPACT OF
PATIENT HEALTH AND
EWMA Document:
LIFESTYLE FACTORS
ON WOUND HEALING THE IMPACT OF PATIENT HEALTH AND LIFESTYLE FACTORS ON WOUND HEALING
PART 1:
STRESS, SLEEP, SMOKING
PART 1: STRESS, SLEEP, SMOKING AND ALCOHOL, COMMON MEDICATION AND ILLICIT
AND ALCOHOL, COMMON
MEDICATION AND ILLICIT
DRUG USE
PART 2:
PHYSICAL ACTIVITY
AND NUTRITION
DRUG USE
PART 2: PHYSICAL ACTIVITY AND NUTRITION
This document aims to provide a synthesis of current research on the impact of lifestyle factors and
risk factors for chronic illness on wound healing. It will also provide a comprehensive resource for
health care professionals and patients on how to integrate different lifestyle factors into their wound
management plan.
Published: March 2022
ES - TISSUE EWMA Document:

GI
TECHNOLO
NEW TECHNOLOGIES FOR TISSUE REPLACEMENT

RE
PLACEME
This document aims to review and highlight the new technologies for surgical management of chronic
wounds. The document targets wound care specialists with an interest in new therapies and aims to
W
NE
NT support the increasing demand for surgical solutions with the adequate indications within the complex
field of wound management.
The topic will be covered in a key session during the EWMA-CICA 2022 Conference:
Date and time: Wednesday 25 May, 13:30-14:30

Room: Amphitheatre Bleu
Expected publication: Summer 2022
EWMA Document:
ANTIMICROBIALS AND NON-HEALING WOUNDS. EVIDENCE, CONTROVERSIES AND
SUGGESTIONS (UPDATE OF DOCUMENT PUBL 2013)
The overall aim of this document is to provide an updated overview regarding use of antimicrobials,
particularly in non-healing wounds. The document will also highlight updated recommendations and
explain the concept of antimicrobial stewardship in wound management.
Expected publication: Summer 2022
40
EWMA Publications
Planned: Publications in 2023
EWMA Document:
HOLISTIC MANAGEMENT OF WOUND RELATED PAIN
The objective of this project is to outline best practice on some of the crucial elements in a successful
management of wound pain. The document will include:
- An overview of wound pain and its causes

- An introduction to a holistic assessment of the patient in pain and its documentation
- Identification and evaluation of strategies that may reduce pain during wound care procedures
(for example, dressing removal and wound cleansing)
- Considerations concerning local factors that may cause wound related pain
- Selection of dressings that can contribute to pain alleviation (atraumatic, pain-free removal, etc.)
EWMA Document:
NEGATIVE PRESSURE WOUND THERAPY
This document will be published as a follow-up document to the EWMA Document Negative Wound
Pressure Therapy: Overview, Challenges and Perspectives, published by EWMA in 2017.
As Negative Pressure Wound Therapy (NPWT) and our knowledge about the efficacy of the treatment
has evolved, this new publication will:
- Provide practical guidance based on the newest evidence and clinical practise
- Highlight the technological advances and new usage areas
- Highlight the challenges and opportunities related to the clinical application of all the
available NPWT solutions
- Explore and describe the role of NPWT in the provision of telemedicine services in
wound management
For download or more information about

the above publications and initiatives,
please visit www.ewma.org or contact
the EWMA Secretariat: ewma@ewma.org
41
EWMA EDUCATION ACTIVITIES
Education has been one of the cornerstones of EWMA since the association was established.
EWMA is committed to contribute to the further improvement of wound management and
wound care education in Europe. The education activities are coordinated by the
EWMA Education Committee. At the EWMA-CICA 2022 Conference, the following
education related activities will take place:
Tuesday 24 May EWMA Education Session 2022

11.15–12.15 EWMA Education Committee:
Room Havane
Equality and inclusivity of different skin tones in wound care teaching
for healthcare students: Sharing Good Practice
This EWMA Education Session will focus on recognizing pressure damage in individuals with
dark skin tones as well as examining how skin tone diversity is taught in undergraduate nursing
and medical student education.
The session is chaired by Samantha Holloway, Chair of EWMA Education Committee
Tuesday 24 May Teacher Network Meeting

13.30–14.30
Room 261 During the EWMA 2022 Conference the members of the EWMA Teacher Network will meet
for the 11th time. The network offers an opportunity for teachers of wound management at
educational institutions all over Europe to get together and share views, experiences, and ideas
with peers from different teaching cultures and backgrounds.
The topics on the agenda of the meeting in Paris are: Use of EWMA Educational Materials in
Learning and Teaching
If you wish to join the network or the meeting, please contact the EWMA Secretariat:
ewma@ewma.org
42
INFORMATION
E-POSTER SESSIONS AND
PAPER POSTER WALKS
E-poster sessions will take place in the e-Poster area located in the Exhibition area.
Paper poster walks will take place in the paper poster area located on level 3.
Monday 23 May
PROGRAMME
OVERVIEW
e-Poster session: Antimicrobials and infection Monday 23 May 2022, 11:45-13:00 CEST Screen 1
e-Poster session: Dressings Monday 23 May 2022, 11:45-13:00 CEST Screen 2
e-Poster session: Acute Wounds Monday 23 May 2022, 15:30-16:30 CEST Screen 1
e-Poster session: Diabetic Foot Monday 23 May 2022, 15:30-16:30 CEST Screen 2
Paper Poster Walk: All categories, Monday 23 May 2022, 15:00-15:30
PROGRAMME
Tuesday 24 May
DETAILED
e-Poster session: E
ducation, e-Health, Nutrition and
Tuesday 24 May 2022, 9:45-11:00 CEST Screen 1
Health Economics & Outcome
e-Poster session: Devices & Intervention Tuesday 24 May 2022, 9:45-11:00 CEST Screen 2
e-Poster session: N
egative Pressure Wound Therapy Tuesday 24 May 2022, 12:30-13:30 CEST Screen 1
e-Poster session: Leg Ulcers Tuesday 24 May 2022, 12:30-13:30 CEST Screen 2
e-Poster session: Wound Assessment Tuesday 24 May 2022, 13:45-14:15 CEST Screen 1
e-Poster session: Burns Tuesday 24 May 2022, 13:45-14:15 CEST Screen 2
e-Poster session: Atypical Wounds Tuesday 24 May 2022, 16:15-17:15 CEST Screen 1
SESSIONS
e-Poster session: Pressure Ulcers Tuesday 24 May 2022, 16:15-17:15 CEST Screen 2
Paper Poster Walk: All categories, Tuesday 24 May 2022, 15:45-16:15
Wednesday 25 May
e-Poster session: Basic and translational Science Wednesday 25 May 2022, 10:00-10:45 CEST Screen 1
e-Poster session: P
revention, Home Care, Covid-19
Wednesday 25 May 2022, 10:00-10:45 CEST Screen 2
and Quality of Life
POSTERS
All abstracts are available in the conference app and in the online programme found on www.ewma2022.org.
SATELLITE
SYMPOSIA
SPONSORS &
EXHIBITORS
43
E-POSTER AND PAPER POSTER OVERVIEW
Underlined = Presenting author
EP = Electronic poster
PP = Paper poster
ACUTE WOUNDS
EP001 A NOVEL TISSUE PRESERVING APPROACH TO TREATMENT OF WOUNDS WITH UNDERMININGS OR WOUNDS WITH POCKETS:
A CASE SERIES
Igor Melnychuk | Julia Juriga
EP002 MODIFIED UNNA BOOT. A NOVEL COMPRESSION THERAPY TO TREAT DEHISCED INCISIONS AFTER BELOW-KNEE
AMPUTATIONS
Terrance Smith | Igor Melnychuk | Tina Davis | Julia Juriga
EP003 WOUND REMODELING. ”EDGE TRENCHING” -- A NOVEL DEBRIDEMENT TECHNIQUE

Igor Melnychuk | Cecily Thompson | Julia Juriga
EP004 CROSS-SECTOR INTERVENTIONS TO ENHANCE HEALING TIMES AFTER LEG AMPUTATION

Jane Hampton | Karina Larsen | Else Buus | Grete Kistrup | Berit Pedersen Haa
EP005 USE OF HYPEROXYGENATED FATTY ACIDS FOR SKIN PROTECTION DURING THE COVID-19 PANDEMIC IN SPAIN:
SURVEY OF PROFESSIONALS
Marc Moliner Llopis | Merce Girona | Jose Bonilla | Miquel Sanz | Roger Garcia Marfany | Serge Bohbot | Josep Garcia
EP006 PREVENT TREAT RECOVER - TURNING AROUND SKIN TEAR MANAGEMENT

Sitthichai Rees | Beth Freeman-Gray
EP007 HYPERBARIC OXYGEN THERAPY IN THE TREATMENT OF POSTOPERATIVE ABDOMINAL WOUND INFECTION - A CASE REPORT
Mia Grkovic | Maja Radić | Emanuela Marcucci | Mario Dugonjić | Mario Franolić | Marin Marinovic | Boris Reinic
EP008 MANAGEMENT OF FULL-THICKNESS SKIN DEFECTS DUE TO HIGH-ENERGY TRAUMA: OUR EXPERIENCES WITH ACELLULAR
DERMAL SUBSTITUTE
Maya Argirova | Yolanda Zayakova | Anastasiya Viktorova | Tanya Dimitrova
EP009 EARLY INTERVENTION OF WOUND SPECIALIST FOR THE PREVENTION OF METATARSAL AMPUTATION AND OTHER MAJOR
COMPLICATIONS: A CASE STUDY
Chausha Weitman Cernica | Irina Greenberg
EP010 PREVENTION AND MANAGEMENT OF MEDICAL ADHESIVE RELATED SKIN INJURY IN THE REPUBLIC OF KOREA
Sojung Kim
EP011 MANAGEMENT OF OBSTETRIC SURGICAL SITE INFECTION IN A TERTIARY HOSPITAL USING POLYMERIC MEMBRANE
DRESSING: A CASE SERIES
Chin Yen Lee | Jacob Abraham
EP012 MEDICAL GRADE HONEY FOR THE TREATMENT OF EXTRAVASATION-INDUCED INJURIES IN PRETERM NEONATES
– A CASE SERIES
Eleftherios Smaropoulos | Niels Cremers
EP013 TREATMENT OF DEEP WOUND DEFECTS IN TRAUMA SURGERY – USE OF A COLLAGEN MATRIX AND SPLIT-THICKNESS SKIN
GRAFTS IN ONE-STEP PROCEDURE IN CRITICAL SITUATIONS
Ercan Sagnak | Marlene Schepers
EP014 THE EFFECT OF TRANEXAMIC ACID ON POSTOPERATIVE ECCHYMOSIS AND EDEMA IN EXCISION OF LIPOMA
Young-Jun Choi
EP015 EVIDENCE OF BACTERIAL BIOFILM FORMATION WITHIN ACUTE WOUNDS: A SYSTEMATIC REVIEW
Bethany Lee Patenall | Joanne D. Ridgley | Toby Jenkins | Amber Young
EP016 MICROGRAFTING FOR BURNS; REVIEW ON ITS OUTCOMES. SEARCHING FOR THE SUPERIOR SKIN GRAFTING TECHNIQUE
Daniëlle Rijpma | Karel EY. Claes | Henk Hoeksema | Ignace De Decker | Jozef Verbelen | Stan Monstrey | Anouk Pijpe | Paul van Zuijlen |
Annebeth de Vries
PP01 PROTEAS-MODULATING POLYACRYLATE BASED HYDROGEL IN THE TREATMENT OF HEMATONA WHEN NPWT FAILED
Guy Duboccage | Hadewijch Pecceu
PP02 IGG-IMMUNE COMPLEXES ACCELERATE WOUND HEALING BY RECRUITING NEUTROPHILS VIA FCΓ RECEPTOR IIA AND LFA-1
Hao Zhang | Qian Tan
PP03 THE USE OF A LIGHT VISCOSE NET DRESSING* IN PATIENTS WITH LARGE POSTOPERATIVE WOUNDS COMPLICATED WITH
MULTIPLE FISTULAS
Sima Ben Shitrit
ANTIMICROBIALS
EP017 AN OZONIDE IN HYDROGEL FORMULATION TO DEBRIDE NECROTIC INFECTIOUS WOUNDS AND PROMOTE GRANULATION AT
THE SAME TIME: PRELIMINARY RESULTS
Roberto Cassino | Gabriela Sofia Barrionuevo Moreno | Lorella Bettaglio | Alessia Mobini | Agnieszka Kopniak
44
INFORMATION
EP018 EFFECT OF NANOCRYSTALLINE SILVER†, DIALKYLCARBAMOYLCHLORIDE (DACC) COATED‡ & NON-MEDICATED GAUZE*
DRESSINGS ON THE PROLIFERATION OF MRSA & P. AERUGINOSA ON SIMULATED CONTAMINATED WOUNDS
Daniel Fitzgerald | Matthew Hardman | Emma Forrest
EP019 EFFECT OF NANOCRYSTALLINE SILVER†, DIALKYLCARBAMOYLCHLORIDE (DACC) COATED‡ & NON-MEDICATED GAUZE*
DRESSINGS ON THE PROLIFERATION OF MRSA & P. AERUGINOSA IN SIMULATED WOUND FLUID
Daniel Fitzgerald | Matthew Hardman | Emma Forrest
EP020 IN VITRO EFFICACY OF A SILVER POLYABSORBENT DRESSING FOR THE PREVENTION OF METHICILLIN-RESISTANT
STAPHYLOCOCCUS AUREUS AND P. AERUGINOSA BIOFILMS FORMATION
Nicolas Desroche | Cindy Dropet | Valerie Baraille | Thomas Wigniolle
EP021 ANTISEPTIC PERFORMANCE FOR CHRONIC WOUNDS USING AN ENHANCED EX VIVO HUMAN BIOFILM SKIN MODEL
Zach Siler | Marnie L. Peterson | Sarah Rogers | Benjamin Noren | Samantha Westgate
PROGRAMME
OVERVIEW
EP022 ANTIBACTERIAL NANOSTRUCTURED POLYMERS FOR PREVENTION OF SKIN WOUND INFECTION
Saba Atefyekta | Anand Rajasekharan | Martin Andersson | Edvin Blomstrand
EP023 BIOFILM CONTROL IN NEGATIVE PRESSURE WOUND TREATMENT

EP024 PERFORMANCE OF ANTIMICROBIAL IRRIGATION SOLUTIONS AND ANTISEPTICS CHALLENGED WITH ACUTE AND CHRONIC
HUMAN WOUND EXUDATE COMPARED TO STANDARD IN-VITRO CHALLENGE SUBSTANCES
Julian-Dario Rembe | Anna-Lena Severing | Mia Borkovic | Dr. Matthias Augustin | Ewa Klara Stürmer
EP025 TRIPLE ALLIANCE AGAINST BIOFILM: A SOLUTION FOR CLEANSING, A PAD FOR DEBRIDEMENT, A GEL FOR PREVENTION.
CHECKING RESULTS WITH A WOUND IMAGING DEVICE
Domitilla Foghetti | Maurizio Carnali | Sabina Sampaolo | Cinzia Ferretti | Silvia Bertinelli | Sara Muzzini | Giovanni Arcuri | Pamela Petroni |
PROGRAMME
Chiara Di Pietro
DETAILED
EP026 NON-THERMAL AIR PLASMA MODULATES SKIN WOUND HEALING IN DIABETIC RATS
Sarka Kubinova | Lenka Uherkova | Milada Chudickova | Kristyna Kekulova | Oleksandr Churpita | Oleg Lunov | Alexandr Dejneka
EP027 THE IMPACT OF ANTIMICROBIAL RESISTANCE ON TOPICAL TREATMENT SELECTION

Brackman Gilles | Tine Neefs | Youtha Van den Eynde | Eveline Torfs
PP04 BACTERIAL BINDING IN VITRO IS RELATED TO THE BACTERIAL LOAD AND COMPOSITION OF THE SURROUNDING MEDIA
Julia Hultén | Eric Wellner | Kristina Hamberg
ATYPICAL WOUNDS
EP029 PYODERMA GANGRENOSUM A CHALLENGE IN DIAGNOSIS AND THERAPY
SESSIONS
Tigla Alexandru
EP030 SEVERE ERYSIPELAS TREATED WITH NEGATIVE PRESSURE THERAPY AND ADJUVANT HYPERBARIC OXYGEN THERAPY
IN A PATIENT WITH FILARIASIS: A CASE REPORT
Raquel Araujo da Silva Carneiro | Mariana Masimessi Fernandes | Arthur César Pacheco Lopes | Luiz Humberto Souza Junior |
Bianca Bastos | Carolina Palmeira
EP031 FOOT ULCER ASSOCIATED WITH EOSINOPHILIC FASCIITIS AGGRAVATED BY ARTERIOVENOUS FISTULA BENEATH THE ULCER
Yuehong Shen | Wu Ding
EP032 EFFICACY AND EFFECTIVENESS OF USING PASTE TYPE OF ACELLULAR DERMAL MATRIX IN VARIOUS TYPES OF CHRONIC
WOUND
Hyung-Sup Shim | Kyeong Soo Park
EP033 PURE ALCOHOL SCLEROTHERAPY FOR MANAGEMENT OF LARGE CHRONIC COMPLICATED WOUND
POSTERS
Hyung-Sup Shim | Kyeong Soo Park
EP034 ATYPICAL WOUNDS OF PYODERMA GANGRENOSUM WITH SIMULTANEOUS HIDRADENITIS SUPPURATIVA: A CASE REPORT
EP035 DELAYED DIEP FLAP DURING CHRONIC INFECTION IN THE SETTING OF BREAST IMPLANT RECONSTRUCTION
Seung-eun Hong
EP036 CHALLENGING ULCERS IN KID SYNDROME - A CASE REPORT

Jane Thinggaard Knudsen | Sumangali Chandra Prasad
EP037 MARTORELL HYPERTENSIVE ISCHEMIC ULCER SUCCESSFULLY TREATED WITH APPROPRIATE WOUND CARE AND TIMELY
SKIN GRAFTING
Sumangali Chandra Prasad | Jane Thinggaard Knudsen
SATELLITE
SYMPOSIA
EP038 EXPERIENCES WITH POLICRESULEN IN THE TREATMENT OF REFRACTORY OVERGRANULATION WOUND

Seung-eun Hong
EP039 PLATELET GEL IN TREATMENT OF SKIN GRAFT DONOR SITE CHRONIC WOUNDS
Saša Milićević | Milica Jačevski
EP041 ULCERS ON THE NASAL DORSUM: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE

Celia Horcajada Reales | Carmen Romero Rodríguez | Alejandro Lledó Carballo | Agustín Crespo Moreno | Elena Conde Montero |
Jesús Borbujo
EP042 INTACT FRAGMENTED FISH SKIN GRAFT USED TO FILL A SINUS PILONIDAL WOUND: A CASE SERIES
Anna Sverrisdóttir
PP05 LOCAL MANAGEMENT OF PYODERMA GANGRENOSUM: OUR EXPIERENCE

SPONSORS &
EXHIBITORS
Pierluigi Gallo | Federica Maiello | Consiglia Staiano | Luigi Cacace | Giuseppina Oliviero | Bruno Iaccarino | Teresa Piccolo | Diana Barone |
Agnese Turco | Serena Striano
45
PP06 HBOT AND ADVANCED WOUNDCARE IN A 38 YEAR OLD WOMAN WITH COMPLEX WOUNDS AND MIXED CONNECTIVE TISSUE
DISEASE
Ellen Kop | Marco Warbout | Nina Lansdorp | Roy van den Berg
BASIC SCIENCE
EP044 A 3D CELL PRINTED MUSCLE TISSUE FOR FUNCTIONAL MUSCLE RECOVERY IN VML INJURIES
Young Joon Jun
EP046 OSCILLATORY SHEAR STRESS PROMOTES ANGIOGENIC EFFECTS IN ARTERIOVENOUS MALFORMATIONS ENDOTHELIAL
CELLS
Hyeon Jun Jeon | Jung Ho LEE | Yun Hyun Kim | Jeong Yeop Ryu | Joon Seok Lee | Jeong Woo Lee | Eun Jung Oh | Hyun Mi Kim |
Seok-Jong Lee | Jongmin Lee | Sang Yub Lee | Seung Huh | Ji Yoon Kim | Saewon Im | Ho Yun Chung
EP047 THE EFFECT OF THREE DIFFERENT TYPES OF SILICONE IMPLANT SURFACE TOPOGRAPHY ON CAPSULE FORMATION
AROUND SILICONE IMPLANTS IN VIVO AND IN VITRO
Hyeon Jun Jeon | Taehyun Park | Joon Seok Lee | Jung Dug Yang
EP048 COMPARATIVE STUDY OF THE VOLUME REPLACEMENT EFFICACY OF VARIOUS DERMAL FILLERS
Sang Wha Kim
BURNS
EP050 THE EFFICACY OF HYALURONIC ACID COMBINED WITH SILVER SULPHADIAZINE IN THE MANAGEMENT OF SECOND DEGREE
BURNS WITH DIFFERENT ETIOLOGY
Mihaela Pertea | Dorin Sumanaru | Alexandru Amarandei | Petru Ciobanu
EP051 APPLICATION OF MEDICAL GRADE HONEY IN HEALING BURN WOUNDS

Renee Hermans
EP052 EFFECTIVENESS OF THE ARGININE-CARNITINE DRUG USAGE IN PATIENTS WITH BURN WOUNDS
Oleksandra Lynnyk | Heorhii Kozynets | Olga Kovalenko
EP053 THE USE OF INTACT FISH SKIN GRAFTS AS A NOVEL METHOD OF MANAGEMENT FOR DERMAL BURNS FOLLOWING
ENZYMATIC DEBRIDEMENT: A CONTROLLED RETROSPECTIVE CASE SERIES
Christoph Wallner | Jana Holtermann
JOURNAL OF WOUND
MANAGEMENT
O F F I C I A L J O U R N A L O F T H E E U R O P E A N W O U N D M A N A G E M E N T A S S O C I AT I O N
A double-blind peer reviewed, free to access journal

for health care professionals worldwide. Widely distributed
to a broad international wound care community
Now accepting submissions for our upcoming issues: https://jowm.manuscriptmanager.net/
Editor: Prof Georgina Gethin
www.ewma.org
INFORMATION
EP054 CLINICAL EXPERIENCE IN BURNS TREATMENT USING LMW-HYALURONIC ACID TOPICS
Camelia Tamas | Caterina Lorenzi | Alexandru Robul | Ecaterina Samoila | Audrey Clebant | Ioana Tamas | Angela Tecuceanu
EP055 AN ALGORITHMIC APPROACH FOR DIFFERENT DEGREES OF FACE BURNS

Gaye Filinte | Cagla Cicek | Zafer Kaya | Murat Yaman
EP056 ENZYMATIC THERAPY IN BURNS TREATMENT : EFFICIENCY AND LIMITS

Angela Tecuceanu | Dan Moraru | Andreea Corduneanu | Dabija Iulia | Olaru Florin | Ioana Munteanu | Nadia Aladari | Camelia Tamas
EP058 FLUORESCENT LIGHT ENERGY IN SECOND DEGREE BURNS: A PRELIMINARY EXPERIENCE

Franco Bassetto | Alberto Crema | Giuseppe Masciopinto | Carlotta Scarpa
EP059 ADVANCED FACIAL BURNS MANAGEMENTS IN SEVERELY BURNED PATIENTS: A SERIES OF 10 CASES
Magaly Yarza | Carlos Segovia
PROGRAMME
OVERVIEW
CASE STUDIES
EP205 TREATING A PILONIDAL SINUS DISPLAYING MALIGNANT TRANSFORMATION, WITH NEGATIVE PRESSURE WOUND THERAPY
WILL BE CLINICALLY APPROPRIATE
Rachel Eyre | Pauline Whitehouse | Katie Jones | Ross Kenny | Joanne Handsaker
EP206 ACELLULAR EXTRACELLULAR MATRIX ON AN INFECTED AMPUTATION WOUND IN A DIABETIC PATIENT - FIRST EXPERIENCE IN
A VASCULAR SURGERY DEPARTMENT
Tiago Ribeiro | Rita Soares Ferreira | Joana Costa | Raquel Alves | Maria Emília Ferreira
EP207 EVALUATION OF THE USE OF HYDROPHILIC FOAM WITH ANTIMICROBIALS FOR THE TREATMENT OF BURNS WITH
PROGRAMME
HYPERGRANULATION
DETAILED
Maria Ines Diaz | Claudia Ramirez | Alberto Felipe Torres Gueren | Karen Perez
EP208 FEASIBILITY STUDY WITH A NEW MICROTRANSPLANT DEVICE AND CONTROLLED COMPRESSION TREATMENT
Andreas Nilsson | Charlotta Arrhenius | Torbjörn (Toby) Lundh
EP209 AN INNOVATIVE APPROACH TO MANAGE PAIN AND STIMULATE HEALING IN ARTERIAL ULCERS USING ELECTRICAL
STIMULATION THERAPY*
Patricia Terrill | Elizabeth Ovens
EP210 EVALUATION OF THE EFFECTIVENESS OF THE USE OF PRODUCTS WITH POLYHEXANIDE (PHMB 0,2%) IN THE TREATMENT OF
GENITAL INJURY CAUSED BY AUTOINFLAMMATORY DISEASE (CAPS)
Vera Lucia Andreoli | Tania Melo
EP211 ANOREXIA NERVOSA AND CHRONIC WOUNDS

Javorka Marković Delić
SESSIONS
EP212 TREATMENT OF A PAINFUL ARTERIAL ULCER WITH HYPERBARIC OXYGEN TREATMENTS AND ELECTRICAL STIMULATION
Irem Tezer Ates
EP213 USAGE OF ELECTRICAL STIMULATION FOR THE TREATMENT OF DIABETIC NEUROARTHROPATHY

Irem Tezer Ates
EP214 SUSTAINABLE WOUND CARE MANAGEMENT

Irem Tezer Ates
EP215 CLINICAL EXPERIENCE OF MOIST TO JUMPSTART HEALING OF STALLED SURGICAL WOUNDS

Tan Kok Kuan | Matthew Tan | Diane Eng
EP216 A CASE SERIES USING MANUKA HONEY TO TREAT WOUND INFECTION IN POST OPERATIVE HEAD AND NECK CANCER
WOUNDS
POSTERS
Inger Jensen
EP217 COVID 19 PANDEMIC

Hasan Murat Arslan | Şerife Kelle Dikbaş
EP218 PERFORMANCE OF AN ANTIMICROBIAL GELLING FIBER DRESSING IN COMBINATION WITH A SOFT SILICONE FOAM DRESSING
IN THE MANAGEMENT OF MEDIUM TO HIGHLY EXUDING WOUNDS – A CASE SERIES
Else Sværke Henriksen
EP219 EFFECTIVENESS OF HYPERBARIC OXYGEN IN A DRUG INDUCED WOUND : A CASE REPORT

Aharon Wanszelbaum | Marina Karasik | rachel malakh | yoav kamkaji | Tsvi Levy | Nahum Greenberg
EP220 HYPEROXYGENATED FATTY ACIDS IN SURGICAL WOUNDS WITH SIGNS OF HYPOXIA

Viviana Goncalves | Maria Luisa Albuquerque
SATELLITE
SYMPOSIA
EP221 PACIENT WITH MALIGNANT WOUND (SKIN CARCINOSIS) - CASE REPORT

Maja Vrhovnik | Andreja Klinc
EP222 LARVAL THERAPY IN COMPLEX WOUND DEBRIDEMENT

Sara Correia | Aida Paulino | Isabel Alves Costa | Otília Maria Sequeira Barata Courela | Maria Teresa Ferreira da Costa de Azevedo Silva
EP223 SECOND DEGREE BURN ON FACE TREATED WITH SPECIAL COVERINGS AND ADJUVANT HYPERBARIC OXYGEN THERAPY:
CASE REPORT
Tammila de Lima Almeida | Ana Flávia Novaes | Arthur César Pacheco Lopes | Luiz Humberto Souza Junior | Bianca Bastos |
Clezio Figueiredo Martins
EP224 THE USE OF INTACT FISH SKIN GRAFTS IN HIDRADENITIS SUPPURATIVA PATIENTS TO AID WOUND HEALING, A CASE SERIES
Baldur T Baldursson
SPONSORS &
EXHIBITORS
EP225 TOBACCO PLANT DERIVED RECOMBINANT HUMAN COLLAGEN IN MANAGEMENT OF ATYPICAL AND HARD-TO-HEAL LOWER
LIMB ULCERS - A CASE STUDY SERIES
Giorgio Guarnera | Raoul Borioni | Laura Fratticci | Maria Chiara Tesori | Carolina Paciotti
47
EP226 THE HEALING EFFECT OF MATRIX RHYTHM THERAPY ON CHRONIC LEG ULCERS (CLU): CASE SERIES FROM A SINGLE
INSTITUTION
Harish Kumar | Ozlem Hammond | Ulrich Randoll
EP227 MOIST EXPOSED BURN OINTMENT AS THE SIMPLE TOOL FOR REGENERATIVE WOUND HEALING
Kee Ai Wong
EP228 PAEDIATRIC WOUND CARE: USE OF ENZYME ALGINOGEL ON A FRICTION BURN

Geraldine McCormack
EP229 AN ALGINOGEL IN THE MANAGEMENT OF A DIABETIC FOOT ULCER (DFU)

Steffi Born
EP231 THE MANAGEMENT OF A DEHISCED BREAST WOUND WITH AN ENZYME ALGINOGEL

Georgina McKay | Paula Smith
COVID-19
EP060 A MULTI-METHODS STUDY INVESTIGATING THE IMPACT OF COVID-19 ON ACTIVE DIABETIC FOOT ULCERATION: A SCOPING
REVIEW AND PILOT PATIENT STUDY
Sinead Flynn | Caroline McIntosh
DEVICES & INTERVENTION
EP061 PHOTOBIOMODULATION IN PRESSURE INJURIES AND IAD: PRELIMINARY RESULTS OF A NEW THERAPEUTIC APPROACH
Roberto Cassino | Irena Cela | Rossana Dovico | Cristina Galuzzi | Agnieszka Kopniak
EP062 HOW TO IMPROVE TELEMEDICINE- NON-CONTACT APPROACH: INFRARED THERMOGRAPHY

Irem Tezer Ates
EP063 PHOTOBIOMODULATION WITH BLUE LIGHT AS ADJUVANT THERAPY IN WOUND MANAGEMENT: THE EXPERIENCE OF MARCHE
REGIONAL HEALTH UNIT – ZONE 2, ITALY
Massimiliano Paolinelli | Barbara Bertini | Daniela Borra | Sabrina Tombolesi | Valeria Vitali | Silvia Bertinelli | Pamela Orazi |
Donatella Rossolini | Remo Ronchi | Maurizio Carnali
EP064 CLINICAL EVALUATION OF THE RESPONSE RATE TO A CONTINIOUSLY ACTIVE, SINGLE-USE ELECTRICAL STIMULATION
DEVICE IN STATIC NON-HEALING WOUNDS
Peter Kurz | Gabriele Danner | Robin Martin
EP065 INFLUENCE OF DIFFERENT PHOTOBIOMODULATION PARAMETERS ON MULTIPOTENT ADIPOSE TISSUE MESENCHYMAL CELLS
IN VITRO
Ana Paula Ferro | Rinaldo Roberto de Jesus Guirro | Maristela Delgado Orellana | Gil Cunha de Santis | Jayme Adriano Farina Junior |
Elaine Calderia de Oliveria Guirro
EP066 MINIMAL INVASIV APPROACH USING COLD ATMOSPHERIC PLASMA TO AVOID A HIGH RISK OPERATION - SUBJECT-SPECIFIC
CONCEPT FOR COMPLEX WOUNDS IN CARDIAC SURGERY
Heinrich Rotering
EP067 DECELLULARIZED FISH SKIN GRAFT IN WOUNDED CHILDREN DURING THE COVID-19/20 ERA
Guido Ciprandi | Hilmar Kjartansson | Serena Crucianelli | Baldur Tumi Baldursson | Francesca Grussu | Craig Fraser | MI Rizzo |
Urbano Urbani | Faustino Simone Maria Marino | Stefano Latorre | Marta Cajozzo | Giancarlo Palmieri | Giorgio Proia | Giorgio Spuntarelli |
Mario Zama
EP068 EASE OF USE OF WEARABLE, SINGLE-USE ELECTRICAL STIMULATION DEVICE FOR THE MANAGEMENT OF HARD-TO-HEAL
WOUNDS
Carlos Cancela | Manuel Cruz | Evo Kaha | Peter Kurz | Hanna Leemet
EP069 INTACT FISH SKIN GRAFT (FSG) RESULTS IN FASTER TIME TO HEALING AND LOWER COST IN PATIENTS WITH VENOUS LEG
ULCERS (VLU ) AND DIABETIC FOOT ULCERS (DFU) COMPARED TO STANDARD OF CARE (SOC): AN OUTCOME-BASED PRICING
MODEL
Hilmar Kjartansson | Craig Fraser | Eduardo Theiler
EP071 TWO PROOF-OF-CONCEPT CASE STUDIES USING MESHED FISH SKIN IN COMBINATION WITH MESHED SLIT SKIN GRAFTS FOR
IMPROVED HEALED WOUND RESULTS
Werner Herzig
EP072 USE OF PLASMA ENRICHED IN PLATELETS AND MONOCYTES FOR TISSUE REGENERATION: 25 CLINICAL CASES
Alessandro Corsi | Ornella Forma | Stefano Fiorentino | Luca Santoleri
EP073 BLUE LIGHT EMISSION IN THE MANAGEMENT OF CHRONIC WOUNDS: OUR EXPERIENCE
Giulia Davini | Agata Janowska | Giammarco Granieri | Cristian Fidanzi | Simona Sbolci | Valentina Dini | Marco Romanelli
EP074 EFFICACY AND SAFETY OF CO2 LASER IN WOUND BED DEBRIDEMENT OF CHRONIC LEG ULCERS
Giammarco Granieri | Giulia Davini | Agata Janowska | Cristian Fidanzi | Marco Romanelli | Valentina Dini
EP075 A CASE STUDY: COMPLETE HEALING OF A CHRONIC VASCULAR WOUND-POST-GANGRENE AMPUTATION/SKIN GRAFTING-
UTILIZING MATRIX RHYTHM THERAPY- A NON-INVASIVE MECHANO-MAGNETICAL APPROACH
Sowkhya Sagare | Ozlem Hammond | Ulrich Randoll
EP076 NEW MEDICAL DEVICE IN WOUND HEALING: OXYGENATED COPPER (CU2O) IN MULTILAYER DRESSING
EP077 THE CURRENT STATE OF PLAY OF PHOTOBIOMODULATION AT 5 YEARS FROM INTRODUCTION ON THEMARKET:
OBESRVATIONAL ANALYSIS ON 500 PATIENTS
Alessandro Corsi | Ornella Forma | Davide Basile
48
INFORMATION
EP078 USE OF KINESIOTAPING FOR THE REDUCTION OF POST-SURGICAL COMPLICATIONS IN DERMATOLOGY
Agustín Crespo Moreno | Celia Horcajada Reales | Alejandro Lledó Carballo | Carmen Romero Rodríguez
EP079 PROOF OF PRINCIPLE: A HYGROSCOPIC CHEMICAL COMPOUND FOR THE RAPID REMOVAL OF BIOFILM AND NECROSIS IN
HARD TO HEAL ULCERS AND WOUNDS
Michel H.E. Hermans
DIABETIC FOOT
EP080 A NOVEL METHOD FOR THE ASSESSMENT OF EFFECTIVENESS OF ANTIBIOTIC THERAPY IN DIABETIC FOOT – PRELIMINARY
DATA (DFIATIM STUDY)
PROGRAMME
Vladimíra Fejfarová | Radka Jarosikova | Jitka Husakova | Veronika Woskova | Ivana Nováková | Jan Polak | Petr Tůma | Alexandra
OVERVIEW
Jirkovská | Michal Dubský | Robert Bem | Jakub Mrázek
EP081 GRAFT OF 3D BIO-PRINTED AUTOLOGOUS MINIMALLY MANIPULATED HOMOLOGOUS ADIPOSE TISSUE FOR THE TREATMENT
OF DIABETIC FOOT ULCER: A PILOT PROSPECTIVE CLINICAL STUDY
Ahmet Çınar Yastı | Ali Emre Akgün | Aziz Ahmet Sürel | Dr. Jeehee Kim | Merve Akin
EP082 INCREASING TRANSCUTANEOUS OXYGEN PRESSURE (TCPO2) IN PATIENTS WITH NEUROISCHAEMIC DIABETIC FOOT ULCERS
TREATED WITH A SUCROSE OCTASULFATE DRESSING
José Luis Lázaro Martínez | Marta García-Madrid Martín de Almagro | Josep Garcia | Serge Bohbot | Jose Luis Garcia Klepzig |
Yolanda García Álvarez
EP083 RESULTS OF A MULTICENTRE OBSERVATIONAL SURVEY ON HEALING PROPERTIES OF A TLC-AG POLY-ABSORBENT

DRESSING ON WOUNDS AT RISK OR PRESENTING SIGNS OF LOCAL INFECTION FOCUS ON DIABETIC FOOT ULCERS
Ralf Lobmann | Michael Dietlein | Winfried Keuthage
PROGRAMME
DETAILED
EP084 DIABETIC FOOT
Hasan Murat Arslan | Şerife Kelle Dikbaş
EP085 BLUE LIGHT PHOTOBIOMODULATION (PBM) TREATMENT AND DIABETIC FOOT: PRELIMINARY RESULTS
Maria Sambataro | Luisa Sambado | Raffaella Gobbo | Lisa Campagnol | Michele Barro | Maria Lisa Marcon | Agostino Paccagnella
EP086 COST EFFECTIVENESS ANALYSIS OF A TLC-SUCROSE OCTASULFATE DRESSING IN COMPARISON TO A NEUTRAL DRESSING
WITHIN THE TREATMENT OF DIABETIC FOOT ULCERS
Dr. Matthias Augustin | Ralf Lobmann | Holger Lawall | Wolfgang Tigges | Prof. Dr. Dr. Reinhard Rychlik | Claas Lüdemann
EP087 RESULTS OF A MULTICENTRE, PROSPECTIVE, OBSERVATIONAL STUDY ON THE HEALING PROPERTIES OF TLC-NOSF
POLY-ABSORBENT DRESSINGS* IN CHRONIC WOUNDS. FOCUS ON THE DIABETIC FOOT POPULATION
Claas Lüdemann | Joachim Dissemond | Steffen Luetzkendorf | Udo Möller | Elisa Becker | Serge Bohbot
EP088 FISH SKIN GRAFTS ARE A COST-EFFECTIVE TREATMENT OPTION FOR DIABETIC FOOT ULCERS
SESSIONS
Christopher Winters | Robert S Kirsner | David J Margolis | John Lantis
EP089 OUTCOMES OF FOOT ULCERS AMONG INDIVIDUALS WITH TYPE 2 DIABETES IN AN OUTPATIENT FOOT CLINIC
Roy Raoul Felipe
EP090 INCREASING TRANSCUTANEOUS OXYGEN PRESSURE (TCPO2) IN PATIENTS WITH NEUROISCHAEMIC DIABETIC FOOT ULCERS
TREATED WITH A SUCROSE OCTASULFATE DRESSING
José Luis Lázaro Martínez | Esther Garcia Morales | Yolanda García Álvarez | Marta García-Madrid Martín de Almagro | Irene Sanz |
Aroa Tardáguila García
EP091 EFFECTIVENESS OF OXIDATIVE STRESS CONTROL IN ISCHEMICAL DIABETIC FOOT ULCERS: CASE SERIES TREATED IN
A THIRD LEVEL HOSPITAL
Ana María Arnáiz Garcia | María Elena Arnáiz García | Sara Bellisco Roncal | Javier Arnáiz-García | María Abando Casuso |
Laura Carrasco Cortijo | Aurelio Sarralde Aguayo
POSTERS
EP092 DESCRIPTIVE STUDY OF HYPERBARIC OXYGEN THERAPY ON DIABETIC FOOT AND ASSOCIATED RISK FACTORS OF LOWER
LIMB AMPUTATION
Ana María Arnáiz Garcia | María Elena Arnaiz-García | Laura Carrasco-Cortijo | Sara Bellisco Roncal | Aurelio Sarralde Aguayo | Javier
Arnaiz García
EP093 BASIC FIBROBLAST GROWTH FACTOR (BFGF) COMBINED WITH NEGATIVE-PRESSURE WOUND THERAPY IN THE TREATMENT
OF DIABETIC LEG ULCERS
Seung-eun Hong
EP094 EFFECTIVENESS OF DEBRIDEMENT OF PLANTAR CALLUS IN PREVENTING DIABETIC FOOT ULCERS AT THE SEVERANCE
HOSPITAL IN THE REPUBLIC OF KOREA
Han Eun jin
EP095 GEL OBTENTION FROM CHILEAN PLANTS REDUCES INFLAMMATORY CYTOKINES IN DIABETIC FOOT ULCERS
SATELLITE
SYMPOSIA
Maria Ines Diaz | Claudia Ramirez | Alexis Zarate
EP096 THE USE OF PLATELETS DERIVED LYOPHILIZED GROWTH FACTORS IN CHRONIC WOUNDS HEALING
Hossam M. Fahmy
PP08 COLD PLASMA IS A NOVEL METHOD TO TREAT DIABETIC FOOT ULCER INFECTION
Mohammad Reza Amini | Mohammad Reza Mohajeri Tehrani
DRESSINGS
SPONSORS &
EXHIBITORS
49
EP097 TOPICALLY APPLIED AUTOLOGOUS BLOOD CLOT: CLINICAL OBSERVATION AND PROPOSED MECHANISM OF ACTION OF
CELLULAR AND TISSUE BASED THERAPY
Robert Snyder | Gregory Schultz | Chinenye Wachuku | Arij Rashid
EP098 PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY WITH AN ABSORBENT BACTERIA-BINDING FOAM DRESSING
– IMPACT ON PATIENTS’ QUALITY OF LIFE
Dr. Matthias Augustin | Christine Blome
EP099 3D-PRINTED ELASTOMERIC POLY (GLYCEROL SEBACATE) ACRYLATE SKIN DRESSING

Maria Fernandes | Luca Gasperini | Lucília da Silva | Rui L. Reis | Alexandra Marques
EP100 THE EFFICACY OF HEMOGLOBIN SPRAY IN WOUND MANAGEMENT: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
OF COMPARATIVE STUDIES
Chumpon Wilasrusmee | Napaphat Poproma | Chairat Supsamutchaia | Chaowanun Pornwaragorna | Suthas Horsirimanonta |
Jakrapan Jirasirithama
EP101 THREE-DIMENSIONAL SHAPE-CONFORMATION PERFORMANCES OF WOUND DRESSINGS TESTED IN A ROBOTIC SACRAL

PRESSURE ULCER PHANTOM
Adi Lustig | Amit Gefen
EP102 RESULTS OF A MULTICENTRE, PROSPECTIVE, OBSERVATIONAL STUDY ON THE PERFORMANCES OF TLC-NOSF

POLY-ABSORBENT DRESSINGS* ON CHRONIC WOUNDS
M Delonge | Udo Möller | Joachim Dissemond | Hauke Groth | Steffen Luetzkendorf | Winfried Keuthage
EP103 EFFICACY, TOLERANCE AND PRACTICALITY OF HYDROFIBER FOAM AND THIN FOAM HYDROCELLULAR DRESSINGS FOR THE
MANAGEMENT OF ACUTE AND CHRONIC WOUNDS: A SURVEY CONDUCTED AMONG REGISTERED NURSES WORKING IN
COMMUNITY SETTINGS ACROSS FRANCE
Pierre-Jérôme Pello | Séverine Bailly | Mohamed Frimane | Céline Saint-Martin | Valérie Cluzan | Grégory Vericel | Audrey Varutti |
Jacky Goslan | Christopher Jarvis | Claude Yvon
EP104 EFFICACY OF SEQUENTIAL TREATMENT OF TECHNOLOGY LIPIDO-COLLOID IMPREGNATED WITH SILVER (TLC-AG) AND
TECHNOLOGY LIPIDO-COLLOID NANO-OLIGO SACCHARIDE FACTOR (TLC-NOSF) IN THE MANAGEMENT OF VENOUS LEG
ULCERS (VLU)
Hui Min Tan | Cheng Cheng, Karine Goh | Peiting Lai | Sivakami D/O Muthuveerappa P | Mohamed Maliki Bin Mohamed Nasir |
Shanying Liang | Wei Leong, Glenn Tan | Sadhana Chandrasekar | Qiantai Hong | Enming Yong | Rhan Chaen, Lester Chong | Li Zhang |
Zhiwen, Joseph Lo
EP105 OPEN PROSPECTIVE OBSERVATIONAL CLINICAL STUDY: LEUKOMED CONTROL (LMC), A HYDROPOLYMER POLYURETHANE
FILM DRESSING, APPLIED FOR 14 DAYS TO IMPROVE INDIVIDUAL DAILY ROUTINE
Thomas Rousseau | Frederic RAYNAUD | Jacques BRESSE | patrick KERIEL | DANIELLE MALACAN | Samer ISMAEL
EP106 EVALUATION OF THE USE OF A SOFT SILICONE-COATED WOUND CONTACT LAYER ON ACUTE WOUNDS
Ulana Pawlak | Ka Chun Tsang | Kristina Blom | Henrik Ahlbom | John Timmons
EP107 EFFICACY AND SAFETY OF COPPER OXIDE IMPREGNATED WOUND DRESSINGS – RESULTS OF A PHASE I/IIA CLINICAL STUDY
Eyal Melamed | Alexey Rovitsky | Tohar Roth | Gadi Borkow
EP108 THE USE OF A NEW ADVANCED DRESSING TO A OLEIC MATRIX: RESULTS OF A CLINICAL STUDY
Stefania Fabrizi | Sara Sandroni
EP109 CARE OF SKIN GRAFT DONOR ZONES USING HYALURONIC ACID

Camelia Tamas | Dan Moraru | Iosip Bogdan | Costel Dobre | Ioana Tamas | Clara Larisa Popa | Diaconu Oana | Ilan Marcovici |
Angela Tecuceanu | Catalina Pintilie | Cezar Doru Radu
EP110 A COMPARATIVE STUDY OF NOVEL HYDROGEL DRESSINGS AND COMMERCIAL WOUND DRESSINGS FOR THE TREATMENT OF
EXUDATING WOUNDS
Manon Minsart | Arn Mignon | Sandra Van Vlierberghe | Peter Dubruel
EP111 WOUND HEALING EFFECT OF REGENERATED OXIDIZED CELLULOSE VERSUS FIBRIN SEALANT PATCH: AN IN VIVO STUDY
Hyunsik Yoon | Youncheon Na | Choonsoo Kim | Ensuk Heo
EP112 EVALUATION OF COMBINATED THERAPY WITH ANTIOXIDANT DRESSINGS AND TWO LAYER COMPRESSION SYSTEM IN
CHRONIC VENOUS ULCERS
Ana María Arnáiz Garcia | María Elena Arnáiz García | Javier Arnáiz-García | María Abando Casuso | Sara Bellisco Roncal |
Laura Carrasco Cortijo
EP113 THE MODERN APPLICATION OF MOIST EXPOSED BURN OINTMENT IN CHRONIC WOUND
Chin Yen Lee | Vilvkumaran Karupayah | Jacob Abraham
EP114 A PROSPECTIVE CLINICAL TRIAL EVALUATING A NOVEL DRESSING* ON PATIENTS WITH CHRONIC AND ACUTE WOUNDS IN
THE POST-ACUTE SETTING
Thomas Serena | Laura Serena | Khristina Harrell | Nicole Schrecengost | Keyur Patel | John Timmons
EP115 RESULTS OF A MULTICENTRE, PROSPECTIVE, OBSERVATIONAL STUDY ON THE PERFORMANCES OF A NEW TLC-NOSF
POLY-ABSORBENT DRESSING* ON CHRONIC WOUNDS
EP116 EPICITEHYDRO - AN ADVANCED TYPE OF BIOSYNTHETHIC CELLULOSE FOR THE TREATMENT OF CHRONIC WOUNDS
Dana Kralisch | Thomas Eberlein | Michael Schmitz | Paul Zahel | Uwe Beekmann | Oliver Werz
EP117 IN VITRO TESTING OF THE MMP BINDING CAPACITY OF TWO POLYURETHANE FOAM DRESSINGS
Horst Braunwarth | Christian Kamp Nielsen | Andrea Friedmann
PP09 MULTINATIONAL OBSERVATIONAL STUDY ON THE PERFORMANCE, HANDLING AND SAFETY OF A NEW ALGINATE WOUND
DRESSING
Claas Roes
PP10 EVALUATION OF A SUPERCORE DRESSING ON EXUDING CHRONIC WOUNDS

Charalambos Agathangelou | Sofoulis Achilleos
50
INFORMATION
PP11 RETENTION OF BACTERIAL PROTEASES BY DRESSINGS: AN IN VITRO EVALUATION
Goran Edenro | Eric Wellner
PP12 WOUNDS IN ONCOLOGY: HOW MANAGE A RISK OF INFECTION, INCLUDING BIOFILM SUSPICION?
Maxime Cheron | Marguerite Nicodeme | Elodie Labedade | Isabelle Fromantin
PP13 SILICONE DRESSINGS AND RE-EPITHELIALISATION - A POSSIBLE LINK TO SUPERIOR WOUND HEALING
Ausra Peciulyte | Fredrik Osla | Kristina Blom | Eric Wellner
EDUCATION
EP118 WOUND CARE WARRIOR PROGRAM
PROGRAMME
OVERVIEW
Shifa Basjarahil
EP119 SIMULATIONS IN WOUND CARE

Beáta Grešš Halász | Lucia Dimunová | Jakub Jánošík
EP120 KRATOM AND WOUND HEALING – A SCOPING REVIEW

Wan Zuraini Mahrawi
EP121 FACTORS INFLUENCING NURSING PERFORMANCE OF INCONTINENCE-ASSOCIATED DERMATITIS

Minkyung Kim
E-HEALTH
PROGRAMME
DETAILED
EP122 SUPPORTING CLINICAL DECISION-MAKING WITH A DIGITAL WOUND MANAGEMENT CHECKLIST
Sari Kaari | Kirsi Isoherranen
EP123 FEASIBILITY AND ACCEPTABILITY OF DIGITAL WOUND ASSESSMENT SOLUTION IN PRIMARY CARE SETTING
Zishan Ali | Alex Man | Nathaniel Bubis
EP124 ACCURACY VALIDATION STUDY FOR CHRONIC WOUND SURFACE AREA MEASUREMENTS ALGORITHM
Nathaniel Bubis | Alex Man | Naomi Yama
EP125 TELEMATICS WOUND CARE ASSISTANCE STAGE 3-4 PRESSURE ULCER IN TIMES OF COVID -19
Cristina Basantes
EP126 AN INTEGRATIVE APPROACH TO PROMOTE WOUND HEALING IN FACIAL-STAGE 3 PRESSURE ULCER SECONDARY TO PRONE
POSITION IN COVID-19 PATIENT: THE BENEFITS OF TELEMATICS ASSISTANCE
Carlos Zambrano | Cristina Basantes
SESSIONS
HEALTH ECONOMICS & OUTCOME
EP127 COST-EFFECTIVENESS OF CLOSED INCISION NEGATIVE PRESSURE THERAPY FOR SURGICAL SITE MANAGEMENT AFTER
REVISION TOTAL KNEE ARTHROPLASTY: SECONDARY ANALYSIS OF A RANDOMIZED CLINICAL TRIAL
Christine Bongards | Ronald Silverman | Herbert John Cooper
EP128 DIAGNOSTIC DELAYS OF THE WOUND PATIENT WITHIN THE PRIMARY CARE
Kirsti Ahmajärvi | Kirsi Isoherranen | Maarit Venermo
HOME CARE
POSTERS
EP129 INTERMITTENT PNEUMATIC COMPRESSION AND THE EFFECT OF DIFFERENT COMPRESSION SEQUENCING FOR TREATING
LOWER LIMB LYMPHOEDEMA
Nyree Dunn | Mark Williams | Gina Dolan | Jane Davies
EP130 PHOTOBIOMODULATION THERAPY, PBMT TREATMENT OF DIFFICULT TO HEAL ULCERS, IN FRAIL ELDERLY SUBJECTS, WITH
MUNICIPALITY HOME HEALTHCARE
Marianne Degerman | micael öhman
EP131 MEDICAL GRADE HONEY SWITCHES STAGNATED WOUNDS TO HEALING IN COMPLEX GERIATRIC PATIENTS
Cristina Quinteiro
PP14 FUNGATIVE WOUND: PSYCHOLOGICAL AND EMOTIONAL DISTRESS

SATELLITE
SYMPOSIA
Nabanita Mandal
INFECTION
EP132 MEDICAL GRADE HONEY OUTPERFORMS CONVENTIONAL TREATMENTS FOR HEALING COLD SORES – A CLINICAL STUDY
Piyu Naik | Dimitris Mossialos | Frank Wagener | Petra Novakova | Niels Cremers
EP133 VALIDATION OF THE TILI (THERAPEUTIC INDEX FOR LOCAL INFECTIONS) SCORE FOR THE DIAGNOSIS OF LOCAL WOUND
INFECTIONS: A RETROSPECTIVE EUROPEAN ANALYSIS
Joachim Dissemond | Robert Strohal | Diego Mastronicola | Eric Senneville | Cécile Moisan | Valerie Edwards-Jones | Kirsten Mahoney |
Adam Junka | Marzenna Bartoszewicz | José Verdú Soriano
SPONSORS &
EXHIBITORS
EP134 HOST RESPONSE DURING COLONIZATION OF BURN WOUNDS BY STAPHYLOCOCCUS AUREUS DIFFERS BETWEEN STRAINS
Bouke Boekema | Willem J.B. Van Wamel | Marcel Vlig | Sadaf Rauf | Esther Middelkoop | Magda Ulrich
51
EP135 ONCOLOGICAL WOUND. TREATED WITH HIPOCLOROUS ACID
Antonia Perez Troya
EP136 NECROTIZING FASCIITIS AFTER SURGERY - MANAGING THE WOUND CARE AND TREATING COMPLICATIONS
Timo Johann Clasen | Oleg Heizmann
EP137 MANAGING NECROTIZING FASCIITIS TO REDUCE MORTALITY AND INCREASE LIMB SALVAGE
Youn Hwan Kim
EP138 STERNAL TUBERCULOSIS: A CASE REPORT

Sang Wha Kim
EP139 GRANULATION OF VENOUS LEG ULCERS AFTER DEBRIDEMENT WITH A HYGROSCOPIC COMPOUND:
A RETROSPECTIVE ANALYSIS
Michel H.E. Hermans | Valter Deanesi | Arrigo Segalla | Alberto Cogo | Hans-Pieter Snels | Bert Quint
EP140 AN ALGINOGEL IN THE MANAGEMENT OF INFECTED INCONTINENCE ASSOCIATED DERMATITIS (IAD)

Amanda Pearson
EP141 SWAB – SMART WOUND ANALYSIS OF BACTERIAL VOLATILES

Shane Fitzgerald | Aoife Morrin | Linda Holland
PP15 EXOGENOUS NITRIC OXIDE IN THE TREATMENT OF INFECTED WOUNDS

Volodymyr Protsenko | Yevhen Solonitsyn | Anatoliy Rushay
LEG ULCER
EP142 PREDILECTION SITES OF 112 PATIENTS WITH CLEARLY CONFIRMED PYODERMA GANGRENOSUM
Maurice Moelleken | Joachim Dissemond
EP143 KNOWLEDGE, TEACHING AND LEARNING ABOUT ULCERS OF VENOUS AETIOLOGY IN NURSING PROFESSIONALS AND
STUDENTS: A SCOPING REVIEW
Iván Durán | Miriam Berenguer Pérez | Pablo Lopez-Casanova | José Verdú Soriano
Make a difference in clinical practice

Become a EWMA Member
Benefits of your EWMA Membership:

n You support the development and improvement of wound care in Europe
n 15% discount on your registration fee for EWMA Conferences
n Right to apply for EWMA Travel Grants
n Right to vote at and stand for election to the EWMA Council
n Update on activities and developments within EWMA via the EWMA Newsletter
Yearly membership fee € 25

Yearly membership fee for members of cooperating organisations € 10
Please register as a EWMA Member at EWMA.ORG

INFORMATION
EP144 COMPRESSION TREATMENT WITH CONTROLLED PRESSURE IN COMBINATION WITH A NOVEL WOUND DRESSING MAY
IMPROVE PATIENT SELF-CARE AND REDUCE HOSPITAL VISITS
Andreas Nilsson | Charlotta Arrhenius | Torbjörn (Toby) Lundh
EP145 EFFICACY AND SAFETY OF AN INNOVATIVE COMPRESSION SYSTEM FOR THE TREATMENT OF VENOUS OR MIXED LEG
ULCERS – FREEDOM CLINICAL TRIAL OUTCOMES
Patricia Senet | Joachim Dissemond | Azeddine Addala | Philippe Léger | Sophie Blaise
EP146 ADJUNCTIVE INTERMITTENT THIGH COMPRESSION FOR THE TREATMENT OF LOWER LIMB ULCERS
Nicola Ivins
EP148 ACCELERATED HEALING OF CHRONIC LEG ULCERS WITH EARLY TOPICAL OXYGEN THERAPY VIA HAEMOGLOBIN SPRAY :
A RETROSPECTIVE CHART REVIEW OF A COHORT FROM SINGAPORE
Diane Eng | Joachim Dissemond
PROGRAMME
OVERVIEW
EP149 THE EFFECT OF MATRIX RHYTHM THERAPY ON WOUND HEALING: A COLLECTION OF SIX CASES WITH CHRONIC LEG ULCERS
(CFU)
Sandeep Bhagwat | Danish Khan | Shirish Birajdar | Varun Naik | Anil Deshpande | Ozlem Hammond | Ulrich Randoll
EP150 RISK BASED WOUND TREATMENT AS ALTERNATIVE TO AMPUTATION

Hildegard Moser
EP151 THE CORRELATION BETWEEN REDUCING WOUND TIME TO HEALING AND IMPROVED QUALITY OF LIFE
Elizabeth Merlin-Kwan | Ross Forbes
EP152 USING INNOVATIVE DRESSING* TO TREAT LOWER LIMB ULCERATION TO OPTIMISE HEALING TIME
Christopher Webb | Fiona Marris
PROGRAMME
EP153 A COMPARISON OF INTERFACE PRESSURES OF 3 COMPRESSION THERAPY SYSTEMS: A FRENCH NURSES ASSESMENT IN
DETAILED
REAL-LIFE CONDITION
Serge Bohbot
EP154 CLINICAL EVIDENCE OF A TWO LAYER COMPRESSION THERAPY SYSTEM: FROM HEALTHY VOLUNTEERS TO REAL LIFE DATA
Jean Patrick Benigni | Serge Bohbot
EP155 IDENTIFICATION AND MANAGEMENT OF PHLEBOLYMPHEDEMA IN/ON LOWER LIMBS. A CASE REPORT
Carmen Romero Rodríguez | Celia Horcajada Reales | Alejandro Lledó Carballo | Agustín Crespo Moreno | Jesus Borbujo
EP156 RESULTS OF A MULTICENTRE, PROSPECTIVE, OBSERVATIONAL STUDY ON THE PERFORMANCES OF TLC-NOSF

POLY-ABSORBENT DRESSINGS* ON LEG ULCERS
PP16 LEVELS OF ANGIOGENIC REGULATORS AND MMP-2, -9 ACTIVITIES IN MARTORELL ULCER: A CASE REPORT
SESSIONS
Oleg Petrenko | Artem Tykhomyrov
PP17 WHAT IS THE EFFECT OF A PLANNED MULTIDISCIPLINARY TEAM APPROACH ON THE PREVENTION OF LOWER LIMB
AMPUTATION, IN PATIENTS SUFFERING FROM PERIPHERAL VASCULAR DISEASE? A SYSTEMATIC REVIEW
Claire O’Sullivan | Aglécia Budri | Declan Patton
NEGATIVE PRESSURE WOUND THERAPY
EP157 THE EFFECT OF FOAM AND GAUZE ON STERNUM WOUND IN NEGATIVE PRESSURE WOUND THERAPY
Muhammad Maleki | Yasaman Zeynalou | Hossein Hasani
EP158 NEGATIVE PRESSURE THERAPY IN PATIENTS WITH PRESSURE ULCERS

Mihaela Pertea | Petru Ciobanu | Dorin Sumanaru | Alexandru Amarandei | Alexandru Filip | Bogdan Veliceasa
POSTERS
EP159 CLINICAL EVALUATION OF A NOVEL, SINGLE-USE, NON-ELECTRICAL INCISIONAL-NEGATIVE PRESSURE SYSTEM BASED ON
SOLID-STATE OXYGEN REDUCTION
Jon Mathy | John Buan | Jeffrey Ustin | Robin Martin
EP160 EVOLUTION OF VIEWS IN THE SURGICAL TREATMENT OF PATIENTS WITH WOUND DEFECTS OF THE CHEST WALL
Mikhail Medvedchikov-Ardiia | Evgenii Korymasov
EP161 TRAUMATIC WOUND TREATED IN SPECIALIZED SERVICE OF WOUNDS USING ADJUVANT THERAPY WITH HYPERBARIC
OXYGEN THERAPY AND NEGATIVE PRESSURE THERAPY: A CASE REPORT
Niomar Aparecida Castro Machado | Laís Oliveira Lima Barbosa | Arthur César Pacheco Lopes | Luis Humberto Souza Junior |
Bianca Bastos | Clezio Figueiredo Martins
EP162 THE USE OF NPWT FOR CHRONIC WOUND MANAGEMENT

SATELLITE
SYMPOSIA
Camelia Tamas | Clara Larisa Popa | Iosip Bogdan | Costel Dobre | Irina Hreniuc | Cezar Doru Radu | Catalina Pintilie | Dan Moraru
EP163 NPWT INDUCED EFFECTIVE WOUND HEALING IN THE TREATMENT OF VASCULAR GRAFT INFECTIONS
Melinda Gadacsi | Gabor Menyhei | Istvan Rozsos | Gergely Vadasz
EP164 NEGATIVE PRESSURE TREATMENT IN MULTIPLE TRAUMA OF AN EIGHT MONTHS INFANT

EP165 MAJOR COMPLICATIONS DURING NEGATIVE PRESSURE WOUND THERAPY IN POSTSTERNOTOMY MEDIASTINITIS AFTER
CARDIAC SURGERY
Sardor Rakhmonov
EP166 POSITIVE RESUTS WITH NEGATIVE PRESSURE, ANALYSIS OF 389 PATIENTS TREATED WITH NPWT
Lenka Veverkova | Petr Doležal | Michal Reška | Petr Vlček | Jan Žák
SPONSORS &
EXHIBITORS
EP167 THE EFFICIENCY OF NEGATIVE PRESSURE WOUND THERAPY (NPWT) IN PLASTIC SURGERY – WOUND BED PREPARATION IN
SOFT TISSUE DEFECTS
Mihaela Pertea | Petru Ciobanu | Diana Al Khazaleh | Oxana-Madalina Grosu
53
EP168 EXTENSIVE WOUNDS IN CHILDREN - TREATMENT RESULTS
Sholpan Mukasheva | Dina Saginova | Tuyak Abiev | Amina Koshanova
EP169 THE ROLE NPWT OF OPEN ABDOMEN IN THE PERIOD 2011 - 2020
Lenka Veverková | Michal Reška | Petr Doležal | Petr Vlček | Jan Žák
EP170 NEGATIVE PRESSURE WOUND THERAPY WITH INSTILLATION AND DWELL TIME: THE FIRST 100 CASES
Franco Bassetto | Eleonora de Antoni | Alberto Crema | Carlotta Scarpa
EP171 THE NEGATIVE PRESSURE WOUND THERAPY IN THE TREATMENT OF STERNAL DEHISCENCE
Carlotta Scarpa | Cesare Tiengo | Eva Kohlscheen | Franco Bassetto
EP172 NEGATIVE PRESSURE WOUND THERAPY WITH INSTILLATION AND DWELL PLUS THE “THROUGH HOLES FOAM”:
AN OBSERVATIONAL RETROSPECTIVE CASE CONTROL STUDY
Carlotta Scarpa | Martina Grigatti | Sandro Rizzato | Franco Bassetto
PP18 THE DIFFICULT CASE: NPWT FOR EXTENSIVE SOFT TISSUE DEFECTS OF THE LOWER EXTREMITY
Rainer Stanek | Eva Pointner | Katja Canigiani de Cerchi | Gerhard Pomberger | Thomas Hölzenbein | Mehdi Mousavi
PP19 NEGATIVE PRESSURE WOUND THERAPY AFTER C. MAMMA SURGERY

Cathrine Kure Pleth Nielsen | Dorte Aude Andreasen | Helena Holm | Annette Høgh
PP20 A COMPACT TRADITIONAL NPWT . REDUCTION IN SIZE BUT NOT IN PERFORMANCE

Kathleen Leak | Susan Johnson
NUTRITION
EP173 THE EFFECT OF BEE POLLEN ON HEALING OF PRESSURE ULCERS IN DIABETIC PATIENTS
Amir Hossein Abdi Dorbashi | Neda Soltannejad
PRESSURE ULCER
EP174 DEVELOPING RISK-ADJUSTED QUALITY INDICATORS FOR PRESSURE ULCERS IN LONG-TERM CARE HOSPITALS IN THE
REPUBLIC OF KOREA
Jung Yoon Kim
EP175 PRESSURE INJURY CHALLENGES RELATED TO PRONE POSITION FOR COVID PATIENTS
Iman Ateeq
EP176 INCIDENCE AND ANALYSIS OF MEDICAL DEVICE RELATED PRESSURE ULCER : KOREA ACUTE CARE HOSPITAL
Jung Yoon Kim
EP177 WHAT MAKES A HYDROGEL-BASED DRESSING ADVANTAGEOUS FOR THE PREVENTION OF MEDICAL DEVICE-RELATED
PRESSURE ULCERS
Angela Grigatti | Amit Gefen
EP178 NATIONWIDE EPIDEMIOLOGICAL ANALYSES OF PRESSURE ULCERS – TEN YEARS FOLLOW UP

Andrea Pokorna | Petra Búřilová | Dana Dolanová | Simona Saibertová | Lenka Krupova | Klára Benešová | Miloslav Klugar | Jitka Klugarová
EP179 IMPROVEMENT IN QUALITY OF LIVE, REDUCTION IN HOSPITAL STAY AND COSTS FOR PATIENTS WITH FOURTH STAGE
PRESSURE ULCERS BY USING NEGATIVE PRESSURE DRESSINGS
Petru Ciobanu | Alina-Mihaela Stan | Diana Alkhazaleh | Dmitrii Leontii | Mihaela Pertea
EP180 PRINCIPLES OF PRESSURE ULCER PREVENTION AND TREATMENT

Diana Al Khazaleh | Alina-Mihaela Stan | Petru Ciobanu | Mihaela Pertea
EP182 THE USE OF NEGATIVE PRESSURE WOUND THERAPY AND HYPERBARIC OXYGEN THERAPY IN THE INTEGRATED CARE OF
SACRAL PRESSURE ULCER COMPLICATIONS: A CASE REPORT
Arthur César Pacheco Lopes | Joubert Felipe Luz Costa Brito | Anderson Souza Costa | Luiz Humberto Souza Junior | Cynara Eloy Ferreira |
Bianca Bastos | Carolina Palmeira
EP183 PRESSURE ULCERS OF COVID-19 PATIENTS RELATED INTENSIVE CARE UNIT ACQUIRED WEAKNESS
Zafer Kaya | Çağla Çiçek | Gaye Filinte | Mehmet Akkurt
EP185 ADVERSE EVENTS AFTER SURGERY

Lenka Veverkova | Petr Doležal | Michal Reška | Dana Damkova
EP187 A SURVEY OF 2 NATIONS PRACTICE OF PRESSURE ULCER CARE

Sylvie Meaume | Hester Colboc | Izabel Freret
PP21 KERATIN BASED GEL USE ON PRESSURE RELATED ULCERS IN LONG TERM CARE
Comprehensive Wound Johnson
PP22 AN INNOVATIVE BIOLOGICAL MATRIX: FIRST CLINICAL STUDY IN THE TREATMENT OF VENOUS LEG ULCERS
Henri-Pierre Suso | Jevgenija Purane | Ralf Schmidt | Luc Téot | Jean-Charles Kérihuel | Enda Kenny | Peter Vowden | Kevin Mercer
PREVENTION
EP189 MANAGEMENT OF SKIN MOISTURE IN HEELS: A SECONDARY ANALYSIS

Thaís Eberhardt | Suzinara Lima | Lidiana Silveira | Rhea Soares | Bruna Pozzebon | Karla Santos | Paulo Alves
EP190 ACTIVITIES TO PREVENT PHLEBITIS IN PATIENTS USING COMPREHENSIVE NURSING CARE SERVICE IN REPUBLIC OF SOUTH
KOREA
Hyunhee Ghil
54
INFORMATION
EP191 PREVENTION OF STERNOTOMY DEHISCENCE WITH NEGATIVE PRESSURE WOUND THERAPY IN PAEDIATRICS
Viviana Goncalves
PROFESSIONAL COMMUNICATION
EP232 PROTEAS-MODULATING POLYACRYLATE BASED HYDROGEL STIMULATES WOUND BED PRÉPARATION WHEN NPWT FAILED
Guy Duboccage | Marleen Dekeyzere | Ronald Cnockaert | Filiep Manderyck
EP233 COMBINATION OF USING SOLUTION BASED ON HYPOCHLOROUS ACID, TOPICALLY HEMOGLOBIN SPRAY AND POLYESTER
AND POLYESTER-COTTON RAPID CAPILLARY ACTION DRESSING IN TREATMENT OF HARD-TO HEAL CHRONIC ULCER CRURIS
WOUNDS
PROGRAMME
Marin Marinovic | Ana Marija Marinovic | Mario Franolić | Stanislava Laginja | Davor Primc | Boris Reinić | Emanuella Marcucci | Nera Fumić |
OVERVIEW
Josip Španjol
QUALITY OF LIFE
EP192 COMPARATIVE STUDY ON WOUND CLOSURE AFTER MINIMAL INVASIVE SURGERY USING SUTURES VS. CLOSURE STRIPS
Stefan Schneider | Michael Dietrich
EP193 EXAMINING THE IMPACT OF IMPLEMENTING AN EVIDENCE BASED PATHWAY AND MEASURING THE EFFECT ON IMPROVING
QUALITY OF LIFE PATIENTS WITH A LEG ULCER
Elizabeth Merlin-Kwan | Julie Mullings
PROGRAMME
DETAILED
TRANSLATIONAL SCIENCE
EP194 CHARACTERIZATION OF POLY(ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS AS POTENTIAL NEW DRUGS FOR CHRONIC
WOUND THERAPY
Nicole Schöfmann | Petra Doerfler | Anton Stuetz | Barbara Wolff-Winiski
EP195 REPURPOSING AN IRON CHELATION DRUG TO TREAT MUSCLE PRESSURE ULCERS IN MICE
N. Jannah M. Nasir | Hans Heemskerk | Nur Hidayah Hamadee | Peter So | Lisa Tucker-Kellogg
EP197 GLYCOSAMINOGLYCAN-BASED HYDROGELS IMPROVE WOUND HEALING IN CHRONIC WOUNDS

Lucas Schirmer | Passant Atallah | Uwe Freudenberg | Carsten Werner
EP198 BIOCOMPATIBILITY INDEX (CYTOTOXICITY AND ANTIMICROBIAL EFFICACY) OF ANTISEPTICS

Vojtěch Pavlík | Monika Štěpánová | Kristína Rusnáková | Hana Vágnerová | Kristina Nešporová | Vladimir Velebny
SESSIONS
PP23 APPLICATION OF THE HPBIOM IN A HUMAN WOUND MODEL FOR THE ANALYSIS OF WOUND HEALING AFTER BACTERIAL
INFECTIONS
Michael Dietrich | Manuela Besser | Ewa Klara Stürmer
WOUND ASSESSMENT
EP199 ULTRA HIGHT FREQUENCY ULTRASOUND ASSESSMENT OF LOWER LEG EDEMA BEFORE AND AFTER COMPRESSION
BANDAGING
Valentina Dini | Agata Janowska | Giulia Davini | Giammarco Granieri | Cristian Fidanzi | Lorenzo Balderi | Marco Romanelli
EP200 PH, TEMPERATURE (C°) AND TCPO2 MEASUREMENT IN HEALING WOUNDS
POSTERS
Luc Gryson | Emmy Hulst | Tom Gryson
EP203 EXPERIENCE OF WOUND MANAGEMENT IN A PRIVATE TERTIARY CARE TEACHING HOSPITAL IN MUMBAI, INDIA
– OVER PERIOD OF 3 YEARS
Avinash Parmar
PP24 THE NOVEL RAT EXCISIONAL WOUND MODEL METHOD

Yoon Jae Lee | Jong Won Rhie
SATELLITE
SYMPOSIA
SPONSORS &
EXHIBITORS
55
wunddach-kongress-2022.org
WundD·A·CH EWMA
Dreiländerkongress SOCIAL
Stuttgart · Deutschland
29. Sep. - 1. Okt. 2022
MEDIA
Get the latest updates about
Ende des Einreichungszeitraums the #EWMA-CICA 2022 Conference
für Abstracts and keep updated on what’s happening
1. Mai 2022 at EWMA:
Early Bird Registrierung
bis 15. Juni 2022
Join @ewmawound
Share your experiences and thoughts

with other attendees and your network by
using the conference hashtag
#EWMA-CICA 2022
2022
Make a difference in clinical practice
Become a EWMA Member
Benefits of your EWMA Membership:

n You support the development and improvement of wound care in Europe
n 15% discount on your registration fee for EWMA Conferences
n Right to apply for EWMA Travel Grants
n Right to vote at and stand for election to the EWMA Council
n Update on activities and developments within EWMA via the EWMA Newsletter
Yearly membership fee € 25

Yearly membership fee for members of cooperating organisations € 10
Please register as a EWMA Member at EWMA.ORG
A5 EWMA ad 250422.indd 1 25/04/2022 09.09
ENABLING DISCOVERY | POWERING EDUCATION | SHAPING WORKFORCES
Journal of Pathology,
Microbiology
IMPACT
FACTOR: and Immunology
3.205 Published since 1924 by the Scandinavian Societies for Medical
Microbiology
Since and Pathology,
1924, APMIS the aim oforiginal
has been publishing APMIS research
is to publish
in
the fields of pathology, microbiology and immunology, and and
original research in the fields of pathology, microbiology
immunology,
from and from areas
related developing related developing
of modern areas
biomedicine.
of modern biomedicine.
Submit your Aim your camera here

for further information
paper now!
Cooperating CWA
Croatian Wound Association
Organisations www.huzr.hr
DGfW
AEEVH German Wound Healing Society
Spanish Association of Vascular www.dgfw.de
Nursing and Wounds
www.aeevh.es
DSFS
Danish Wound Healing
D A N I S H WO U N D
AFIScep.be Society
HEALING S O C I E T Y
French Nurses’ Association www.saar.dk

in Stoma Therapy, Wound Healing
and Wounds
www.afiscep.be ELCOS
Portuguese Wound Society
www.sociedadeferidas.pt
AISLeC
Italian Nurses’ Cutaneous Wounds
Association FWCS
www.aislec.it Finnish Wound Care Society
www.shhy.fi
AIUC
Italian Association for the GAIF
study of Cutaneous Ulcers Associated Group of Research in
www.aiuc.it Wounds
www.gaif.net
AMP Romania
Wound Management GNEAUPP
Association Romania National Advisory Group for the
www.ampromania.ro Study of Pressure Ulcers and
Chronic Wounds
www.gneaupp.org
APTFeridas
Portuguese Association for the
Treatment of Wounds HSWH
www.aptferidas.com Hellenic Society of Wound Healing
and Chronic Ulcers
www.hswh.gr
AWA
Austrian Wound Association
www.a-w-a.at ICW
Chronic Wounds Initiative
www.icwunden.de
AWTVNF
All Wales Tissue Viability
Nurse Forum LBAA
www.welshwoundnetwork.org Latvian Wound Treating
Organisation
BEFEWO
Belgian Federation of LUF
Woundcare The Leg Ulcer Forum
www.befewo.org www.legulcerforum.org
BWA LWMA
Bulgarian Wound Lithuanian Wound Management
Association Association
www.woundbulgaria.org www.lzga.lt
CNC MASC
Clinical Nursing Consulting – Maltese Association of Skin
Wondzorg and Wound Care
www.wondzorg.be www.mwcf.madv.org.mt/
CSLR MSKT
The Czech Society for Wound Healing Hungarian Wound Care Society
www.cslr.cz www.euuzlet.hu/mskt/
58
MWMA SSPLR
Macedonian Wound The Slovak Wound Healing Society
Management Association www.ssplr.sk/en
NATVNS STV
National Association of Tissue Viability Society of Tissue Viability
Nurses, Scotland www.societyoftissueviability.org
NIFS STW Belarus

Norwegian Wound Healing Association Society for the Treatment of Wounds
www.nifs-saar.no (Gomel, Belarus)
www.burnplast.gomel.by
PWMA SUMS
Polish Wound Management Association Icelandic Wound Healing Society
www.ptlr.org.pl www.sums.is
SAfW Holding Association SWHS

SAfW Dachgesellschaft, Serbian Wound Healing Society
SAfW Societé Faîtière www.lecenjerana.com
SAfW URuBiH
Swiss Association for Wound Care Association for Wound Management
(German section) of Bosnia and Herzegovina
www.safw.ch www.urubih.ba
SAfW UWTO
Swiss Association for Wound Care Ukrainian Wound Treatment
(French section) Organisation
www.safw-romande.ch www.uwto.org.ua
SAWMA V&VN
Serbian Advanced Wound Management Wound Expertise, Netherlands
Association www.venvn.nl
www.lecenjerana.com
WCS
SEBINKO
Hungarian Association for the Knowledge Center Woundcare
Improvement in Care of Chronic www.wcs.nl
Wounds and Incontinentia
www.sebinko.hu
WMAI
Wound Management Association of
SEHER Ireland
The Spanish Society of Wounds www.wmai.ie
www.sociedadespanolaheridas.es
WMAK
SFFPC Wound Management
The French and Francophone Society f Association of Kosova
Wounds and Wound Healing
www.sffpc.org
WMAS
Wound Management Association
SSiS Slovenia
Swedish Wound Care Nurses www.dors.si
Association
www.sarsjukskoterskor.se
WMAT
Wound Management Association
SSOOR Turkey
Slovak Wound Care Association www.yaradernegi.net
www.ssoor.sk
59
International
Partner Organisations
AAWC IWII
Association for the Int. Wound Infection Institute
Advancement of Wound Care www.woundinfection-institute.com
www.aawconline.org
KWMS
Alliance of Wound Care Korean Wound Management Society
www.woundcare.or.kr/eng
Stakeholders
www.woundcarestakeholders.org
MSWCP
Malaysian Society of Wound Care
IAMCICHAC Professionals
Asociación Mexicana para el Cuidado Integral www.mswcp.org
y Cicatrizatión de Heridas, A.C.
www.amcichac.org NZWCS
New Zealand Wound Care Society
CTRS www.nzwcs.org.nz
Chinese Tissue Repair Society
www.chinese-trs.com/en SILAUHE
Iberolatinoamerican Society of Ulcers
Debra International and Wounds
Dystrophic Epidermolysis Bullosa www.silauhe.org
Research Association
www.debra.org.uk SOBENFeE
Brazilian Wound Management
ECET Association
European Council of www.sobenfee.org.br
Enterostomal Therapy
www.ecet-stomacare.eu WAWLC
World Alliance for Wound and
EFORT Lymphedema Care
European Federation of National www.wawlc.org
Associations of Orthopaedics and
Traumatology Wounds Australia
www.efort.org
www.awma.com.au
EPUAP Wounds Canada

European Pressure Ulcer Advisory
www.woundscanada.ca
Panel
www.epuap.org
ETRS
Other Collaborators
European Tissue Repair Society
www.etrs.org DFSG
Diabetic Foot Study Group
www.dfsg.org
FIP-IFP
International Federation of
Podiatrists, Fédération EADV
Internationale des Podologues European Academy of Dermatology
www.fip-ifp.org/ and Venereology
www.eadv.org
ILF
International Lymphoedema EBA
Framework European Burns Association
www.lympho.org www.euroburn.org
ISTAP ESNO
The International Skin Tear European Specialist Nurses
Advisory Panel Organisation
www.skintears.org www.esno.org
60
ESPEN Associated
The European Society for Clinical
Nutrition and Metabolism Organisations
www.espen.org
ESPRAS Leg Club

European Society of Plastic, Lindsay Leg Club Foundation
Reconstructive and Aesthetic Surgery www.legclub.org
www.espras.org
LSN
ESVS The Lymphoedema
European Society for Vascular Surgery Support Network
www.esvs.org www.lymphoedema.org/lsn
ICC
International Compression Club
www.icc-compressionclub.com Media Partners
IWGDF JWC
The International Working Group
on the Diabetic Foot Guidelines Journal of Wound Care
www.iwgdfguidelines.org www.magonlinelibrary.com
UEMS PPC
The European Union of Medical Practical Patient Care
Specialistst
www.uems.eu
For more information about

EWMA’s Cooperating Organisations
and other Partner Organisations
please visit ewma.org
61
DFCon2022 SEPTEMBER 29 - OCTOBER 1 , 2022 · LOS ANGELES, USA
O U R A B ST R ACT
REGISTE R AND SUBMIT Y
AT DFCON.COM
22nd edition of the Interdisciplinary

Global Diabetic Foot Conference
www.dfcon.com
SPONSORS
AND
EXHIBITORS
THE JOINT EWMA

& JOURNÉES
CICATRISATIONS
CONFERENCE
2022
23 - 25 MAY
PARIS
PALAIS DES CONGRÈS
ORGANISATION OF CARE, PATHWAYS

AND COORDINATION AROUND
COMPLEX WOUND HEALING
ENGLISH
PROGRAMME
EWMA-CICA2022.ORG
SATELLITE SYMPOSIA & WORKSHOPS
Amphitheatre Room Room Room Room Room Room
TIME
Bleu Maillot Havane 352A 252B 243 212+213
MONDAY 23 MAY
12:30-13:30 Mölnlycke Essity Debx
M.O.I.S.T Antimicrobial DEBRICHEM®:
– putting the Stewardship in a Novel
concept into wound care Desiccant
clinical and Gel for the
practice the role of Removal
DACC-coated of Biofilm
dressings and
Necrosis
( ) ( ) ( )
15:30-16:30 3M Amryt URGO Mölnlycke Emoled

Effective Pharma Innovation and Excellence in Photobio
Exudate Epidermolysis Medical DFU modulation
Management: Bullosa education to management: and the
Minimize the – Wound treat venous accelerate Bio-Physical
risk of infection Management leg ulcer healing with approach:
through appro- at its Most patients topical oxygen a paradigm
priate exudate Challenging therapy shift in wound
management management
( ) ( )
64
INFORMATION
MONDAY 23 MAY
12:30–13:30 Mölnlycke
Amphitheatre M.O.I.S.T – putting the concept into clinical practice
Bleu During this symposium, sponsored by Molnlycke Health Care, the speakers will provide an overview of
( ) the rationale for the M.O.I.S.T.(moisture balance; oxygen balance; infection control; support; tissue
management) wound healing concept and how it was developed. Numerous case studies will be
presented to demonstrate how the principles of M.O.I.S.T. can be applied in clinical practice. The
discussion will also focus on the use of the concept by wound care specialists in the training of
generalists.
PROGRAMME
OVERVIEW
Chair: Joachim Dissemond
Speakers:
Introduction to M.O.I.S.T.
Joachim Dissemond
M – Moisture balance
Paul Chadwick
O - Oxygen balance
PROGRAMME
Peter Kurz, Austria
DETAILED
I – Infection control
Matthew Malone
S – Support
Joachim Dissemond
T – Tissue management
Paulo Alves
12:30–13:30 Essity
SESSIONS
Room Maillot Antimicrobial Stewardship in wound care and the role of DACC-coated dressings
( ) Chair: Hadar Lev-Tov
Speakers:
Silver resistant bacteria in Venous leg ulcers: Interim results from an RCT
Hadar Lev-Tov
Meeting the challenges in pediatric wound care: Clinical experiences with DACC-coated dressings
Guido Ciprandi
Antimicrobial stewardship in wound care: Implementation and measuring outcomes
POSTERS
Karen Ousey
SATELLITE
SYMPOSIA
SPONSORS &
EXHIBITORS
65
12:30–13:30 Debx
Room Havane DEBRICHEM®: a Novel Desiccant Gel for the Removal of Bioﬁlm and Necrosis
( ) Biofilms and necrosis are known to have a significant and negative impact on wound healing.
Thus, their formation needs to be prevented and, when present, they need to be removed.
The removal process, debridement, can be executed using several different approaches and techniques,
from simply using the bodily mechanisms of autolysis, via an approach using enzymes, ultrasound, and
other means, to surgical excision. The latter technique is fast and efficient but needs to be done in a
medical setting and by trained personnel, which makes for a complicated and expensive procedure.
Debrichem is a new, acid-based debriding agent which has been shown to be very effective in a clinical
trialİin patients with 54 serious and very serious (Wagner III and IV) foot and lower leg ulcers: 93% of all
ulcers, some of which had been in existence for years, reached complete granulation and
reepithelialization was complete in 74% which, for this type of patient cohort, is quite significant.
The DEBx scientific symposium will discuss the importance of biofilms, the scientific background and
working mechanisms of Debrichem. Also, the results of the trial and a series of illustrative cased will be
presented.
Submitted for publication.
Chair: Michel H.E. Hermans
Speakers:
Introduction and background
Michel H.E. Hermans
Results of DEBRICHEM® treatment on Peripheral Arterial Disease (PAD) Patients in Germany

Ewa Klara Stürmer
Spanish experience with DEBRICHEM® treatment, a new resource for biofilm control and healing of
hard-to-heal wounds
Joan Enric Torra-Bou
Cost-effectiveness of DEBRICHEM® in managing non-healing venous leg ulcers in the UK

Julian Guest
Q&A Panel Member

Alberto Cogo
15:30–16:30 3M
Room Maillot Effective Exudate Management: Minimize the risk of infection through appropriate exudate
management
Chair: Jacqui Fletcher
Speakers:
The Science behind Silver Oxysalts in woundcare
Andrew McBain
Managing wound infection using AG Oxysalts™ technology in hard to heal wounds

Luxmi Dhoonmoon
15:30–16:30 Amryt Pharma

Room 352A Epidermolysis Bullosa – Wound Management at its Most Challenging
Understand the clinical aspects of EB from birth and potential management
Explore how EB impacts on children’s lives and those of their parents and carers
Review the impact (and management) of EB through teenage years into adulthood and the escalating
burden of disease
Explore current and potential strategies to mitigate the devastating cutaneous effects of EB
Chair: Maya El Hachem
Speakers:
The Beginning - Birth and Childhood
Maya El Hachem
The Escalating Burden of Disease

Dimitra Kiritsi
Wound management present and Future

Nathalia Bellon
66
INFORMATION
15:30–16:30 URGO
Room 252B Innovation and Medical education to treat venous leg ulcer patients
( ) Chair: Elena Conde Montero
Speakers:
Joachim Dissemond
Elena Conde Montero
PROGRAMME
OVERVIEW
Room 243 Excellence in DFU management: accelerate healing with topical oxygen therapy
( ) During this symposium, sponsored by Mölnlycke Health Care, the speakers will discuss the role of topical
oxygen therapy as an adjunct topical wound therapy when used as part of the management of diabetic
foot ulcers (DFUs). Real-life clinical experience of using a topical haemoglobin spray, Granulox®, and
imaging analysis used to measure wound tissue oxygenation will be presented. The value of Granulox
from a health economics perspective will also be explored.
Chair: Paul Chadwick
Speakers:
Welcome and introduction to topical oxygen therapy
PROGRAMME
Paul Chadwick
DETAILED
‘Seeing is believing’: personal experiences of using Granulox on DFUs and imaging analysis to measure
oxygenation
Sandra Janssen
‘Rethinking revascularisation in DFU management’

Ivan Cvjetko
‘Can we afford it? Yes, we can!’ Focus on value of Granulox, particularly in relation to health economic
analysis of UK study data
Gerhard Bothma
SESSIONS
15:30–16:30 Emoled
Room 212+213 Photobiomodulation and the Bio-Physical approach: a paradigm shift in wound management.
Speakers:
Bringing back chronic wounds on the healing track with Blue Light Photobiomodulation: clinical
evidence
Elia B. Ricci
Blue Light Photobiomodulation as a therapeutic option in an outpatient daily practice
POSTERS
Marino Ciliberti
Blue Light Photobiomodulation therapy on neuroischemic patients: the HERMES study experimental
design and protocol
Alessia Scatena
How physical therapies can help reshape wound care management according to a hospital and
community practice shared care model
Sara Sandroni
SATELLITE
SYMPOSIA
SPONSORS &
EXHIBITORS
67
Amphi
Room Room Room Room Room Room Room Room
TIME theatre
Maillot Havane 352A 252B 241 243 343 212+213
Bleu
TUESDAY 24 MAY
10:00–11:00 3M Convatec Polymem
Never The value
Advancing
Loose The of Perfect
Clinical
Pressure: Partner-
Practice:
The ships;
Impacting
Patient patient,
the
Journey protocols
Noci
from and
ceptive
Hospital to products
Response
Home – to
to Wound
support
Pain and
best
Inflamma-
outcomes
tion
( ) ( ) ( )
12:25-13:25 Regenlab
Regen-
PRP/ATS
Glue for
Diabetic
Foot
Ulcers &
Varicose
Leg Ulcers
manage-
ment,
evidence-
based
medicine
13:30-14:30 Möln Coloplast URGO

lycke Your 5 Improving
Improving step guide patients
patient- to wound with DFUs’
related healing outcomes
outcomes – Introduc- through
through ing the the 3
value- Wound dimen-
based Care sions of
wound Pathway care
care
( ) ( ) ( )
16:15-17:15 Essity Debx AOTI Fidia Vulma- Vistacare New

#Skinmat- Cost- Topical HYALU nin Medical Techno
ters effective- Wound RONIC (Prof WEC logy
- making a ness of Oxygen ACID: Diet) therapy Biovotec
difference DEBRI (TWO2) a pioneer Unmet with the NEUdebri
CHEM® in therapy for in all needs in novel Polynovo
managing sustaina- wound wound device:
non- bly healing healing healing: VistaCare
healing chronic aminoac-
stages
venous wounds, ids and
leg ulcers correcting HA as an
in the UK health effective
inequities, strategy
reducing in wound
hospitali- healing
zations
and
amputa-
tions
( ) ( ) ( )
68
INFORMATION
TUESDAY 24 MAY
10:00–11:00 3M
Amphitheatre Never Loose The Pressure: The Patient Journey from Hospital to Home
Bleu Chair: Luc Teot
( ) Speakers:
Science & Technology in Woundcare
Bart Maene
PROGRAMME
The treatment of hard to heal wounds with NPWT in the hospital setting
OVERVIEW
Ibby Younis
The transitioning of patients with NPWT to the out of hospital setting

Claire Porter
10:00–11:00 Convatec
Room Maillot The value of Perfect Partnerships; patient, protocols and products – to support best outcomes
( ) Putting the Patient first and the value of Perfect Partnerships. Patient centricity is a core element of
value-based healthcare. Our Symposium will focus on how protocols of care are effective tools to assist
with clinical decision support and identifying the most appropriate management for patients living with a
PROGRAMME
DETAILED
wound. It will also include evidence of partnerships in dressing design and application in practice, to
support positive patient outcomes. Results from an Observational Study will be presented to demonstrate
how choice in dressings as perfect partners helps to achieve the best experience and outcome for the
patient in addition to a patient sharing their own personal wound experience.
Chair: Claude Yvon
Speaker:
Focus on importance of Patient centricity (wound, patient and quality of life..)
Emma Candas
Importance & value of protocols in practice - how clinical pathways are effective tools to assist with
SESSIONS
clinical decision support, identifying the most appropriate wound management
Nathalie Salles
Protocol plus products in practice. Perfect Parners - Observational PARTNER Study;

Outline of study design & outcomes.
Jacques Tomasi
Patient testimonial - pre-recorded broadcast
10:00–11:00 Polymem
Room Havane Advancing Clinical Practice: Impacting the Nociceptive Response to Wound Pain and Inflammation
POSTERS
( ) This program will provide a clinical review of the nociceptive and neuropathic pain signaling pathways
and the scientifically validated impact provided by polymeric membrane dressings which positively
impact wound pain and hyperalgesia. Dr. Yap will then present his research and results on the use of
polymeric membrane dressings for pressure injury prophylaxis in critically ill patients with SARS-CoV-2.
Chair: Tami Siewinski
Speaker:
Prophylactic Use of Polymeric Membrane Dressings to Minimize Pressure Injuries in Critically Ill Patients
with SARS-CoV-2
Alan Yap Jiann Wen
SATELLITE
SYMPOSIA
12:25–13:25 Regenlab
Room 241 RegenPRP/ATS Glue for Diabetic Foot Ulcers & Varicose Leg Ulcers management,
evidence-based medicine
Speakers:
Bruno Boezennec
Sanaa Benkirane
Sarah Berndt
SPONSORS &
EXHIBITORS
69
Amphitheatre Improving patient-related outcomes through value-based wound care
Bleu An Interactive Panel discussion led by Gary Hopkins to examine the topic of value in health and wound
( ) care and what value really means to a range of stakeholders across the wound care industry
Chair: Gary Hopkins
Speakers:
Intro video: Value
What does value mean to you?

Gary Hopkins
Panel discussion
Luc Teot
Kimberly DiSanto
Sian Fumerola
Matthew Malone
Q And A: Summary and takeaways
13:30–14:30 Coloplast
Room Maillot Your 5 step guide to wound healing – Introducing the Wound Care Pathway
( ) The Wound Care Pathway is a step-by-step guide to wound healing. It has been developed in
collaboration with over 2200 Healthcare Professionals from around the world and offers a unique,
evidence-based approach to managing chronic wounds.
Chair: Astrid Strebel
Speakers:
David Keast
Caroline Dowsett
Christoffer Hoffmann
13:30–14:30 URGO
Room Havane Improving patients with DFUs’ outcomes through the 3 dimensions of care
( ) Chair: José Luis Lazaro Martinez
Speakers:
Early and appropriate DIAGNOSIS is the first step to optimizing patients outcomes
Marco Meloni
How can treatment DECISION influence patient quality of life ?

José Luis Lazaro Martinez
Importance of DIALOGUE to empower patients to take control of their DFU healing

Graham Bowen
16:15–17:15 Essity
Room Maillot #Skinmatters - making a difference
( ) Chair: Trish Idensohn
Speakers:
#skinmatters - in more ways than one
Trish Idensohn
#skinmatters - why?
Beth Freeman - Gray
#skinmatters - how?
Liezl Naude
70
INFORMATION
16:15–17:15 Debx
Room Havane Cost-effectiveness of DEBRICHEM® in managing non-healing venous leg ulcers in the UK
( ) Chair: Michel H.E. Herman
Speakers:
Introduction and background
Michel H.E. Hermans
Cost-effectiveness of DEBRICHEM® in managing non-healing venous leg ulcers in the UK

Julian Guest
PROGRAMME
OVERVIEW
16:15–17:15 AOTI
Room 352A Topical Wound Oxygen (TWO2) therapy for sustainably healing chronic wounds, correcting health
inequities, reducing hospitalizations and amputations
This symposium will first summarize the growing burden that chronic wounds impose on patients,
caregivers, clinicians, and healthcare systems alike. The critical psycho-social impact of DFU,
hospitalization and amputation and how the associated effects impact outcomes will be discussed. It
will then introduce the extensive body of RCT, RWE, Systematic Reviews and Meta Analyses will be
summarized, which support the recent evidence based Clinical Practice Recommendations for topical
oxygen from the American Diabetes Association (ADA). It will provide an overview on how the unique
PROGRAMME
cyclical-pressurized Topical Wound Oxygen (TWO2) therapy from AOTI can address these burdens
DETAILED
directly by sustainably healing wounds to provide patients with more ulcer free days, resulting in
significantly less hospitalizations and lower extremity amputations. Finally, real world case examples of
chronic DFU and VLU ulcers treated with TWO2 therapy, applied by patients at home, will be presented.
Chair: Andrew JM Boulton
Speakers:
The growing burden chronic wounds impose on patients, caregivers, clinicians, and healthcare systems
alike
Andrew JM Boulton
SESSIONS
The Role of Psychological Factors in Guiding Selfcare Behaviors and Determining Healing Outcomes
Loretta Vileikyte
A review of RCT, RWE, Systematic Reviews and Meta Analyses evidence for cyclical-pressurized
Topical Wound Oxygen (TWO2) therapy in sustainably healing DFU
Robert Frykberg
A real-world case of multi-morbid chronic wound patient cases treated with Topical Wound Oxygen
(TWO2) therapy and its impact on their ulcer healing and ulcer reoccurrence
Matthew G. Garoufalis
POSTERS
16:15–17:15 Fidia
Room 252B HYALURONIC ACID: a pioneer in all wound healing stages
75 years of experience and research into Hyaluronic Acid molecule have placed Fidia at the forefront in
the production of both natural and functionalized hyaluronic acid.
The need to challenge and innovate encouraged Fidia to exploit its expertise on Hyaluronic Acid and to
step forward from TIME concept to TIMER offering a Pioneer molecule in the field: from a product able
to boost the healing and so helping WBP, passing from a bioactive dressing that supports dermal
structure during the repair phase and, finally a product to help wound closure and re-epithelialization.
Chair: Jan Stryja
Speakers:
SATELLITE
SYMPOSIA
Boost healing since the beginning

Maria Giuseppina Onesti
Fill the gap with a bioactive dressing

Jan Stryja
Speed up wound closure

Valerie Hanssens
SPONSORS &
EXHIBITORS
71
16:15–17:15 Vulmanin (Prof Diet)
Room 243 Unmet needs in wound healing: aminoacids and HA as an effective strategy in wound healing
Chair: Marco Romanelli
Speakers:
The role of hayluronic acid and a specific cluster of aminoacids in wound healing
Marco Romanelli
From clinical evidences to clinical practice: aminoacids and HA in wound healing

Roberto Cassino
HA and AA in pressure injuries in spinal cord patients

Carla Pezzuto
HA and Aminoacids in tissue regeneration: application in clinical practice

Arkadiusz Krakowiecki
16:15–17:15 Vistacare Medical

Room 343 WEC therapy with the novel device: VistaCare
( ) Chair: Franck Duteille
Speakers:
VistaCare and the WECTherapy* principle
Thierry Sarda
Interest of WECTherapy in patients suffering from acute and chronic wounds of the leg
- Review of more than 50 patients in 3 centers
Franck Duteille
16:15–17:15 New Technology

Room 212+213
16:15-16:30
BIOVOTEC
An innovative biological matrix: First clinical study in the treatment of venous leg ulcers
Luc Téot
16:30-17:00
NEUDEBRI
A fundamental treatment approach for non-healing wounds
Annalyn Garcia
17:00-17:15
POLYNOVO
Overcoming barriers to wound closure despite vascular compromise by using a novel synthetic
dermal matrix
Christopher Delaney
72
INFORMATION
Room Room Room Room
TIME
351 352A 252B 212+213
WEDNESDAY 25 MAY
09:45-10:45 BenQ Thuasne
Utilization of single-use How to improve venous
NPWT in managing chronic ulcer management
complex wounds nowadays ?
Comment améliorer la prise
en charge de l'ulcère
PROGRAMME
veineux de nos jours ?
OVERVIEW
( )
12:15-13:15 SoftOx Mölnlycke Reddress New Technology:

Future practical solutions Optimising prevention of Exploring the Power of Pixacare
for fighting antimicrobial surgical wound complica- Autologous Headling with Molteni
resistance in wound care tions: Detection, diagnosis, Actigraft Regenlab
surveillance and prediction
PROGRAMME
DETAILED
SESSIONS
POSTERS
SATELLITE
SYMPOSIA
SPONSORS &
EXHIBITORS
73
WEDNESDAY 25 MAY
09:45–10:45 BenQ
Room 352A Utilization of single-use NPWT in managing chronic complex wounds
Chair: Waye Chen
Speakers:
To focus on how to battle with chronic wounds attaining clinical experience through a case series
utilizing a single-use NPWT system
Harikrishna KR Nair
09:45–10:45 Thuasne
Room 252B How to improve venous ulcer management nowadays ?
( ) Comment améliorer la prise en charge de l'ulcère veineux de nos jours ?
Speakers:
More than 20 years of Venous Ulcer investigation but what are the key lessons/and current debates?
Plus de 20 ans d’étude Clinique sur l’ulcère veineux, quelles leçons et quels débats persistent ?
Christine Moffat
What makes COMPULCE trial in Venous Ulcer management different from other studies?
Quelles différences entre l’étude COMPULCE et les autres dans le traitement de l’ulcère veineux ?
Sophie Blaise
Is real life experience so different from clinical trial? specific practical cases studies.
Est-ce que l’expérience de vie réelle est très différente des essais cliniques ? étude de cas pratiques
Christine Jurus
12:15–13:15 SoftOx:
Room 351 Fighting antimicrobial resistance in wound care
Serious clinical infections, especially in wound care, are a strongly increasing burden to patients.
And with the wide spread use of antibiotics in for example the food industry, to the continious
emergence of super bugs in hospitals, clinicians are increasingly concerned about the ability to treat
their patients effectively.
Join the speakers to review the history, trajectory, and current status of antimicrobial resistance, its
mechanisms of action, new solutions, and preliminary clinical study results indicating a new effective
approach to fight antimicrobial resistance
Chair: Geir Almås
Speakers:
Antimicrobial resistance in your practice: an ever more powerful adversary
Niels Frimodt-Møller
Countering antimicrobial resistance: its history and mechanism of action

Thomas Bjarnsholt
Fighting antimicrobial resistance in wound care tomorrow: clinical research today

Klaus Kirketerp-Møller
Room 352A Optimising prevention of surgical wound complications: Detection, diagnosis, surveillance and
prediction
Speakers:
Early identification and prevention of surgical site infection: how to optimise clinical practice, the
evidence
Kylie Sandy-Hodgetts
The role of ERAS in improved healing outcomes: an orthopaedic perspective

Tom Wainright
A surgeons perspective on optimising the patient for surgery: what is in the clinicians toolkit?
Rhidian Morgan-Jones
74
INFORMATION
12:15–13:15 Reddress
Room 252B Exploring the Power of Autologous Headling with Actigraft
Chair: Thomas Wild
Speakers:
ActiGraft Mechanism of Action- Snyder
Robert Snyder
Exploring ActiGraft Potential Wound Applications- Snyder

Robert Snyder
PROGRAMME
OVERVIEW
ActiGraft Case Study Review -Wild
Thomas Wild
Autologous therapy in wound care today- Wild

Thomas Wild
The ActiGraft experience-wild

Thomas Wild
The future of ActiGraft (research & development)-snyder

Robert Snyder
PROGRAMME
DETAILED
12:15–13:15 New Technology
Room 212+213
12:15-12:30
PIXACARE
How to optimize wound care monitoring?
Remote wound monitoring software
Matis Ringdal
SESSIONS
12:30-13:00
MOLTENI
A Game Changer in Wound Care:
Photo Dynamic Therapy and the management of wound infection
13:00-13:15
REGENLAB
A new PRP-HA combination for wound management
POSTERS
Farid Gomri
SATELLITE
SYMPOSIA
SPONSORS &
EXHIBITORS
75
® ™
PRP ® & Cell Therapy Specialists
TECHNOLOGY PLATFORM FOR STANDARDISED

AUTOLOGOUS REGENERATIVE MEDICINE
Platelet-Rich Plasma (PRP) and others autolo

autolo-
gous biologics (such as autologous thrombin)
have been used since many years in
different therapeutical areas (wound ma-
ma
nagement, osteoarthritis, gynecology
etc …) with proven impact on cells
proliferation and differentiation.
(Berndt, Turzi et al. 2019, Berndt,

Carpentier et al. 2021)
C-Symposium New Technologies

in Wound Care Symposia
Tuesday 24th May, 12.25 – 13.25 Wednesday 25th May, 13.00 – 13.15
Room 251 (220 seatings) Room 202 – 203
RegenPRP/ATS Glue for Diabetic Foot A new PRP-HA combination

Ulcers & Varicose Leg Ulcers management, for wound management
evidence-based medicine.
Dr. Bruno Boezennec, MD Mr. Farid Gomri, MSc

Dr. Sanaa Benkirane, PhD
Ms. Sarah Berndt, PhD
Visit us @ Booth #246b
références
• Berndt, S., G. Carpentier, A. Turzi, F. Borlat, M. Cuendet and A. Modarressi (2021). «Angiogenesis Is Differentially Modulated
by Platelet-Derived Products.» Biomedicines 9(3): 251.
• Berndt, S., A. Turzi, B. Pittet-Cuenod and A. Modarressi (2019). «Autologous Platelet-Rich Plasma (CuteCell PRP) Safely Boosts
In Vitro Human Fibroblast Expansion.» Tissue Eng Part A 25(21-22): 1550-1563.
www.regenlab.com
1. Assessment
1. Assess
How to include the patient
and their caregivers How to monit
ment
andtheirwou or
Research shows that patients who are included in planning
nd prog patient
treatment and educated on effective self-care are more likely to
adhere to their treatment plan. To evalu ression
2. Treatment plan
2. Treatm
ate woun
should co d progre
nd uct a ssi on and
an asse
ssment basic assessmen check for infec
Including patients and
ent plan
tool, such t tio
as the Tri at ever y dressin ns, you
The cond angle of g change
their caregivers means:
Pathway
itio Wound ,
and targe n of both the Assessm using
nd Care
e
wo ent.
tep guid
ts identi
fied in yo und and patient
The Wou • Listening to the patient. At ever y
ur treatm
ent plan
should ma
(see page tch the goals
s
4-6 week
3. Wound management
3. Wound
r
patient s yo 16
u
an u shou -17 ).
o
and widt d wound - includ ld conduct a ful
Y healing
• Working with the patient to find solutions. h ing meas l re-asse
and treatm- to monitor he uring th ssment
managem
aling e wo of th
d
ent plan
concorda progression, ov und depth, len e
u n
• Considering the patient as a partner in care planning.
o
nce. erall pa gth
to w
tient we
llness
ent
• Encouraging patient ownership of their own health outcomes.
• Providing tools to help keep patients on track (e.g. providing a

copy of the care plan, diaries, progress tracking tools).
4. Dressin
4. Dressing choice
• Recognizing and discussing the patient's economic and social
g choice
realities.
• Accepting the patient’s wishes.

Healthy
wound edg
5. Wound
e
5. Wound progression
Healthy
periwound
skin
Granulatin
g wound
progressio
A treatment plan should always consider personal preferences bed
and take the patient’s ability to self-care and their personal
support-network into account.
n
nicians
ns for cli
When to
by clinicia
When to refer
d
Develope
Day 0:
Wound
refe
dep th 9mm
and wid Day 40
th 40mm
r
. :
18 | Wound Care Pathway 36 | Wo Wound
und dep th 2mm
Care Pat and wid
hway th 25mm
.
Do you want to achieve the

shortest way to wound healing?
The Wound Care Pathway is a go-to guide for chronic wound management
in 5 simple steps. It’s fully evidence-based and developed by clinicians for
clinicians. 2200 healthcare professionals from around the world have
provided their feedback and input.
How can you use it?

• Get a deep dive into the basics of wound care with hands-on
checklists, tips and detailed images.
• Get answers to your questions before or after treating
patients with (chronic / hard to heal) wounds.
• Access practical recommendations.
Scan the QR code to download and learn

more about The Wound Care Pathway.
Coloplast A/S, Holtedam 1, 3050 Humlebaek, Denmark

www.coloplast.com The Coloplast logo is a registered trademark of Coloplast A/S. © 2022-04. All rights reserved Coloplast A/S.
EXHIBITORS
3M 3M focuses on providing better care through patient- 257
www.3m.co.uk/medical centered science. Helping transform patient outcomes by
msd-ner@mmm.com elevating the critical role skin plays in care. From solutions
+44 1509 611 611 designed to protect and maintain the integrity of skin to a
full portfolio of advanced and surgical wound care, our
team is ready to partner with you to protect skin and
reduce trauma for patients.
ABIGO Medical AB ABIGO Medical manufactures and markets advanced 214

www.sorbact.com wound management products. The range of Sorbact®
info@sorbact.com wound dressings help patients in more than 65 countries
+46 (0)31 748 49 50 around the world. ABIGO Medical was founded in 1989.
Since May 2021, ABIGO Medical is a subsidiary to Essity.
ActivCell Group AG The Swiss company ActivCell Group AG has succeeded in 293
https://activcellgroup.com/en/ integrating cold plasma technology into a compact wireless
andrea.preuss@activcellgroup.com device, the ActivCellpen®, that facilitates the application of
+41 41 924 11 88 modern plasma medicine in daily practice.
ACTO GmbH ACTO® is specialized in manufacturing, sales, and 377

https://actogmbh.com/en/mainpage/ marketing of hygiene, disinfection, wound care, personal
info@actogmbh.com care, industrial cleaning, food supplements, cosmetics,
+49 (0) 531 239 50 80 and veterinary products, and agriculture & livestock fertilizers.
+49 (0) 531 239 50 811
Adtec Healthcare We welcome you to our booth to see our medical device, 270
www.adtechealthcare.com the Adtec SteriPlas. Generating cold plasma which is used
info@adtecplasma.com to heal chronic wounds, surgical site infections &
+44 (0) 208 737 5500 dermatological conditions, even for those which are
non-healing & stalled by biofilm.
Advanced Oxygen Therapy Inc. Advanced Oxygen Therapy Inc. (AOTI) provides a proven 255
https://aotinc.net effective cyclical-pressure Topical Wound Oxygen (TWO2)
USACUSTOMERSERVICE@aotinc.net therapy for nonhealing wounds. This multi-modality
+ 1 760 431 4700 adjunctive treatment provides continuity-of-care to the
patient at home; invaluable during the COVID-19
Pandemic.
Advancis Medical Advancis Medical is based in the UK where we develop and 291
www.advancis.co.uk manufacture our wound healing solutions. We have built a
info@advancis.co.uk global reputation as an expert manufacturer of advanced
+44 (0) 1623 751500 wound healing dressings that truly make a difference to
patients’ and clinicians’ lives.
AISleC AISLeC is an interdisciplinary, non-profit nursing 327

www.aislec.it association dedicated to the study and research of skin
segreteria@aislec.it lesions of different etiology. It is a scientific reference at the
0039-02 66703640 service of health professionals, institutions and citizens for
the knowledge, development, and organization of activities
in the field of wound care. Present on the national territory
since 1993, AISLeC is the recognized association that has
had the greatest impact in the care and assistance of
patients with skin lesions.
AIUC – Associazione Italiana Ulcere Cutanee The Association aims at sharing state-of-the-art knowledge 328
www.aiuc.it in terms of research, physiopathology, diagnostics and
info@aiuc.it treatment of skin ulcers. A clinical-diagnostic
+39 0112446911 interdisciplinary approach combined with competence,
humbleness and enthusiasm is key to addressing this
problem. Continuous studying and researching is a vital
condition which underpins the notion that in order to be
informative, you have to be able to act with competence
and eagerness to learn. Always.
78
INFORMATION
Amryt Pharma DAC Amryt is a global, commercial-stage biopharmaceutical
www.amrytpharma.com company focused on acquiring, developing and
medinfo@amrytpharma.com commercializing novel treatments to help improve the lives
+ 33 3 20 28 13 13 of patients with rare and debilitating diseases. Our Mission
is to transform the lives of people affected by rare,
debilitating conditions by providing innovative medicines
that bring hope to those in greatest need.
Argentum Medical Argentum Medical pioneered the use of silver-plated nylon. 224
www.silverlon.com Specializing in the development of innovative products made
customerservice@curasurgical.com from silver-plated nylon, the companies continue to explore
PROGRAMME
+1 630-232-2507 new applications and markets for SILVERLON® technology
OVERVIEW
in keeping with their corporate mission to improve clinical
outcomes.
Arjo France SAS At Arjo, we believe that empowering movement within 266
www.arjo.com healthcare environments is essential to quality care. Our
Info.france@arjo.com solutions are designed to promote a safe and dignified
+ 33 3 20 28 13 13 experience through patient handling, medical beds,
personal hygiene, disinfection and the prevention of
pressure injuries and venous thromboembolism.
Aroa Biosurgery Limited AROA™ is a New Zealand based soft-tissue regeneration 241b
www.aroabio.com company. Our advanced wound care products have been
PROGRAMME
DETAILED
globalsales@aroabio.com trusted in more than 5 million acute and chronic wound
+64 9-869 3035 procedures globally. Find out more about our affordable
proprietary AROA ECM™ technology, and how it can
benefit you and your patients.
ATD emolda ATD emolda manufactures materials for advanced 316

www.atdemolda.com woundcare, including our high performing, environmentally
info@atdemolda.com friendly Abderma® range of aliphatic PU foam & silicone
+35318251500 adhesive for on-the-body applications. These materials can
be combined with PU films to enhance performance of
dressings (e.g absorption, retention and breathability).
370
SESSIONS
AVANEO / EKABIO Avaneo and Ekabio are French distributors of innovative
www.avaneo.fr technologies. We represent :
www.ekabio.fr • CINESTEAM : anti-oder dressing based on cinnamon
info@avaneo.fr • NEVELIA : dermal substitute from collagen
+33 6 11 84 59 82 • SUPRATHEL : second skin dressing against burns
• HUMECA : dermatomes and MEEK (unique device for
graft expansion)
• And other new products to discover on site !
Axio Biosolutions MaxioCel is a next-generation active wound care dressing 285

https://axiobio.com/ based on Bioactive Microfibre Gelling Technology (BMG)
Int.sales@axiobio.com and is ideal for managing pain along with scar
POSTERS
+91 804114 3774 improvement properties. It can be used for mild to heavily
exuding wounds of varying depths, shapes, and sizes.
BAP Medical BAP Medical - Products for a 'skin in distress’. 289

https://www.bap-medical.com/ BAP Medical provides solutions for skin ‘in distress’.
info@bap-medical.com Our products are developed in conjunction with patients
0031 (0)55 355 25 80 and with those providing treatment. We offer products for
wound-care, scar management and the aftercare of
specific skin problems.
BDK Medical BDK is a world class material converter. We create 264

www.bdk.uk.com innovative components and finished medical devices for
sales@bdk.uk.com the advanced wound care, diagnostic and wearable
SATELLITE
SYMPOSIA
+44 (0) 1473 659 059 markets. Visit our team to discuss your new or existing
project and explore our range of perforated silicones,
dressings and patches.
Beiersdorf S.A.S- Eucerin Chez Eucerin, nous avons la conviction que les soins 379
www.eucerin.fr dermo-cosmétiques ont le pouvoir de changer la vie.
Jennifer.bedran@beiersdorf.com Depuis 100 ans, nous dédions toute notre expertise à la
+33 1 7037 3340 science des soins de la peau. Développer de nouveaux
ingrédients actifs et des solutions innovantes cliniquement
prouvées est notre mission.
SPONSORS &
EXHIBITORS
79
BenQ Materials Co. Ltd. Anscare is part of BenQ Materials, whose parent company 273
(Wound Care Brand: Anscare) BenQ Group has an emphasis on healthcare solutions for
https://www.anscare.com/ over a decade. Anscare developed a series of market-
Waye.Chen@BenQMaterials.com leading products covering clinical hemostasis solutions,
+886 -3-374-8800 Ext.2810 scar care, wound management, and negative pressure
wound therapy.
Biovotec Résultats de traduction 272

www.biovotec.com Biovotec is a Norwegian startup with subsidiaries in France
henri@biovotec.com and Ireland. Biovotec has developed an innovative medical
+33678664606 device based on a new biomaterial, intended for the
healing of chronic wounds. Biovotec's ambition is to market
its first medical device in 2022, after obtaining the CE
mark.
Cerdak Cerdak is the sole manufacturer of ceramic wound 276

www.cerdak.com dressings with unique absorptions and bacterial binding
sales@cerdak.com properties. The product is manufactured in South Africa
+421 37 658 00 66 and distributed throughout Europe from the European
office in Slovakia.
CF Pharma CF Pharma are an ISO13845 accredited facility based in 376

www.cfpharma.ie Ireland that manufacture the active ingredient “Hypochlor-
info@cfpharma.ie ous Acid” on site in their facility. This active ingredient is
+353 51 439010 manufactured for a range of medical devices Effigerm
Wound Care, Effigerm Wound Wash and Effigerm First Aid
in both liquid and hydrogel formulations.
Chemviron Cloth Division Manufacturer of Zorflex® wound dressings. Naturally anti- 315
www.zorflex.com microbial without releasing anything into the body, reduce
zorflex.ccc@kuraray.com elevated proteinase (MMPs), are conductive and manage
+44 191 584 6962 odour, contributing to accelerated healing. Zorflex and
Zorflex LA available now, Zorflex Plus launches in 2022.
Cica Biomedical Ltd Cica Biomedical Ltd is an independent UK-based company 314d
www.cica-biomedical.com that provides contract pre-clinical research services to the
info@cica-biomedical.com wound healing, wound management and tissue viability
+44 (0) 1423 799091 sectors
Coloplast At Coloplast we are united by a shared purpose and 236

www.coloplast.com/products/wound passion to achieve Fewer days with wounds. Come by the
woundcare@coloplast.com booth and experience our products of intelligent design
+45 49 11 11 11 and how we provide deeper knowledge and guidance to
improve the global standard of care.
ConvaTec ConvaTec is a leading developer of pioneering medical 240

https://www.convatecgroup.com/ solutions in Advanced Wound Care, Ostomy Care,
wound.webcare@convatec.com Continence and Critical Care and Infusion Devices that
+44 800 289 738 help improve the lives we touch.
Cook Biotech Cook Biotech is dedicated to providing advanced tissue- 298

https://www.cookbiotech.eu/ repair products for improving patient outcomes globally.
EMEAenquiry@cookbiotech.com Products are manufactured using proprietary extracellular
+ 45 56868686 matrix (ECM) technologies and manufacturing processes.
Through collaboration with partners and distributors, Cook
Biotech products are available globally under several brand
names including Biodesign® and OASIS®.
CoopMed We are a cooperative medical sales company offering 380

www.coop-med.com startups and SME’s easier access to the European market.
info@coop-med.com We are an international group of experienced local sales
managers, who act as your sales team.
Covestro Deutschland AG Covestro, one of the world’s largest polymer companies, 301a
https://solutions.covestro.com/en/industries/ focused on the manufacture of high-tech polymer
healthcare materials, offers raw materials for wound dressings/incision
martin.huettner@covestro.com films/wearable patches/medical packaging: high
info@covestro.com performance films, foams and adhesives.
0049 214 6009 2000
80
INFORMATION
curea medical GmbH We aim to be industry experts in the area of exudate 211
www.curea-medical.com management! In order to improve patients’ quality of life
info@curea-medical.com and effective wound healing our curea ranges of products
+49 (0)36071 9009 500 containing the unique SuperCore® are offering market-
leading exudate management benefits for light to heavy
exuding wounds.
Datt Mediproducts Pvt. Ltd. Datt Mediproducts, established in 1995, is a manufacturer 252
www.dattmedi.com & marketer of high-quality traditional/advanced wound
siddhant.datt@dattmedi.com care & cell-based products. Our aim is to “deliver next-gen
+91 9810634815 healing solutions globally” while adhering to the strictest
PROGRAMME
quality/ethical standards. We have also forged lasting
OVERVIEW
relationships with customers around the world and received
7 US patents.
DEBRA International DEBRA International is a global consortium of nearly 50 305a

www.debra-international.org national autonomous non-governmental patient support
samira.oulahsein@debra-international.org and research funding entities. The collective goal of all of
office@debra-international.org these entities is to increase the quality of life for those living
+43 1 876 40 30 / 044 7931812889 with epidermolysis bullosa (“EB”) by doing two things in
parallel: providing services to those with EB and funding
innovative science directed at symptom relief and a
systemic cure.
PROGRAMME
DETAILED
DEBx Medical BV DEBx Medical is a Dutch medical technology company 241a
www.debx-medical.com dedicated to revolutionising the management of chronic
info@debx-medical.com wounds and improving the outcomes for millions of
+31 10 798 6950 patients. Our first pipeline product, DEBRICHEM®, received
CE mark in early 2021 and is currently launching in
markets around the world.
Drawtex Drawtex® is the first hydroconductive wound dressing. It 294

www.drawtex.com features exclusive LevaFiber™ Technology aiding effective
info@drawtex.com wound bed preparation without damaging newly formed
+27 31 7100400 tissue
314e
SESSIONS
eKare Europe eKare inSight. Complete mobile 3D measurement solution
www.ekare.eu and fully equipped documentation for advanced wound
info@eKare.eu care.
+ 31 (0)20 765 36 09 Obtaining high quality data for assessment and monitoring
is as simple as taking a photo using a tablet.
Elkem Silicones Under its Silbione™ brand, Elkem Silicones designs medical 216
www.elkem.com grades silicones which have been used for years in
silicones.webmaster@elkem.com Healthcare and especially Soft Skin Adhesive Gels that
+33 4 72 13 19 00 facilitate wound healing and provide a gentle, non-irritating
adhesion, even to the most delicate skin.
Emoled SrL EmoLED is an Italian company that develops innovative 265
POSTERS
www.emoled.com medical devices, the result of advanced research in the
info@emoled.com field of photonics. It has developed the first medical device
+39 055 0751960 for Photobiomodulation with blue light (EmoLED) as a
therapy for skin lesion.
Essity Essity is a leading global hygiene and health company 207

www.essity.com dedicated to improving well-being through products and
ewma@essity.com solutions. With world-renowned brands such as the
registered trademarks Leukoplast, Cutimed and JOBST,
Essity is among the global market leaders in a number of
therapeutic areas.
SATELLITE
SYMPOSIA
European Pressure Ulcer Advisory Panel The EPUAP was created in London in 1996 with a goal to 314a
(EPUAP) provide relief for persons suffering from pressure ulcers,
www.epuap.org through research and the education of the public and by
office@epuap.org influencing pressure ulcer policy in all European countries
+420 251 019 379 towards an adequate patient-centered pressure ulcer care.
Exelderma We offer innovation in skin repair. Our Dermaexel™ cream 380

www.dermaexel.com contains essential skin growth factors (5 Growth Factor
geral@exelderma.pt Complex) that will improve the skin’s physiological repair
process to support hydration, firmness, and smoothness of
the skin.
SPONSORS &
EXHIBITORS
81
FB Dermatotology FB Dermatology is a Biotech company offering innovative 262
www.fb-dermatology.com and exclusive patented solutions for tissue regeneration,
info@fb-dermatology.com dermatology conditions and aesthetic alterations.
+39 0735 56 88 20 LumiHeal® uses Fluorescent Light Energy (FLE) to
stimulate the skin’s own repair mechanisms. It is designed
to specifically target the three critical phases of wound
healing, while minimizing pain and bacterial growth. The
use of FLE induces biological responses of mitochondria,
ultimately supplying energy and impacting cell function.
This can help the damaged tissue manage and support the
progression of the body’s own healing mechanisms from
the inflammatory stage to wound closure
Ferris Manufacturing Corp. – Ferris Mfg. Corp. are the founders and manufacturers of 245
Manufacturers of PolyMem the patented PolyMem advanced wound therapy
https//www.polymem.com technology. They are a privately owned producer and
info@polymem.com distributor of PolyMem®, Shapes®, SportsWrap®, and
+1(817) 900-1301 Nursicare® Dressings.
Fibroline SA Fibroline is an engineering company based in France, 284

https://www.fibroline.com/ which developed and patented dry impregnation
contact@fibroline.com technologies. Those cleantechs enable to impregnate
+334 28 29 85 40 functional powders into porous structures (textiles,
nonwovens, foams) thanks to high intensity alternating
electric fields.
FIDIA FARMACEUTICI S.p.A. Fidia Farmaceutici 235

https://fidiawoundcare.com/ Italian developer and leading manufacturer of innovative
Rperdon@fidiapharma.it products mainly based on hyaluronic acid (+1,100
+393371088103 patents), in joint care, wound care, ophthalmology,
uro-gynecology, aesthetic and regenerative medicine.
Products are available in +100 countries, through wholly
owned subsidiaries and partners
Flen Health Flen Health - about living the life You love 288a
https://www.flenhealth.com/ We want to improve the quality of life of people suffering
info@flenhealth.com from inflammatory or infectious skin diseases such as
+352 26 34 06 27 1 wounds in a responsible way, by providing added value for
patients, healthcare professionals, health authorities and
the society.
Fluidnatek by Bioinicia Fluidnatek by Bioinicia are specialists in medical-grade 226

www.bioinicia.com electrospinning equipment for research, development and
contact@bioinicia.com manufacture. The level of process control enables these
+34 96 134 77 80 electrospun materials to enter clinical use in wound
therapy, trans-mucosal drug delivery and tissue
regeneration.
Freudenberg Performance Global expert in designing and manufacturing innovative 205a

Materials SE & Co. KG components for advanced wound care. Next generation of
www.freudenberg-pm.com silicone foam dressings, innovative debridement foam,
med@freudenberg-pm.com preventative materials, hydrophilic PU foams, super-
+49 6201 80 5056 absorbent and flexible nonwovens and multi-layer
solutions.
Genadyne Biotechnologies Genadyne Biotechnologies is a US based developer and 373

www.genadyne.com manufacturer of negative pressure wound therapy systems,
info@genadyne.com including disposable and manual NPWT units and wireless
+1 (516) 487 8787 telemedicine solutions for wound care.
GERGONNE INDUSTRIE Gergonne Industrie offers medical expertise and high 297
www.gergonne.com performance components designed for advanced
contact.fr@gergonne.com woundcare applications: high MVTR PU films, skin-friendly
+33 4 74 73 39 01 adhesives and wound contact layers, as well as a clean
room conversion and packaging service.
Grapheal Grapheal is developing a digital assistant WoundLAB for 296

www.grapheal.com better management of difficult-to-heal wounds such as
info@grapheal.fr chronic wounds.
+33 4 57 42 25 96 WoundLAB is a smartphone-connected wearable biosensor
that continuously records and track biochemical parameters
of the wound to a telemedicine cloud.
82
INFORMATION
Graphic Packaging International Graphic Packaging International is one of the largest 301
www.ar-packaging.com manufacturers of paperboard and paper-based packaging
info@graphicpkg.com for some of the world’s most recognized brands of food,
+32 2 721 85 62 beverage, foodservice, beauty, healthcare and other
products. With a product portfolio that emphasizes
renewable, recycled, and recyclable materials, we are as
committed to our customers to protecting the environment.
Gunze Fabrics were the beginning of GUNZE Limited in 1896 and 267
https://www.gunze.co.jp/e/medical/index.html the outset of our journey into the medical field. With our
+49 (0) 211 3613971 innovative approach and high product standards, we
PROGRAMME
produce high-class bioabsorbable materials like our
OVERVIEW
artificial dermis Pelnac and our reinforcement felt Neoveil.
Hydrofera Blue Hydrofera produces a unique line of antibacterial wound 317

www.hydrofera.com dressings, utilizing its proprietary PVA and PU foam
Matt@hydrof.com technology in combination with two natural organic
+1 (860)930-9257 pigments. Hydrofera Blue powerfully tackles any type of
chronic or non-healing wound.
IBSA PHARMA IBSA, spécialiste de l’innovation, s'engage à améliorer la 248

www.laboratoires-genevrier.com qualité de vie des patients en leur offrant les produits de
ffiorucci@laboratoires-genevrier.com santé dans leurs meilleures formes pour une effi cacité
+33 (0) 4 92 91 15 60 prouvée et augmentée.
PROGRAMME
DETAILED
En dermatologie, nous proposons des produits innovants
pour le traitement des plaies, psoriasis, vitiligo avec des
marques reconnues comme IALUSET® IALUSET® PLUS
IALUSETCARE® BETESIL® VITICELL®
imito AG imito stands for digital transformation in healthcare; 263

www.imito.io radically simplified wound management & visual clinical
contact@imito.io documentation for hospitals, rehabilitation clinics and
+41 44 521 73 74 outpatient care services. The headquarters of imito AG is
located in Zurich, Switzerland.
INTEGRA Integra is the global forerunner in the development of 290
SESSIONS
www.integralife.eu dermal regeneration. Its unique expertise has given it a
emeatissuestechnologiesmarketing@integralife. leadership position in reconstructive plastic surgery and the
com regenerative medicine industry.
+33 4 37 47 59 00
International Society for Cutaneous ISCU is a new-established, member-based society that 305
Ultrasound (ISCU) promotes the use of high frequency and ultra-high
mhs@cap-partner.eu frequency ultrasound in dermatology through conferences,
+45 70 20 03 05 courses, building an online learning platform and
developing educational material to exploit the full potential
of these tools.
ISPEW The International Society for Pediatric Wound Care 305
POSTERS
www.ispew.org (ISPeW) continues to portray the paediatric wound care
info.ispew@gmail.com vision in an universal land, where small and sometimes
+39 050 7215305 invisible patients are often neglected, even though
blanketed with skin lesions, ulcers, injuries, damages and
tears.
Journal of Wound Care (JWC) The Journal of Wound Care (JWC) is the leading monthly 314
www.magonlinelibrary.com/journal/jowc peer-reviewed, international wound care journal. Publishing
emma.blick@markallengroup.com the latest, most relevant research and clinical expertise to
+4420 7738 5454 support the delivery of best practice and innovation in
SATELLITE
SYMPOSIA
wound care management and tissue viability.
Kerecis Kerecis is pioneering the use of fish skin and fatty acids in 246
www.kerecis.com the globally expanding cellular-therapy and regenerative-
support@1wound.info medicine markets. The fatty-acid-rich products from the
+41 43 499 15 66 company’s patented technologies protect the body’s own
tissues and enable the body to regenerate tissues.
SPONSORS &
EXHIBITORS
83
KONFORT ÖZEL SAǦLIK H İZMETLER İ CONFORT,Konfort Özel Saİlık Hizmetleri Tıbbi Malz. San. 286
TIBB İ MALZ. SAN. VE T İC. LTD. ŞT İ. ve Tic. LTD. STI, whose foundations are based on 2002,
CONFORT started to manufacture Technological,effective, high-
www.confortnpwt.com quality Negative Pressure Wound Treatment Systems and
www.confortostomi.com Ostomy Care Products have been accepted by hospitals
export@confortnpwt.com and patients at a high level of satisfaction as a result of the
+90 222 236 03 27 joint work carried out with healthcare professionals and
+90 542 357 66 05 patients.
L’Oréal Cosmétique Active France La Roche Posay et CeraVe s’associent pour améliorer la 225
https://www.laroche-posay.fr/ qualité de vie des patients porteurs de plaies et
https://www.cerave.fr/ cicatrices, en proposant des soins et produits d’hygiène
romain.callier@loreal.com dont l’efficacité est cliniquement prouvée, avec une haute
+33 (0)1 57 77 00 00 tolérance et une texture favorisant l’observance.
Laboratoire Bioderma BIODERMA est une marque NAOS, passionnée par la 227
https://www.bioderma.fr/ biologie de la peau, depuis 40 ans. Innover, prendre part
+330472114800 aux avancées de la dermatologie pour améliorer la santé
de la peau, font de nous des experts pionniers du soin
dermatologique.
LABORATOIRE SVR The SVR laboratory was created in 1962 by a couple of 222a
https://fr.labo-svr.com/ pharmacists on the belief that dermatology makes you
hellosvr@svr.com more beautiful.
+33188400310 SVR supports the most sensitive skin with dermatological
solutions ultra-concentrated in active ingredients for visible
and rapid results.
Laboratoires HARTMANN HARTMANN Laboratories, true partners and key players in 217
https://www.hartmann.fr the healthcare chain, develop quality medical devices and
https://www.hartmann.info/en-corp associated services that are efficient and tailor-made in order
contact@hartmann.fr to best meet the needs of patients and healthcare system
+33 388824343 players.
Laboratoires Urgo At Urgo Medical, our mission is to support Healthcare 243

www.urgogroup.com Professionals to deliver evidence-based advanced wound
p.ollier@fr.urgo.com care treatments from the beginning so that life can start
+33185652424 again for patients.
Our 1 500 employees are committed every day to making
a difference for patients.
Les Laboratoires Brothier Brothier, laboratoire pharmaceutique français indépendant, 292

https://www.brothier.com/ développe, fabrique et commercialise des alginates de
info@brothier.com calcium destinés à l’hémostase et à la cicatrisation.
+33 1 56 38 30 00 Algostéril est indiqué dans les plaies profondes,
hémorragiques, infectées et à risque infectieux.
Levabo ApS Levabo ApS is a Danish company which is developing, 340

www.levabo.com manufacturing and selling positioning aids for the
Info@levabo.dk prevention and treatment of pressure ulcers. Our core
+45 31704025 products are single patient cushions and our new Automatic
30 degree side tilt mattress for immobile patients – Turn All.
LimbO Waterproof Protectors LimbO waterproof protectors keep patient dressings, plaster 314f
www.limboproducts.co.uk casts and PICC lines dry in the bath or shower. With a soft
info@limboproducts.co.uk non-constrictive neoprene seal the LimbO is easy to use and
+44 (0) 1243 573417 comfortable. Durable, single patient, multiple use. UK
manufactured, available worldwide and on FP10
prescription in the UK.
L-Mesitran® In 2002, we were the first company to obtain CE 288

www.mesitran.com certification and FDA approval for our supplemented
office@mesitran.com Medical Grade Honey: L-Mesitran. We deliver high-quality
+31 (0)433 251 773 products to ensure fast and efficient wound healing.
L-Mesitran is more than honey.
Lohmann & Rauscher Lohmann & Rauscher (L&R) is a leading international 234
www.Lohmann-Rauscher.com supplier of forward-looking medical devices and hygiene
info@de.LRmed.com products of the highest quality. We develop customised
+49 2634 990 solutions for the problems faced by patients and healthcare
professionals – from classic wound dressing material to
modern therapy and patient care systems.
84
INFORMATION
Medaxis AG Medaxis is a Swiss Company specialized in the 278
www.medaxis.ch development, production and international sales of the
elvira.caparelli@medaxis.ch micro water jet technology devices and systems for modern
+41 62 823 88 00 wound treatment.
MedCu Technologies MedCu Technologies is the world’s first provider of FDA and 210
www.medcu.com CE innovative wound dressing products incorporated with
nimrodb@medcu.com copper. Leveraging copper’s antibacterial and healing
+972-54-2498508 properties, MedCu provides a unique cost-effective
proposition to address acute, critical and chronic wounds.
305b
PROGRAMME
Médecins Sans Frontières Médecins Sans Frontières est une association d’aide
OVERVIEW
www.msf.fr médicale d’urgence qui pallie au manque d’accès aux
julie.moncere@paris.msf.org soins partout dans le Monde.
+33-1 40 21 29 18
medi GmbH & Co. KG Founded in Germany in 1951, medi GmbH & Co. KG has 280
www.medi.de/en become one of the world's leading manufacturers of medical
export@medi.de aids. As a manufacturer of medical devices, we are working
+49 921 9120 passionately in the interest of patients' wellbeing. For further
information please visit our website www.medi.de/en.
Medline INTERNATIONAL Medline manufactures and distributes a wide range of 228
PROGRAMME
DETAILED
https://www.medline.eu/ medical and surgical devices to healthcare facilities
Fr-customerservice@medline.com worldwide. It has become the largest independent
+31 88 0011 900 manufacturer and distributor of healthcare products and
services in the United States and is actively expanding
internationally. Medline is present in 128 countries with
27,000 employees worldwide.
Mesi, Ltd MESI provides digital arterial assessment in woundcare. 302

www.mesimedical.com This includes 1-minute ABI and TBI to help distinguish
info@mesimedical.com between venous and arterial wounds, determine
+386 1 620 34 87 appropriate compression therapy, and discover PAD in
high-risk patients, including diabetics.
SESSIONS
Métanoïa Sante METANOIA™ is specialized in manufacturing products for 304
www.metanoiasante.com cutaneous protection. They prevent or treat skin alterations
contact@metanoiasante.com which may result from bedsores, incontinence dermatitis,
+33 9 72 63 09 05 irritations linked to friction or maceration (prosthesis,
orthosis, dressings, compression stockings, etc)
Milliken Healthcare Driven by our purpose to improve patient lives, Milliken is 268
healthcare.milliken.com creating a healthier future through Active Fluid Manage-
healthcare@milliken.com ment®, SelectSilver® and CoFlex® TLC compression
+1 800.432.6686 technologies to help solve unmet patient needs. Focusing
on edema and moisture management, we offer a wide
range of solutions.
POSTERS
MIMEDX MIMEDX is a transformational placental biologics 222
www.mimedx.com company, developing and distributing placental tissue
www.customerservice@mimedx.com allografts with patent-protected, proprietary processes for
1-770-651-9100 multiple sectors of healthcare.
MOLTENI FARMACEUTICI Molteni Farmaceutici is a privately held pharmaceutical 287

www.moltenifarma.it company founded in 1892 with a strong knowledge and
corporatecommercial@moltenifarma.it experience in opioids, and a wide spectrum of
(00) 39 055 73611 pharmaceutical products for the treatment of pain, drug
addiction and wounds’ management.
SATELLITE
SYMPOSIA
MOSS S.p.A. Certified as Manufacturer of Class IIB Medical Devices, 314 g

www.novox.it MOSS developed a family of 12 cutting-edge products,
moss@moss-info.it offering a new concept of dressing in Wound Care
+39 0322 772032 applications, intended for delivering natural and simple
solutions to patients and healthcare professionals.
Mölnlycke Health Care Mölnlycke is a world-leading medical solutions company. 245b

www.molnlycke.com We’re here to advance performance in healthcare across
info@molnlycke.com the world, by designing and supplying medical solutions to
+46 31 722 30 00 enhance performance at every point of care – from the
operating room to the home.
SPONSORS &
EXHIBITORS
85
NATROX® Wound Care NATROX® Oxygen Wound Therapy is an innovative, simple 261
https://www.natroxwoundcare.com device delivering pure humidified oxygen 24/7 directly to a
marketing@natroxwoundcare.com wound to stimulate and improve healing. Battery-powered,
+44 (0)1223 661830 portable, and completely silent, this active therapy can be
maintained across all care environments until a wound
heals.
ON CALL SOLUTIONS INTERNATIONAL CV On Call Solutions is a company that promotes the 372
www.neudebri.com innovative surgical debridement tool, neudebri. It represents
oncall_solutions@yahoo.com, all distributrors worldwide, giving exploitation rights to future
neudebri.com@gmail.com distributors and universities/trainiong institutes.
(+32) 011 495 111
NOVENTURE SL Noventure offers innovative and effective products for the 202
www.noventure.com management of skin lesions of any depth.
mestruch@noventure.com We translate therapeutic needs into solutions and build
+34 932301173 extensive network of partners and distributors by providing
high quality products, services and support, as country-
based market strategies.
Omnidermal Biomedics s.r.l Our Mission is to use our knowledge in artificial intelligence 390
https://www.omnidermal.it/en/ and development of medical devices to reduce the distance
info@omnidermal.it between patients and healthcare professionals, making
+393807342667 patient’s care more effective, more sustainable
economically, better organized and the healing quicker,
with maximum quality even at home in the field of wound
care.
OTR3 OTR3, the leading biotechnology company in Matrix 326

www.otr3.com Therapy, is fully committed to the development of new
contact@otr3.com therapies based on the revolutionary RGTA® technology.
+33 (0)1 83 64 23 00
Perfectus Biomed Group Perfectus Biomed Group are leaders in standard and 275
www.perfectusbiomed.com customized microbiology testing services for a variety of
info@perfectusbiomed.com sectors, including wound care, medical devices, &
UK +44 01925 737 237 disinfectants. Our UK laboratory is GLP-compliant and
US +1 307 264 1572 UKAS accredited ISO 17025 and both laboratories hold
ISO 9001 certification.
Piomic Medical AG With concurrent optical and magnetic stimulation 391

www.piomic.com (COMS®) therapy, Piomic provides a new solution to
info@piomic.com promote wound healing in chronic leg and foot ulcers. The
+41 (0) 44 244 1970 intuitive product design of the COMS® therapy system
allows to fasten the transition to homecare and enables
patient self-management.
Pixacare Pixacare is a wound monitoring app that allows precise and 375
www.pixacare.com standardized skin documentation, in a secure and
contact@pixacare.com integrated way. We are developing AIs capable of
+33 (0)1 84 80 92 01 measuring and analyzing chronic and post-operative
wounds. Our vision is to turn the smartphone camera into
a medical device.
PLASTOD SPA Plastod Spa is a leading company in the production of 371

www.plastod.com medical adhesive devices since 1915
info@plastod.com Our CMS, in accordance with the regulations and
+39 0516465811 prescriptions of ""good manufacturing"", guarantees
products and according to the legislative and regulatory
affair, is able to manufacture medical devices belonging to
all the risk classes provided by the current legislation.
PolyNovo UK Limited NovoSorb BTM (Biodegradable Temporising Matrix) is a 274

https://eu.polynovo.com/ unique synthetic dermal scaffold that provides an effective
info@polynovo.com reconstructive option for a range of complex wounds,
+61 (0) 3 8681 4050 including full thickness wounds, pressure ulcers, venous
and diabetic ulcers, trauma wounds, burns, and
reconstruction.
86
INFORMATION
Protex Healthcare NV Dedicated to heal complex wounds 318
www.protexhealthcare.com Protex Healthcare develops innovative wound dressings, like
info@protexhealthcare.com VACUTEX™, a dressing autologous to 68mm Hg NPWT,
0032 51 80 14 46 but without pump! Our mission is to make significant
contributions to better, objective diagnostics in wound care,
faster and better wound debridement and complete healing
of complex wounds.
R2 HEALTHCARE SOLUTIONS SRL R2HCS is a pharmaceutical company focused on 374

https://curefini.eu/ developing and commercializing innovative and differen-
info@curefini.eu tiated medical, pharmaceutical and dermocosmetic
PROGRAMME
+39 06 45473813 products.
OVERVIEW
RedDress ActiGraft, an autologous wound care solution, enables 201
www.reddressmedical.com providers to produce in real time in vitro blood clots from
info@reddressmedical.com your patient’s whole blood. Once applied, it serves as a
+1-800-674-9615 protective covering, biologic scaffold and wound micro-
environment to promote the natural wound healing
processes of the body.
Regen Lab Regen Lab is a leading innovator of medical device in the 246b
www.regenlab.com field of products intended for autologous regenerative
contact@regenlab.com medicine, based on an extemporaneous preparation of
+41 0 21 864 01 11 Platelet-Rich Plasma (PRP, autologous thrombin…) from
PROGRAMME
DETAILED
the patient’s blood, cell therapy and combined therapy.
SOCIETE FRANCAISE ET FRANCOPHONE Depuis 20 ans, la SFFPC réunit des professionnels de 378
PLAIES ET CICATRISATIONS (SFFPC) différentes spécialités et compétences autour d’une
www.sffpc.org problématique commune : la plaie. Riche des différences
secretariat@sffpc.org qu’elle rassemble, notre société savante est engagée dans
de nombreuses actions (formations, réflexions autour de
bonnes pratiques, participation aux travaux sur le thème
des plaies auprès des Autorités, etc).
Smith & Nephew Improving outcomes for patients, conserving resources for 241
http://www.smith-nephew.com/key-products/ health care systems. Offering imaginative solutions in
SESSIONS
advanced-wound-management/ advanced wound dressings & NPWT for healthcare
maricel.pamely@smith-nephew.com professionals. We keep an ambitious objective in mind:
+44 1482 225181 ZERO.
Zero pressure ulcer incidence.
Zero surgical site complication.
Zero diabetic amputations.
Zero delay in wound healing.
Zero chronic wound recurrence.
Zero wound-related readmissions.
Zero waste of healthcare resources.
Society of Tissue Viability Our work is focused around three key areas: building 314c
POSTERS
https://societyoftissueviability.org/ community; sharing expertise; and creating change-
support@societyoftissueviability.org makers. All our activities are designed to encourage the
+44 7860 926404 collaborative thinking and action needed to solve wound
and skin challenges.
SoftOx Solutions AS Our mission is to Help the World fight infections. We are a 381
www.soft-ox.com technology company offering innovative, patented, and
post@soft-ox.com effective infection control solutions for various healthcare
+47 948 59 599 segments and solutions for wound healing, sensitive skin,
hand & surface disinfection, and respiratory tract. The
perspectives are many.
Spincare (Nanomedic Technologies Ltd) Spincare is the first and only commercially available 260
SATELLITE
SYMPOSIA
www.nanomedic.com portable electrospinning system for wound therapy. Please

info@nanomedic.com stop by stand #260 to hear how our electrospun healing
+972 (0)8 915 3001 fiber technology can help your patients ‘live while they
heal’, and how we ‘make hard tasks easy’. Change history
– not dressings!
TC TRANSCONTINENTAL High-performance medical components for wound 295

www.transcontinentaladvancedcoatings.com dressings aimed at the advanced wound care market.
communications@tc.tc The inspire® portfolio offers a variety of medical coating
+44 1978 660 241 components for wound care, ostomy and medical devices.
inspire® includes polyurethane films, foams, silicone and
SPONSORS &
EXHIBITORS
pattern adhesive coatings.
87
Ten Bio Ten Bio provides optimal human skin models for skin 341
www.ten-bio.com biology testing. By restoring and maintaining physiological
info@ten-bio.com skin tension using our unique culture platform, Ten Bio has
+44 7428438184 succeeded in creating a truly functional and realistic testing
platform for skin-based research.
Our products and research services help generate exacting
and clinically relevant data to more accurately predict
product performance in vivo. Ten Bio can significantly
lower R&D costs and accelerate product development.
terraplasma medical GmbH TPM introduces the plasma care®. A hand-held and mobile 320
www.terraplasma-medical.com medical device for wound treatment with cold atmospheric
info@terraplasma-medical.com plasma for the double effect: Inactivation of micro-
+49 (89) 588 05530 organisms and support of the wound-healing process.
Thuasne Thuasne imagines, develops and manufactures medical 244

www.thuasne.fr devices allowing everyone to become actors in their own
back-office@thuasne.fr health. For 6 générations, the Group offers concrete,
+331 41 05 92 92 adapted and innovative health solutions in the fields of
orthopaedics, medical compression.
T-MED Put an end to medical deserts and strengthen social ties 392
http://t-med.fr through telemedicine and teleconsultation by offering
christophe.bonnot@t-med.fr secure videoconferencing solutions and connected medical
+33 6 10 75 17 22 devices. Preserve the maintenance of the social link of the
elderly and dependent people.
UPM Biomedicals UPM Biomedicals is the forerunner in producing high quality 271
www.upmbiomedicals.com nanocellulose for medical and life science applications. Our
biomedicals@upm.com products are free from animal-derived components making
+358 (0) 204 15 111 them ideally suited to serve as a biomaterial in wound care,
cell therapy and tissue engineering applications.
VIATRIS Viatris est un nouvel acteur de santé mondial né du 322

https://www.viatris.com rapprochement de Mylan et Upjohn, une ancienne division
accueil@viatris.com de Pfizer. En France, notre mission est de permettre aux
+33 (0)1 56 64 10 70 68 millions de personnes dans notre pays, de vivre en
meilleure santé à chaque étape de leur vie. Nous nous y
engageons via trois axes majeurs que sont l’accès, le
leadership et le partenariat.
VistaCare Medical VistaCare Medical develops, manufactures and distributes 277

http://www.vistacare-medical.com/ medical devices for the treatment of the critical phase of
tsarda@vistacare-medical.com wounds, whether acute or chronic, with *WEC concept,
+33384525365 thanks to VIstaCare.
* WEC : Wound Environment Controlled
Vulnamin Professional Dietetics is an Italian company specialised in 246a

www.vulnamin.com patented amino acid formulas whose core business is
www.professionaldietetics.com based on patents and clinical research both in Clinical
info@pd-international.com Nutrition and Tissue Regeneration. Vulnamin (topical MD)
+39-02-744020 and Vulnamin WH (FSMP) are the main products in tissue
regeneration.
Wacker Chemie AG WACKER is a globally active chemical company with some 213
www.wacker.com/healthcare 14,300 employees and annual sales of aroundİ4.69 billion
infoservice@wacker.com (2020).
+49 89 6279 0 WACKER has a global network of 26 production sites,
23 technical competence centers and 52 sales offices.
Walgreen Health Solutions The HEELIFT® name in the Wound Care Industry has 205
www.walgreenhealthsolutions.com become synonymous with high-quality offloading products
info@walgreenhealthsolutions.com for heel pressure ulcer prevention. Walgreen Health
1-847-328-9540 Solutions has one mission in mind – ensure that heel
pressure ulcers are truly “never events”.
Welcare Industries S.p.A Founded by Fulvia Lazzarotto in 2001 in Orvieto, Welcare 242
https://www.welcareindustries.com/en/ Industries is a leading and innovative manufacturing
info@welcaremedical.com company in the field of Medical Devices for the prevention
+39 0763 316353 of infections and for the treatment of skin pathologies and
chronic wounds. From July 2021 Welcare became part of
Labomar Group.
88
INFORMATION
WINNCARE French key player on the European medical devices 212
www.winncare.com market, Winncare Group is committed to enhance people’s
contact@winncare.fr autonomy and living conditions at home or in institutions
+33(0)4 66 02 15 15 by providing them solutions adapted to their needs. Our
teams share the same goal: offering hight quality products
and services.
Winner Medical Co., Ltd Winner Medical is the top ODM advanced wound dressing 203
www.winnermedical.com manufacturer in China with 5 core technologies including
info@winnermedical.com foaming, silicone, gelling fiber, antimicrobial technologies,
+86-755-28138888 and biotechnology. With 30-year dedication in wound care
PROGRAMME
industry and CE & FDA certificates, our products have
OVERVIEW
entered 110+ countries.
WoundEl Health Care Our mission is to improve the quality of life of the patient 211a
www.woundel.com and caregivers by relaunching the natural healing process.
contact@woundel.com Our WoundEL® device is an electrostimulation system
+33 (0)4 27 40 28 41 designed to accelerate, accelerate the healing process and
reduce pain related to wounds.
Wounds International Wounds International is a major healthcare 314b

www.woundsinternational.com communications business with a global reach in wound
info@omniamed.com management. Come visit us and see our range of
+44 (0)20 3735 8244 educational publications, like our Global consensus
PROGRAMME
DETAILED
documents, Made Easy’s & others.
SESSIONS
POSTERS
SATELLITE
SYMPOSIA
SPONSORS &
EXHIBITORS
89
EXHIBITION
EXHIBITION FLOOR PLAN
Please see exhibition floor plan on the following pages
3M 257 eKare Europe 314e
ABIGO Medical AB 214 Elkem Silicones 216
ActivCell Group AG 293 Emoled SrL 265
ACTO GmbH 377 Essity 207
Adtec Healthcare 270 European Pressure Ulcer Advisory Panel (EPUAP) 314 a
Advanced Oxygen Therapy Inc. 255 Exelderma 380
Advancis Medical 291 FB Dermatotology 262
AISLeC 327 Ferris Manufacturing Corp. – Manufacturers of PolyMem 245
AIUC – Associazione Italiana Ulcere Cutanee 328 Fibroline SA 284
Argentum Medical 224 FIDIA FARMACEUTICI S.p.A. 235
Arjo France SAS 266 Flen Health 288a
Aroa Biosurgery Limited 241b Fluidnatek by Bioinicia 226
ATD emolda 316 Freudenberg Performance Materials SE & Co. KG 205a
AVANEO / EKABIO 370 Genadyne Biotechnologies 373
Axio Biosolutions 285 GERGONNE INDUSTRIE 297
BAP Medical 289 Grapheal 296
BDK Medical 264 Graphic Packaging International 301
Beiersdorf S.A.S- Eucerin 379 Gunze 267
BenQ Materials Co. Ltd. (Wound Care Brand: Anscare) 273 Hydrofera Blue 317
Biovotec 272 IBSA PHARMA 248
Cerdak 276 imito AG 263
CF Pharma 376 INTEGRA 290
Chemviron Cloth Division 315 International Society for Cutaneous Ultrasound (ISCU) 305
Cica Biomedical Ltd 314d ISPeW 305
Coloplast 236 Journal of Wound Care (JWC) 314
ConvaTec 240 Kerecis 246
Cook Biotech 298 KONFORT ÖZEL SAǦLIK HİZMETLERİ TIBBİİ

286
MALZ. SAN. VE TİC. LTD. S
˛Tİ. CONFORT
CoopMed 380
L’Oréal Cosmétique Active France 225
Covestro Deutschland AG 301a
Laboratoire Bioderma 227
curea medical GmbH 211
LABORATOIRE SVR 222a
Datt Mediproducts Pvt. Ltd. 252
Laboratoires HARTMANN 217
DEBRA International 305a
Laboratoires Urgo 243
DEBx Medical BV 241a
Les Laboratoires Brothier 292
Drawtex 294
90
INFORMATION
Levabo ApS 340 Protex Healthcare NV 318
LimbO Waterproof Protectors 314f R2 HEALTHCARE SOLUTIONS SRL 374
PROGRAMME
OVERVIEW
L-Mesitran® 288 RedDress 201
Lohmann & Rauscher 234 Regen Lab 246b
Medaxis AG 278 SOCIETE FRANCAISE ET FRANCOPHONE PLAIES ET

378
CICATRISATIONS (SFFPC)
MedCu Technologies 210
Smith & Nephew 241
Médecins Sans Frontières 305b
Society of Tissue Viability 314c
medi GmbH & Co. KG 280
PROGRAMME
SoftOx Solutions AS 381
DETAILED
Medline INTERNATIONAL 228
Spincare (Nanomedic Technologies Ltd) 260
Mesi, Ltd 302
TC TRANSCONTINENTAL 295
Métanoïa Sante 304
Ten Bio 341
Milliken Healthcare 268
terraplasma medical GmbH 320
MIMEDX 222
Thuasne 244
MOLTENI FARMACEUTICI 287
T-MED 392
SESSIONS
MOSS S.p.A. 314g
UPM Biomedicals 271
Mölnlycke Health Care 245b
VIATRIS 322
NATROX® Wound Care 261
VistaCare Medical 277
ON CALL SOLUTIONS INTERNATIONAL CV 372
Vulnamin 246a
NOVENTURE SL 202
Wacker Chemie AG 213
Omnidermal Biomedics s.r.l 390
Walgreen Health Solutions 205
OTR3 326
POSTERS
Welcare Industries S.p.A 242
Perfectus Biomed Group 275
WINNCARE 212
Piomic Medical AG 391
Winner Medical Co.,Ltd 203
Pixacare 375
WoundEl Health Care 364
PLASTOD SPA 371
Wounds International 314b
PolyNovo UK Limited 274
SATELLITE
SYMPOSIA
SPONSORS &
EXHIBITORS
91
92
EXHIBITION OVERVIEW
LEVEL 2
TO TO
SESSION SESSION
ROOMS ROOMS
268
Milliken 260
Healthcare Spincare
267 (Nanomedic Technologies)
266 261
Gunze NATROX®
Arjo 265 264 262
263 Wound Care
France Emoled BDK FB
imito
Medical Dermotology 278
Medaxis
205
Walgreen Health 270
201
Solutions Adtec
RedDress Healthca
re 277
VistaCare
205a 241b 271
UPM Medical
Freudenberg Performance 202 AROA
Materials Noventure 240 241 Biosurgery Biomedic
als 276
ConvaTec 243 Smith & 245 257
3M Cerdak 280
URGO Nephew Ferris 245b 272 medi
Manufacturing Mölnlycke Biovotec
Corp. – Health
203 275
Manufacturers Care
211a 211 210 Winner 285
of PolyMem 273 Perfectus 284
WoundEl curea MedCu Medical Biomed Axio
Health medical 241a BenQ Fibroline
DEBx Medical 274 Biosolutions
Care 207
Materials
PolyNovo
Essity
UK
216
212 Elkem 292 291
Les Laboratoires Advancis 286
Winncare Silicones 246a
242 Brothier Medical CONFORT
Vulnamin 293
Welcare Industries 298 290
246 297 ActivCell 287
214 Exhibitor Cook Integra
Abigo Kerecis 246b
Gergonne Group AG Molteni
213 Service Biotech
Regen 289 Farmaceutici
Wacker 294
Chemie 244 Lab Drawtex BAP
235 Medical 288a
Thuasne
234 FIDIA 236 296 Flen
Lohmann & FARMACEUTICI Coloplast 248 252 295 288
217 Rauscher IBSA Datt Grapheal TC L-Mesitran Health
S.p.A. ROOM MAILLOT TRANS-
Laboratoires PHARMA Mediproducts
HARTMANN CONTINENTAL
255
CAFÉ Advanced Oxygen Therapy
CAFÉ
222 222a 224 226 227 228
225
MIMEDX LABORATOIRE Argentum L’Oreal Fluidnatek Laboratoire Medline
SVR Medical by Bioinicia Bioderma INTERNATIONAL
EXHIBITION OVERVIEW
LEVEL 3
TO TO
SESSION SESSION
ROOMS ROOMS
AND FRENCH AND FRENCH
PAPER POSTERS PAPER POSTERS
328
AIUC
327
AISLeC 373
Genedyne
14
314a 3 C
JW HEALTH R2
C
EPUAP SOLUTIOARE
314d 370 NS
14c Cica 326 374 375
314b 3 c. Bio- ROOM HAVANE AVANEO /
u n d s So ica l O TR3 SPEAKERS EKABIO
Pixacare
301 W o m e d 377
a ti o n a l TV LOUNGE 371 3
Graphic Intern e 314g ACTO 76
Packaging 314 f 314 MOSS 322 Plastod GmbH CF Pharma
International LimbO eKare V ia tris
of 372
301a Waterpro rs
378 3
Protecto 320 ON CALL SFFPC 79
Covestro 318 sma Beiersdo
rf
ea SOLUTIONS
Prote x H lthcare terrapla l
dica 381 38
7 m e 392 391 SoftOx 0
16 31 ra 390
315 3 Hydrofe T-MED Piomic Omnidermal Solution CoopMed
n A T D s Exeld
erma
C h emviro a Medical Biomedics
304 Cloth emold
302
Métanoïa Division
MESI
Sante
305 E-poster
ISPEW/ISCU screen 1
340 CAFÉ
305a
Levabo
DEBRA
305b 341
Médecins Ten Bio
Sans
Frontières ROOM BORDEAUX
E-POSTER
E-poster
screen 2
SEATING
93
SPONSORS & SATELLITE DETAILED PROGRAMME
POSTERS SESSIONS INFORMATION
EXHIBITORS SYMPOSIA PROGRAMME OVERVIEW
Joachim Dissemond
Knut Kröger
Initiative
Chronische
Wunden e. V. (eds.)
CHRONIC WOUNDS
Diagnostics – Therapy –
Health Care
1st edition: published 04/20/2021 / 408 pages, 200 coloured images /

cardboarded / € (D) 59,00 / ISBN 978-0-7020-6762-4
ORDER NOW!
icw-shop.de
You can ﬁnd the table of

contents and a sample
chapter in the shop or
simply scan the QR code.
FOR ORDERS
OUTSIDE THE EU:
Please send us an e-mail to
shop@icwunden.de
96
97
THANK YOU TO OUR SPONSORS
WIFI Sponsor Conference bags

kindly sponsored by kindly sponsored by
Web-app sponsor
kindly sponsored by Water Bottles
kindly sponsored by
Pocket Program
Lanyards kindly sponsored by
kindly sponsored by
98
CORPORATE SPONSORS
A-SPONSORS
MEDICAL DEVICE INDUSTRY CONSULTING

Americas Europe Asia
B-SPONSORS
LAYOUT & PRINT: KAILOW GRAPHIC · DENMARK 2022

EWMA2022 Programme

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

EWMA2022 Programme

Uploaded by

Copyright:

Available Formats

THE JOINT EWMA

ORGANISATION OF CARE, PATHWAYS

VIEW THE CONFERENCE WEB-APP

GO DIRECTLY TO THE WEB-APP

EWMA-CICA 2022 web-app kindly sponsored by

DEAR PARTICIPANT, About SFFPC 7

Theme of the EWMA-CICA 2022 Conference is: E-poster sessions and

During these three conference days, we will dedicate a

We wish all conference participants a very pleasant and

Sebastian Probst, Luc Téot,

Share your experiences and thoughts

Members of EWMA receive a 10 % discount for the course.

The course is endorsed by EWMA

Philippe Léger, Médecin vasculaire, Toulouse

EWMA SECRETARIAT CONFERENCE HOURS

The web app is kindly sponsored by URGO. BADGES

WiFi name: EWMA-CICA freeWIFI_by Molnlycke CURRENCY

PRINT YOUR CERTIFICATES PRESENTER AWARDS

THE 33RD CONFERENCE

WOUND CARE – FROM ART TO SCIENCE

porte Neuilly 3 foyer lobby porte Paris 1

porte Maillot 3 porte Maillot 2 porte Maillot 1

Escalator Lift Toilets Pharmacy Cash point

236M 251 241 226M

Hall Maillot 204

Escalator Lift Toilets Recharge mobile

For exhibtion floor plan see page 92.

Speakers prep room

Escalator Lift Toilets Recharge mobile

For exhibtion floor plan see page 92.

12:30- Industry Sponsored Industry Sponsored Industry Sponsored

BORDEAUX 342AB 241 251 243 343 212-213

Module 7 : Module 8 : Module 9 : Module 10 : Module 11 : Communications Communications

sponsorisé par sponsorisé par sponsorisé par management in Association

12:30-13:30: e-Poster sessions: Negative Pressure Wound

13:45-14:15: e-Poster sessions: Wound Assessment (screen 1), 13:15-14:30

BORDEAUX 342AB 241 251 243 343 212-213

Module 12 : Module 13: Module 14 : Module 15 : SPE01 : Communications Module 16 :

BORDEAUX 342AB 241 251 243 343 212-213

Module 22 : Module 23 : Module 24 : Module 25: SPE03 : Module 26 :

SPE04 : Module 28 : Module 29 : Module 30 : Communications Module 31 : Communications

BORDEAUX 342AB 241 251 243 343 212-213

Module 32 : Module 33 : Module 34 : Module 35 : SPE05 : Communications

Symposium satellite Symposium satellite Symposium satellite Industry Sponsored

Module 41 : Module 42 : Module 43 : Module 44 : Communications Module 46 :

Module 47 : Module 48 : Module 49 : Module 50 : Communications Module 51 : Communications

09:30-10:00 EWMA-CICA 2022 Opening Ceremony ( ) Amphitheatre

Crossing the red sea of the Covid-19 pandemic

Opening through the VWHA President

11:45-13:00 e-Poster Session and display: Dressings e-Poster

12:30-13:30 Industry Sponsored Satellite Symposium ( ) Amphitheatre

12:30-13:30 Industry Sponsored Satellite Symposium ( ) Room Maillot

Saving tissue in complex wounds using complementary techniques

Raymund E. Horch, Germany

Strategies in war tissue salvage

3 biggest mistakes of my career 1: Inflammatory ulceration

Offloading in the Diabetic Foot

Laser treatment of open wounds: what does it add?

15:30-16:30 e-Poster Session and display: Diabetic Foot e-Poster

15:30-16:30 Industry Sponsored Satellite Symposium Room Maillot

Welcome to the 25th anniversary of the VWHA

AI for a better diagnosis of chronic wounds

16:45-18:00 Free Paper Session: Basic Science Room Havane

DEAR PARTICIPANT, About SFFPC 7

12:30-13:30: e-Poster sessions: Negative Pressure Wound

13:45-14:15: e-Poster sessions: Wound Assessment (screen 1), 13:15-14:30

15:30-16:30 e-Poster Session and display: Diabetic Foot e-Poster

15:30-16:30 Industry Sponsored Satellite Symposium Room Maillot

16:45-18:00 Free Paper Session: Basic Science Room Havane

10:00-11:00 Industry Sponsored Satellite Symposium ( ) Amphitheatre

10:00-11:00 Industry Sponsored Satellite Symposium ( ) Room Maillot

12:30-13:30 e-Poster Session and display: Leg Ulcers e-Poster

13:15-14:30 G-ScarS Guest Session Room 351

13:30-14:30 Industry Sponsored Satellite Symposium ( ) Room Maillot

13:45-14:15 e-Poster Session and display: Burns e-Poster

08:30-09:30 Journees CICA Session: Plenary session No. 2: Persistent wounds ( ) Amphitheatre

08:30-09:30 Cooperating Organisations Session: Room 352A

08:30-09:30 Journees CICA Session: Module 32: Peristomal skin complications ( ) Room

13:30-14:30 Key Session: New technologies in Tissue Replacement ( ) Amphitheatre